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ABSTRACT 
The national identification of high performing providers in surgery is of prime 
importance to patients, surgeons and commissioners of healthcare. This thesis 
explores how high performance is identified, defined and measured nationally and 
attempts to identify the factors that underlie high performance in colorectal cancer 
surgery during the peri-operative period. 
An introduction into the determinants of high performance in surgery as well as 
defining quality as it pertains to surgery is then undertaken. Identification of 
available national data sources and metrics for national performance are then 
identified. Comparison is made between voluntary and compulsory reporting 
systems highlighting greater capture of peri-operative mortality in compulsory 
reporting datasets.   
A novel marker that reflects outcome following complication management is 
developed. This marker is based on re-operations and is derived from compulsory 
reporting datasets. The use of non-operative re-interventions is then assessed in 
oesophago-gastric cancer resections as proof of concept. An appraisal of all 
colorectal cancer units in England is then undertaken using a panel of metrics 
demonstrating that analysis on a single marker alone may be too simplistic. 
Identifying factors that pertain to high performance beyond those available from 
routinely available datasets using a novel methodological approach called HiPer 
(High Performance) is performed. The interview based methodology identified rich 
qualitative factors in a group of colorectal cancer units worldwide that may be 
causal in their performance status.  
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Finally, results from the interview study were related to hard outcome data from 
each unit which demonstrated some correlation between the HiPer methodology 
and the outcome data in the final section of the feasibility study. The implications 
of this may be that a dual approach of analysing routinely collected data with a 
more qualitative HiPer style methodology may help us better understand how high 
performing units achieve their results. 
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1.0 WHY SEEK OUT HIGH PERFORMANCE IN 
SURGERY? 
 
1.1 Chapter overview 
This chapter sets the context for the thesis by identifying why it is of value and 
necessary to identify high performance in surgery. Previously demonstrated 
variation in surgical outcome across different specialities and the consequences of 
such variation are discussed. The definition of high performance in the context of 
the quality of surgical practice then follows.  
 
1.2 High performance in surgery 
In healthcare it is paramount to ensure firstly no harm is done, but secondly, that 
any interventions undertaken serve our patients well. By identifying outcome 
differences following surgical intervention, it may be possible to understand the 
causes of such variability. Where the variation is undesired, recognition could lead 
to efforts to improve it. When taken into the context of the estimated 234 million 
major surgical procedures undertaken each year world-wide (Weiser et al., 2008) 
any marginal improvements in outcome that are adopted, may potentially benefit 
large numbers of patients.  
 
1.4 Defining High Quality in surgery 
The need to achieve high quality service provision within healthcare is a global 
desire. The term quality will be attributed to more qualitative aspects of care and 
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performance will be used to reflect those aspects of care that are traditionally more 
easily measured- so called quantitative aspects. Prioritisation of ‘quality’ as a 
central theme in future healthcare planning in the United Kingdom has been 
demonstrated recently by an influential government report entitled ‘High Quality 
Care for All’ (Crown, 2002). Universal healthcare improvement initiatives, such as 
the development of a pre-operative surgical checklist by the World Health 
Organization, further reflect the contemporary global commitment to prioritising 
high quality care within surgery (Haynes et al., 2009).  
Having a clear definition of what quality in surgery means as well as how to 
measure it, are pre-requisites for improving surgical standards. Although it is 
accepted that service providers should strive to improve quality, what exactly does 
quality mean to surgeons and their patients? Previous attempts have been made to 
define quality markers in surgery and specifically in colorectal cancer surgery by 
using qualitative research  methodologies ( McGory et al., 2006).  
Delivery of quality care 
Having understood what the elements of quality assessment may be, it is natural to 
try to understand how such quality is delivered in practice. Maxwell in his 
influential paper: “Quality Assessment in health”, outlines six dimensions of health 
care quality. Recognition and measurement of his proposed six dimensions are 
necessary to prove to stakeholders whether a service represents quality care or not 
according to him.  
 
 
 
 
 
 
 
Table 1- Table summarising Maxwell's Six dimensions 
 Access to services 
 Relevance to need (for the whole community) 
 Effectiveness (for individual patients) 
 Equity (fairness) 
 Social acceptability 
 Efficiency and economy 
Maxwell’s Six dimensions from Quality in Health, RJ Maxwell, 
BMJ 12/5/1984 
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Maxwell when critiquing the delivery of healthcare asked the questions of 
whether patients had access to care wherever and whenever they needed it. Do 
all patients with similar needs get the same care?  Plus ensuring that the care 
they receive is acceptable to them. Furthermore, does the care that is provided 
to them do what it is intended on doing and at a reasonable cost with minimal 
waste? Finally, is the care received and delivered sensitive and appropriate 
when considering the need of the whole community? Not only does an 
appreciation of Maxwell’s dimensions help us understand delivery of 
healthcare but it also allows us to understand variability in such delivery. If a 
quality standard is set, variability beyond certain thresholds from this may 
represent exceptional or sub-optimal care. 
 
 
The Institute Of Medicine (IOM) produced six domains of quality care that 
should be sought in an ideal healthcare system. These six domains are listed 
below- 
 
Table 2- The Institute of Medicine domains of quality 
Safety Minimizing medical errors and adverse 
events 
Effectiveness Maximizing intended health outcomes 
Patient-
centeredness 
Focusing on patient and family 
comprehension, preferences, goals and 
priorities in making treatment decisions 
Timeliness Minimizing delay between onset of illness 
and initiation of treatment 
Efficiency Providing maximally cost-effective care 
Equity Providing care of equal quality regardless of 
gender, ethnicity, region, socioeconomic 
status or insurance coverage 
 
With respect to surgery, each of these domains is indeed very relevant to the 
pursuit of high quality care. Ensuring that patients that require operations receive 
the correct operation at the correct time, irrespective of location or socioeconomic 
status, and without complication is vital to ensuring the best outcome possible. 
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Therefore Maxwell’s domains in part are just as relevant to surgery as they are to 
wider healthcare systems. 
 
 
1.4.1 Defining and measuring quality in surgery 
The National Institute of Medicine in the United States (US) defines quality as the 
‘degree to which health services for individuals and populations increase the 
likelihood of desired health outcomes and are consistent with current professional 
knowledge’ (Institute of Medicine, 1990). Importantly, this definition recognises 
the importance of the structural factors and surgical service processes that may 
enhance the likelihood of achieving positive outcomes. Furthermore, emphasis 
upon contemporary practice is echoed within the definition.  
 
In the United States (US) the Agency for Healthcare Research and Quality defines 
a quality measure as ‘a mechanism that enables the user to quantify the quality of a 
selected aspect of care by comparing it to a criterion’ (Center for Health Policy 
Studies, 1995). According to Bergman and colleagues an ideal quality metric 
should be universally relevant to clinicians, decision-makers and patients 
(Bergman et al., 2006). Moreover, as suggested by Mayer and co-workers (Mayer 
et al., 2009b), a structured quality framework should incorporate both clinical 
pathway measures and patient reported outcomes. The former objective measures 
are arguably of greater relevance to clinicians whilst the latter subjective measures 
perhaps better reflect the patient perspective. Furthermore, metrics must be able to 
discriminate between good and poor quality and should also be resilient to 
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‘gaming’ - i.e. achieving apparent quality improvement through chasing targets 
rather than through genuine quality improvement (Smith, 1995).    
Thus defining quality in surgery would acknowledge each of these factors. 
Demonstrable timely assessment/intervention using evidence based foundations 
that improve a patient’s health status in a manner acceptable to patients would 
represent a generalised proposed definition of quality in surgery. High quality 
would be the demonstration of the above factors reproducibly and with minimal 
variation given presenting case-mix. 
 
1.3 Variation in practice and surgical outcome 
Variation in practice and outcome occurs throughout healthcare. Taking the most 
commonly performed procedure in emergency surgery- the appendicectomy, this 
seems to be the case. Worldwide circa 5-10% of patients undergoing emergency 
open appendicectomy may develop a superficial wound infection (Shaikh et al., 
2009). The practice of open removal of the appendix has been fairly standardized 
from its first description in 1735 by Claudius Amyand. This being the case, why is 
there a twofold difference in this outcome? If outcome can differ by such a 
magnitude for a procedure that most would agree is performed in a standardized 
fashion almost universally, what is expected from more complex procedures? An 
attempt to understand how and why such variation occurs is thus a critical 
precursor to understanding high performance in surgery. 
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1.3.1 Variability in tonsillectomy rates in England 
The first published description of surgical variation has been attributed to and 
demonstrated by James Allison Glover (1874-1963). In 1938 he demonstrated a 10 
fold variation in tonsillectomy rates in England, United Kingdom (Glover, 1938). It 
has been reported that it was only when Glover formally published his findings that 
variability in surgical practice was formally recognized in the literature. More 
striking than the procedural variation was the 8 fold difference in risk of death that 
Glover also identified across the nation.  
Glover noted that despite similar age and sex demographics, children in more 
affluent areas were three times more likely to have undergone tonsillectomy. The 
findings also uncovered that diametrically opposite rates often occurred in 
neighboring counties which were unexplainable at the time. However what Glover 
postulated was that the differing rates were more likely to be a function of 
physicians’ decision making and beliefs than actual clinical need. Whilst some 
degree of variation is expected due to differing populations, presentation and 
natural disease course, the notion of unwarranted variation is central to 
understanding why variation in outcome is important to improving patient 
outcomes. In the former example, unnecessary procedures would have also 
subjected the children to the associated morbidity of surgery and risk of death, 
without apparent clinical benefit. Such an example highlights why the study of 
unwarranted variation is important. 
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1.3.2 Mortality in US Cardiac centers 
In 1987 hospital level coronary artery by-pass graft rates (CABG) were published 
by the Health Care Financing Administration (HCFA), the then administrator of 
the national Medicare program in the United States of America (USA). This 
document highlighted wide variation in outcome from CABG procedures 
(Publication, 1986). This led a group of cardiac surgeons and epidemiologists from 
New England (USA) to undertake a prospective audit of their results as they were 
convinced their outcomes (which were worse than the national median) were 
attributable to them operating on a more co-morbid population that had not been 
properly accounted or ‘adjusted’ for by the HCFA report. In 1991 the results of the 
participating 5 hospitals were published in the Journal of the American Medical 
Association (JAMA) and the authors concluded- 
“the observed differences in in-hospital mortality rates among institutions and 
among surgeons in northern New England are not solely the result of differences in 
case mix as described by these variables and may reflect differences in currently 
unknown aspects of patient care” (O'Connor et al., 1991). 
In other words the authors are describing a scenario where they believe their 
outcomes are not expected given the patients and the pathology that presented to 
their service. Their outcome lay outside the expected control limits and hence 
required further investigation. This seminal piece of work identified that the study 
of populations can reveal unwarranted variations in surgical outcome. 
 
 
1.3.3 Dartmouth Atlas 
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At the same time, in the United States what is now known as the Dartmouth Atlas 
of Healthcare was being devised with the arrival of John E. Wennberg to 
Dartmouth College. The Dartmouth Institute as it later became known began to 
publish outcome data by common medical and surgical conditions and by region of 
the United States. The purpose of this undertaking was to unmask any variation in 
practice and outcome in the country (College., 1996) in healthcare in general. 
Broadly the findings of the atlas demonstrated wide variation both in the 
procedures performed for matched pathologies but also in hard outcome measures 
across most specialties and procedures examined. More specifically, in its first 
edition several surgical procedures were analyzed. In particular with respect to 
breast surgery the atlas uncovered significant variation in the use of breast sparing 
surgery versus more radical surgery. It was discovered that the proportion of 
women undergoing breast sparing surgery varied by a factor of 33 across the 
United States from the examined Medicare patients. Looking at another surgical 
procedure from the same report it reported a greater than ten-fold difference in the 
rates of radical prostatectomies (0.6 to 7.0 per thousand men) after adjusting for 
differences in age and race. As Glover surmised, the differences in such rates in the 
US were not attributable to any conceivable factors at the time. It was becoming 
apparent that even in advanced healthcare systems great variability occurred 
without apparent causality given the presenting populations and pathologies. For 
this reason a pressing need developed to understand why such variability existed. 
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1.3.4 Variation in Abdomino-perineal excision rates in England 
A contemporary English study by Morris and colleagues looked at the differences 
in Abdomino-perineal excision rates (APER) for rectal cancer in England using 
routinely collected data (Morris et al., 2008). Rectal cancer can be treated using 
two main surgical methods. Excision of the tumour and maintaining intestinal 
continuity at the same or subsequent procedure is termed an anterior resection. 
Excision of the tumour and anus and leaving an end stoma is termed an Abdomino-
perineal excision (APE). Tumours that are too close to the anus are not amenable 
to salvaging the anus to maintain oncological clearance. The study demonstrated 
variation in the use of APE resections ranging from 8.5% to 52.6% by hospital 
Trust from 1998 to 2004 (Morris et al., 2008). The recommended target figure by 
national bodies is 30% (ACPGBI). Although this initial study did not take into the 
height of the tumour above the anal margin (a key consideration in determining 
operative approach) or case-load, the findings were still of relevance to questioning 
contemporary colorectal practice. Subsequent analysis by Morris on a sub-group 
(only Trusts in Northern & Yorkshire Regions) demonstrated that units with higher 
APE rates were also those operating on tumours higher up in the rectum (with a 
correlation co-efficient of 0.71). Clinically it would be expected that lower tumours 
would be considered for the more radical APE procedure. The sub-group analysis 
goes against expected and recommended practice and supported initials calls that 
further investigation was warranted (Morris et al., 2008). 
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1.3.5 Atlas of variation England 
More recently in England, routinely collected data have been the basis of a 
department of health initiative entitled The Atlas of Variation (Care., 2010). This 
report first published in November 2010 described its purpose as demonstrating 
“variation and the utilization of health care services that cannot be explained by 
variation in patient or patient preferences” in England. The atlas uncovered some 
38 fold variation in the use of bariatric surgical procedures across the country. 
Some two fold difference in the undertaking of cataract extraction surgery and 30 
fold differences in primary hip replacement; all standardized for the catchment 
populations they represented in England. These figures and the magnitudes of 
differences are clearly undesirable in an equitable health care system. However, 
although the variation in processes in the examples given may be worrying, apart 
from the cardiac surgery audit from New England, outcomes have not been 
demonstrably affected by similar magnitudes. This asks the question of whether 
variability in the number and type of procedures undertaken is relevant if 
seemingly little outcome differences exist nationally. 
 
1.3.6 Bristol Paediatric Cardiac Surgery 1984-1995 
Between 1991-1995 the post-operative mortality rate for children undergoing 
cardiac surgery aged less than one was twice the national average with a greater 
difference observed for babies under the age of 30 days at Bristol Royal Infirmary. 
Criticism has come from the delay in recognizing such variation in outcome. The 
number of procedures and volumes in themselves were not worrying. In the official 
report to the events at Bristol, it was noted that nationally comparable data existed 
in the form of Hospital Episodes Statistics (HES) from 1990 and “it was not 
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recognized as a valuable tool for analyzing the performance of hospitals. It is now, 
belatedly” (Health.). This is just one example whereby variation in outcome if 
recognized should have led to further investigation into practice and may have 
prevented unnecessary deaths. This takes us on to consider whether outcome 
variation is indeed a relevant marker of quality. It is seen from the subsequent 
enquiry into the failings at the Bristol Royal Infirmary several recommendations 
were set out. Of relevance these included- 
1. There must be a single, coherent, co-ordinated set of generic standards: that is, 
standards relating to the patient's experience and the systems for ensuring that 
care is safe and of good quality. 
2. The monitoring of clinical performance at a national level should be brought 
together and co-ordinated.  
3. The new system should provide a mechanism for surveillance whereby patterns 
of performance in the NHS which may warrant further scrutiny can be 
identified as early as possible. 
4. At national level, the indicators of performance should be comprehensible to 
the public as well as to healthcare professionals. They should be fewer and of 
high quality, rather than numerous but of questionable or variable quality. 
5. The Hospital Episode Statistics database should be supported as a major 
national resource which can be used reliably, with care, to undertake the 
monitoring of a range of healthcare outcomes (Copyright, 2001). 
The points highlighted from the enquiry into the failings at Bristol are very salient 
to understanding why measurement of variation in healthcare and specifically 
surgery is important. The final report identified that national measures of 
performance should be used to identify any unwanted variation in practice. 
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Furthermore they identify the HES database as a potential tool for taking this 
forward.  
In order to identify variation there must be some appreciation of a high performing 
unit/department with which to set benchmarks. How or where are such units 
identified? Whilst it is seen that variation in surgery is inevitable, each patient is 
unique, as is the pathology, when case-mix differences are accounted for it would 
be expected that outcome should be predictable. For example, a unit that only 
operates on recurrent rectal cancers would, it is expected, have differing outcome 
form those operating on primary early cancers. However, when the aforementioned 
units are compared to similar units as themselves undertaking similar case-load and 
case-mix, it would be expected that variation between such similar units be 
minimal if there is equity in the care delivered. Thus, the extent of acceptable 
variation may be different for each type of unit dependent on the presenting 
workload.  
However, in surgical practice variation in outcome is not necessarily inevitable. 
There are centers of surgical excellence around the world and better understanding 
how they deliver their care and achieve their results would be a natural starting 
point. 
 
1.4 Excellence in practice and surgical outcome 
Whilst it may seem that given inevitable variation in patients presenting health 
status- for example body mass index, co-morbidities and presenting degree of 
severity of illness, outcome variation is inevitable too. However there are centers 
that despite such variation report consistent high quality outcome. By looking 
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further at an example of such a unit it may be possible to further elucidate how 
such results are achieved. 
 
1.4.1 The Shouldice Hospital, Canada 
One unit that is unequivocally regarded as a center of excellence and high 
performance is the Shouldice Hospital in Canada. This hospital was founded in 
1945 and is the unquestionable world leader in primary inguinal hernia repair in 
terms of outcome. The hospital employs 150 people and has a greater than 99.5% 
success rate in repair. They report having the lowest recurrence rates in the world 
for the past 65 years (Hospital, 2012). Operating surgeons are required to 
undertake >700 cases per year. Patients are offered diet, weight loss advice and 
massage therapy to optimize their outcome. All patients have the same assessment, 
local anaesthetic operations without a mesh and where possible undertaken in 
exactly the same fashion every time. They are immediately given an exercise 
routine and asked to mobilise and encouraged to do so. The care is not limited to 
the operative procedure itself but Shouldice pride themselves on a standardized 
care package where the post-operative care is as important as the pre- or inter-
operative care. In terms of cost, a surgeon and healthcare commentator Atul 
Gawande reported that most hernia repairs cost in the region of $4000 in the US 
compared to the $2000 at the Shouldice hospital. The key to the success he 
reported was the automation associated with dealing with unfamiliar situations. 
Most general surgeons will not do as many hernia repairs in their life-time 
compared to one to two years as a Shouldice surgeon. As a result Gawande argues, 
“Shouldice surgeons are more familiar with how things should look and any 
deviations are immediately apparent to them” (Atul Gawande, 1998).  
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Perhaps what favours the Shouldice clinic is not only the volume of similar work 
undertaken but also the whole patient pathway relies upon standardization of care. 
Whilst this level of standardization and outcome is immediately attractive, some 
degree of patient selection is likely to be undertaken; but this is supposition as such 
data are not publically available. Arguably, although there is no published 
evidence, patients may be selected for their likelihood of success. What is known is 
that obese patients are counseled and asked to lose weight before being offered 
surgery and more complex procedures are not undertaken by the unit. This reflects 
to some degree the selection process that is known about with respect to the 
Shouldice hospital. 
Whether such a level of standardization is possible in a national health service is 
debatable. An obese patient that is reportedly house bound and unable to engage in 
exercise because of hernia associated pain is a difficult patient to refuse despite the 
increased risk of recurrence and perioperative morbidity. Furthermore, whilst using 
the Shouldice clinic as the exemplar of high performance in the setting of elective 
hernia repair, comparative centers of excellence are arguably more difficult to 
identify when moving to more complex and varied procedures.  
 
1.5 Summary of chapter 
In this chapter it has been demonstrated how variation in both procedures and 
practice occurs in surgery. This is not always attributable to the presenting 
demographics of the population. By analysing those units of excellence and high 
performance and learning from their methods and systems, it may possible to 
reduce unwanted variation in healthcare systems if these prove to be applicable 
more widely. However, what remains to be identified is how to identify such units 
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and what measures should be used for the comparisons? This is the next 
fundamental question and what follows is an appraisal of what exactly does 
surgical quality and high performance mean in the context of what is measureable. 
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2.0 MEASURING QUALITY/HIGH PERFORMANCE 
IN SURGERY 
2.1 Chapter overview 
In this chapter conceptual frameworks for assessing and measuring quality in 
healthcare are visited. These will firstly consider Donabedian’s structure-process-
outcome paradigm. A detailed analysis of each of these components is generically 
made with respect to its application to surgical practice. Following on from this, it 
is appreciated that the Donabedian paradigm does not capture some of the more 
qualitative elements that may be important to consider, such as team-work and 
leadership. These types of factors are considered by introducing Lilford’s concept 
of intervening variables, which highlights factors such as teamwork and leadership 
which are potentially important determinants of surgical outcome. 
 
2.2 Donabedian Structure Process Outcome 
A paradigm that serves as a useful means of categorising and understanding quality 
in healthcare is the Avendis Donabedian 1919-2000, structure-process-outcome 
approach (Donabedian). An Armenian General Practitioner in Jerusalem who 
subsequently moved to the United States to take up a post as a Public Health 
Professor is credited with providing a framework for understanding quality 
appraisal in healthcare systems. Shortly after joining the University of Michigan, 
Donabedian was given the role of revising and clarifying contemporary writings on 
quality assessment. By summarizing every article in press at the time on small 
index cards, Donabedian realized some common themes. These common themes 
provided the framework around which the quality of medical care could be 
40 
 
understood and his proposition that quality of care could be considered using the 
mantra of structure-process-outcome. His seminal work entitled: “Evaluating the 
Quality of medical care” was published in 1966 in the Milbank Memorial Fund 
quarterly and to this date is one of the most cited scientific articles of its century 
(Donabedian, 1966). He proposed a methodology for systematically assessing a 
healthcare system and its constituent components for the purpose of better 
understanding it. This approach has given a framework for many social scientists 
to develop a way of understanding and attempting to measure quality in practice 
within a healthcare setting.  
 
2.3 Structural measures 
Structural measures are relatively straightforward to measure and quantify. They 
tend to relate to the physical resources of an institution, be they human- as in staff 
numbers and experience and specialty- to availability of equipment and equipment 
for investigations. They tend to change very little with short to medium timeframes 
and thus measurements can be discretely performed rather than continuously. 
Structural measures can include anything from submission of data to outcome 
registries to the volume of cases undertaken by surgeons and units - these specific 
factors will be considered in greater detail in the subsequent chapter. 
 
 
2.4 Process measures 
Process measures reflect the actions by the medical teams that engage the patient 
directly. Donabedian in his summary regarding process measures concluded that in 
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their description they may be better suited to answering the question of “whether 
medicine is properly practiced”.  These measures are now common place in use as 
quality indicators. Measures include the use of thrombophrophylaxis in surgical 
patients and antibiotics for wound prophylaxis at surgical induction and these are 
also substantiated with a large body of clinical evidence including many 
randomised clinical trials and meta-analyses (Gomez-Outes et al., 2012, Nelson et 
al., 2009, Sanabria et al., 2007). The attraction of using process measures is in part 
due to the relative ease in which interventions can be implemented or omitted and 
duly any outcome differences be purportedly related to the change. There is also 
evidence whereby implementation of process measures has led to quality and 
outcome improvement specifically in the use of perioperative beta-blockers. In the 
highly cited study perioperative cardiac outcome of patients was improved with 
appropriate instigation of blood pressure control versus those that did not have this 
process instigated (Mangano et al., 1996). This caused a paradigm shift at the time 
in anaesthetics.  
 
2.5 Outcome measures 
Outcome measures are the least challenging to understand and many identify their 
measurement as robust and transparent irrefutable evidence of quality. This notion 
is usually too simplistic. Traditionally outcome measures have been the measures 
used to understand performance of hospitals and compare institutions.  
Outcome measures can be thought of as what actually happens to the health of the 
patient - the outcome - as a result of the treatment and care they receive. The recent 
government white paper ‘Liberating the NHS: Transparency in outcomes – a 
framework for the NHS’ states that “at a national level the focus and accountability 
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should, as far as possible, be centred around the outcomes of care” (Health, 2010). 
The report states the benefits of outcome reporting- 
1. will allow accountability of healthcare commissioning and ultimately “a 
mechanism by which the Secretary of State can hold the new NHS 
Commissioning Board to account for securing improved health outcomes for 
patients through the commissioning process".  
 
2. are intended to “act as a catalyst for driving up quality across all NHS 
services” and not for punitive performance comparisons.  
 
Now whilst clearly each of the individual components of the Donabedian triad are 
important factors they each have individual qualities that are unique to them. By 
better understanding these qualities it allows us to see how they might be applied to  
a surgical system. 
 
2.6 Characteristics of structure, process and outcome measures 
What follows is a more in depth appraisal of the characteristics of the Donabedian 
triad of proposed measures. Each of these measures has a unique place for 
assessing and appraising healthcare systems and a greater understanding of these 
follows with specific reflection on their applicability to surgery. 
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2.6.1 Characteristics of structural measures 
Structural measures are the readily calculated and collated factors, such as number 
of nurses and nurse-patient ratios or the availability of resources, such as CT 
scanners and operating theatres. These measures share common characteristics. 
 Efficiency: one structural measure may be shown to impact on numerous 
outcome measures. This may be true across surgical specialties as well. This 
may make the argument for investing in improving such a measure as having 
widespread benefit. For example, the number of operating theatres can give an 
idea of the capacity of a unit and potential throughput. This would apply across 
many surgical specialties if the theatre usage is shared, as is commonly the 
case. The specialist skill set within an organization and specifically within a 
speciality can give insight into the potential standard of care received for that 
individual speciality. For example, a colorectal unit with a dedicated specialist 
nurse in colorectal cancer and specific multi-disciplinary cancer meetings with 
dedicated oncologists, radiologists and pathologists would reflect intention of 
delivering a high quality service (if nothing else). Thus structural factors can 
give insight into wider surgical capability across an institution as well as more 
refined aspects within a certain specialty and the slight temporal change makes 
analyzing such factors attractive. 
 
 Expediency: many of these measures can be very quickly assessed and 
measured due to the fact they change infrequently. Furthermore such data are 
usually held by institutions or centrally without the need for extra resources to 
calculate.  
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 Actionability: few structural measures are readily and easily changed. This 
may make their use of academic importance without being practically 
actionable to improve results. For example, a chief executive looking to 
improve outcome in one department will no doubt have difficulty appointing a 
slew of new specialist staff and equipment and realistically expect immediate 
returns. 
 Discrimination: crudely measuring structural measures may not discriminate 
between individual surgeons or teams. In other words there may be several 
departments in the hospital that share the same structural measure e.g 
interventional radiology. However, where one team does not appropriately 
make use of this facility or indeed uses the facility too late in the patient 
pathway, simply the presence and availability of this structural resource may 
not impact on the performance of the unit. Thus simply the presence of a 
structural measure such as intensive care beds or out-of hours endoscopy 
services may not reflect good care if they are inappropriately utilized. 
Importantly, structural measures tend to be the most difficult to influence and 
change. It has been noted though that structural measures are useful for setting 
minimum standards (Cooperberg et al., 2009).  
 
Structural measures can be informative and be useful as predictors of future 
outcome. In the example given below structural measures have been shown to be 
more predictive of a unit’s outcome in the future than relying on historic outcome 
data. The graph below shows units undertaking pancreatic (top graph) and 
oesophageal resections (bottom graph) in the USA. It shows in both instances 
previous risk adjusted mortality (2005-2006) poorly predicted which hospital will 
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go on to to perform well in subsequent years (2007-2008). However in both 
instances hospital volume showed a monotonic effect in predicting performance. 
Graphs redraw using data and graphs taken from Performance management in 
Surgery for ACS Surgery, Dimick & Birkmeyer [book chapter]. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Relative ability of historical (2005–2006) measures of hospital volume and risk-adjusted 
mortality to predict subsequent (2007–2008) risk-adjusted mortality in US Medicare patients. (a) 
Pancreatic resection. (b) Oesophageal resection percentages shown. 
 
If used in this manner they can be extremely useful in guiding what criteria, from 
minimum volume of cases required to re-certify a specialist to the minimum levels 
of staffing required to operate a safe emergency surgical service.  
Pancreatic Resections 
Oesophageal Resections 
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2.6.2 Characteristics of process measures 
Process measures are the procedures that are actually undertaken by a unit or 
institution to achieve its results. These can reflect almost any aspect of a healthcare 
interaction from pre-operative optimization of patients to the way patients are 
intra-operatively monitored. As with structural measures, these also share some 
common characteristics. 
 
 Relationship: their use may be easily related to outcome measures. When 
attempting to identify the impact of use, samples of patients can undergo the 
intervention process and another control group can be compared. Assuming all 
other factors are equal, the benefit/impact of the process intervention should be 
relatively easy to interpret, as in the example given. In other words, it is 
arguably easier directly to attribute the influence of process measures to 
outcome by comparing similar groups that do and do not undergo the process 
measures.  
 
 Actionable: if certain process measures are found to be of use, they are, in 
comparison to structural measures generally easier to implement. Process 
measures tend to be more ‘material’ in the sense that they usually involve a 
physical intervention/action e.g. the giving of  a certain medication/substance 
or undertaking a procedure in a novel or refined way e.g. using ultrasound 
guidance to facilitate central venous line placement. These tend to be more 
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binary or discrete events whose undertaking is usually easily recorded and thus 
outcome followed up. 
 
 
 Abstractable: process measures are usually more easily abstracted from data 
and information already held. This allows for comparisons from already 
collected data such as electronic patient records. Given the fact the events are 
usually discretely separable from ‘normal’ procedures they are usually easily 
recorded. The most notable advances in pre- and peri-operative optimization of 
patients and reductions in length of stay have been demonstrated and directly 
attributable to institution of certain process measures, such as fluid restriction 
and early mobilization (Khoo et al., 2007, Noblett et al., 2006). 
 
 Validity: to institute a process measure into clinical care there must be good 
evidence that its use has an impact on outcome. This may require pooling of 
results, as in the case of meta-analyses, before validity can be demonstrated 
(Varadhan et al., 2010, Gouvas et al., 2009a). 
 
 Identification: it may be difficult to identify which process measures in 
particular are having the beneficial effects if they are part of a group of 
measures established in practice. Identifying the individual impact of each 
process measure may be very difficult to establish in true clinical practice. 
Such has been the case with the so called enhanced recovery pathways, where 
at the outset over 12 different facets of care were instituted. More recent 
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research has attempted to focus in on the specific facets that are of 
importance to outcome (Fearon et al., 2005). 
 
Process measures however are not the panacea of quality measurement. 
Implementation of a process measure is no guarantee of preferential outcome, for 
example an ultrasound guided central venous insertion by a medical student is 
likely to have worse outcome than ‘traditional’ non-ultrasound aided placement by 
an expert. This hypothetical example highlights that use of a process measure 
needs to be appropriate for the clinical situation and patient. The application of a 
process measure needs to appropriate for that individual patient and not simply be 
undertaken to tick an audit box. Pre-operative β-blockade in a bradycardic patient 
would be dangerous, although many studies have shown outcome benefit if  β-
blockade is appropriately used (Talati et al., 2009). 
 
2.6.3 Characteristics of outcome measures 
There has been a drive towards the reporting of outcome measures in England. 
With the publication of national outcome from vascular and colorectal surgery, 
mortality and re-operation rates have been reported. These allow for rapid cross-
unit and in some instances individual surgeon comparisons. The characteristics of 
outcome measures can also be summarised by grouping their qualities. 
 Focus: a focus on outcomes directs attention towards the patient (rather than 
the service) and helps nurture a ‘whole system’ perspective. Whilst it is 
thought that many individual processes are important into achieving goals, the 
ultimate outcome reflects all of these interactions. Thus it seems sensible to 
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consider the ultimate outcome before attempting to understand the individual 
processes that make up the outcome. In other words, even if the best goal-
directed therapy is used and the most up-to-date processes are employed if the 
patient does not survive this encounter or the resulting functional outcome is 
unacceptable to the patient this is of importance and must be recognised. This 
is the domain of outcome measures.  
 Goals: health outcome measures more often clearly represent the goals of care 
and the NHS. Although the phrase ‘targets’ is becoming synonymous with 
negative connotations, many healthcare systems are target or goal driven. This 
gives an identifiable number/value that people can work towards. For example 
in the context of surgery the so called “Two week wait rule” attempted to 
improve the diagnosis of patients with suspected cancer by expediting 
diagnostics and primary referral. Whilst units are assessed on how well they 
achieve these targets, this outcome measure has not necessarily reflected in 
better identification of patients with suspected colorectal cancer (Thorne et al., 
2006). 
 Meaningful: outcome measures tend to be more meaningful to potential users 
of indicators and may be more easily understood as measures of patient safety 
than other perhaps more specific methods of measuring safety. Once justified, 
end targets may be easier to understand than other measures of quality. For 
example, a unit with low post-operative 30 day mortality is likely to be viewed 
with higher regard in terms of quality than one with all imaging modalities 
such as PET/CT scanners on site (structural measures). 
 Innovation: a focus on outcomes means providers are encouraged to 
experiment with new modes of delivery to improve patient care, safety and 
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experience. As with process measures, novel ways of managing patients, or 
patient flow may impact on outcome. For example, recently outcome benefits 
in terms of length of stay and re-admissions were given as the benefits of 
introducing so called enhanced recovery pathways in colorectal surgery. The 
panel of different interventions in some centres has been shown to improve 
some outcome end points, such as length of stay (Khoo et al., 2007). 
 Far sighted: focusing on outcomes allows for providers to adopt a long-term 
strategy, such as health promotion, which may realise longer term benefits and 
improve safety more generally. For example, in cancer surgery long-term 
outcome such as functional outcome and cancer recurrence rates may drive up 
quality to a greater extent than focusing on short term goals, such as volume of 
cases (Almoudaris et al., 2011c). Short term goals tend to be driven by short 
term cost efficiencies. Concentrating on longer term outcome may balance this 
focus. 
 Manipulation: outcomes are less open to manipulation or ‘gaming’ than 
process measures / indicators. However outcomes can be influenced if risk-
adjustment models are exaggerated/ upstaged. Some outcomes such as crude 
mortality are not open to gaming. However, when adjustment is made for 
confounding variables such as palliative patients and patients with many co-
morbidities, these figures may be open to potential gaming (Klugman et al., 
2010). 
 Measurement definition: while some aspects of measuring outcomes are 
relatively easy to measure and unambiguous (e.g deaths) others are not (e.g 
wound infections). This is true not only between units but also within units, 
where one clinician may describe a wound infection as anything that prolonged 
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hospitalisation or required further therapy such as antibiotics or opening up of 
the wound, versus another clinician who may only describe wound infections 
as those requiring operative intervention. Although extreme examples are 
given here, this emphasises the potential problem of definition. However, it is 
acknowledged that standardised systems, such as the Clavien classification, 
exist for such scenarios- yet these are not routinely implemented in clinical 
practice (Clavien et al., 1992). 
 Attribution: outcomes may be influenced by many factors that are outside the 
control of the health care organisation (e.g length of stay and availability of 
nursing homes/community care placement). Almost all outcome measures are 
influenced by other factors. Even on-table deaths in theatre may not be 
attributable to surgical misadventure. This may be related to unexpected 
anaesthetic complications or unpredicted patient factors, such as underlying 
cardiac pathology unrecognised at the time of surgery. Whilst this metric may 
be reflective of the wider unit and patient selection, it is not necessarily (as one 
may first assume) directly attributable to surgeon error. 
 Sample size: outcome assessment requires large sample sizes to detect a 
statistically significant effect. This is especially true for the assessment of 
complications. By their definition complications and thus their rates occur less 
often than routine events and are undesirable. The difficulty here is that some 
complications (especially the most undesirable) or so-called ‘never events’ 
may require hundreds if not thousands of data points till they are 
observed/occur. For these to gain statistical significance large samples need to 
be analysed. Appreciating this fact is why they are termed ‘never events’ and 
even one occurrence is viewed as a system failure, hence overcoming the effect 
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of requiring a large sample size to detect. This is considered in greater detail in 
the subsequent chapter. 
 Timing: outcome may take a long period of time to observe. Most outcome 
measures are usually collectable after a patient care episode has finished and 
thus can be thought of as lagging indicators. In other words, outcome measures 
are reflective indicators rather than reactive indicators. They reflect what has 
happened. This means that this information can only be used to improve care 
for the next cohort of patients rather than for the assessed cohort, thereby 
explaining the term ‘lagging indicators’. 
 Interpretation: observed measures of safety outcomes may be difficult to 
interpret if the processes that produced the outcome are complex or occurred 
distant to the observed outcome. There may be many interactions that lead to 
the observed outcome that may not be easily discernible by measuring just an  
endpoint/outcome. For example, in the previously used example of fast track 
surgery or enhanced recovery, the observed reductions in length of stay are 
difficult to interpret when so many processes are introduced that may 
synergistically combine to infer benefit. However, without further probing it 
may be that only one or two processes are salient in achieving the observed 
outcome. In other words, it may be difficult to assess what factors in particular 
translate into the desired outcome. 
 Ambiguity: good outcomes can often be achieved despite poor processes of 
care and levels of safety. This follows Jim Reasons model (Reason, 2000) that 
failures in care or safety are usually the product of many failings that align to 
result in a poor outcome. The opposite is true that many failures in safety go 
unnoticed as they do not align to produce a poor outcome. 
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Outcome measures are useful but can be more complex than initially thought. 
Measuring mortality as an outcome measure for elective groin hernia repairs is on 
the whole a meaningless exercise. This exceptionally infrequent occurrence would 
be a meaningless outcome measure in this cohort of patients as almost all surgeons 
would have a zero, if not near zero, mortality rate, meaning that comparisons 
would be non-discriminatory. Outcome measures must also take into account the 
complexity of individual cases and the so called case-mix adjustment. Without 
allowing for concurrent morbidities and the ages of patients and the other 
surrounding factors many outcome measures are of limited value, requiring 
complex statistical manipulation to case-mix adjust.  
However the benefit of considering outcomes is they can be specialty specific and 
informative. For example, a unit’s cancer recurrence rates at 1,3 and 5 years are a 
very important metric for appraisal. Increasingly functional outcome measures, 
such as the UK NHS’s Patient Reported Outcome Measures (PROMS), are being 
used. These measures attempt to consider the surgical interventions actual benefit 
to the patient. Whilst these are still largely confined to a few clinical scenarios 
(joint replacement, groin hernias), patient functional outcome measures are also 
hugely important in appraising a service’s level of quality. 
These will be further considered in general in chapter 3.0 Contemporary methods 
of appraising national surgical performance’ and with particular emphasis on 
colorectal surgery in subsequent chapters.  
 
  
54 
 
2.6 Intervening Variables 
Whilst the structure-process-outcome framework for assessing a healthcare system 
has many conceptual benefits, one aspect it does not fully account for are the more 
subtle factors that may be influential in surgical quality. These factors include how 
teams function, institutional culture, morale and leadership which may be 
important determinant of surgical quality. The augmentation of Donabedian’s 
model was undertaken by Lilford in 2004 (Figure 2) to incorporate these other 
aspects(Lilford et al., 2004). This has been refined more recently to demonstrate a 
more stepwise schematic by Vincent, 2011 (Figure 3). To date however there is 
still little direct evidence that improvements in these domains directly and 
reproducibly influences outcome.  
 
 
 
 
 
Figure 3- Adaptation of Lilford et al 2004 schematic adapted from ‘Patient Safety’ 2nd Edition 
Wiley, Vincent, 2011 
Figure 2- Schematic of Lilfords Intervening variables and their relationship to other 
variables. Adapted from ‘Patient Safety’ 2nd Edition Wiley, Vincent, 2011 
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There are many demonstrably important factors that Lilford has identified that 
have direct relevance to surgery. The table below describes some of these factors 
where evidence exists. 
Table 3 Expansion of intervening variables 
Intervening 
Variable 
Component of interest Example 
Team Work Communication 
hierarchy 
 
(Sutcliffe et al., 2004) 
There should be the ability for members of 
the team to cross professional boundaries 
and be free to contact other members 
without fear of hierarchical boundaries- so 
called ‘speaking up’. 
 
This is also extremely important in 
considering complication identification 
and management. Aberration in vital signs 
are usually the forewarning that a 
complication is developing. Nurses are 
usually the first recipients of this 
information and must feel at will to pass 
this information on without fear. 
 
Availability For a high quality service all members of 
the team (nursing staff, junior doctors and 
allied healthcare professionals) should be 
contactable.  
 
Predefined criteria should exist with 
respect to escalation and whom to contact 
if initial contacts are unavailable. 
 
Information exchange 
 
(Sanfey et al., 2011) 
Handover (hand-off in the USA) is a 
recognized area where information 
degradation occurs and mistakes occur.  
 
Handovers are increasing due to shift 
pattern styles of work and thus there is 
greater likelihood of information 
degradation. 
 
Leadership Emotional competence/ 
Awareness 
 
(Patel et al., 2010) 
By understanding one’s own and others’ 
circumstances and motives, consultants 
can effectively manage their team and 
patients.  
 
Such understanding may avoid conflict and 
create a more harmonious and effective 
work environment. This extends to 
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relationships with management as well as 
within the clinical setting. 
 
Senior review In surgery little can make up for an 
experienced observation or assessment of a 
situation/patient. As a result demonstration 
by senior clinicians of this fosters a high 
quality service. 
Culture Performance feedback  
 
(Lytle et al., 2007) 
A supportive environment where 
performance in analytically considered and 
appraised is vital to create a quality 
service. This extends beyond clinicians 
analyzing their results to wider 
engagement by management level staff in 
continual performance appraisal, feedback 
and constructive review. 
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2.7 Conclusions and implications  
This chapter has reviewed the parameters of assessing surgical quality.  It can be 
seen that ideally, it would be possible to assess a number of different aspects of a 
surgical service.  Structural measures might include the nurse to patient ratios and 
the availability of specialist teams. Process measures may include the use of 
laparoscopy or enhanced recovery pathways. Outcome variables of interest may 
include both peri-operative measures of complications and long-term cancer 
survival. Finally, intervening variables might consider the departmental culture and 
organisational management styles and their influence of the clinical teams.  The 
next chapter considers how this might be done in practice.   
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3.0 CONTEMPORARY METHODS OF APPRAISING 
NATIONAL SURGICAL PERFORMANCE 
 
 
3.1 Chapter overview 
This chapter aims to explore how some of the different measures in current use for 
national surgical quality appraisal are reported and collated. This is with a view to 
understanding what method(s) would be most suitable for identifying high 
performing surgical and colorectal units on a national basis. Clinical registries are 
firstly considered including understanding their inception from the days of 
Codman. Such registries are also analysed for their contemporary use and how they 
have developed. Then the Hospital Episodes Statistics (HES) database is 
introduced to consider which metrics are derivable. This is a nationwide national 
data repository with administrative origins but this may have potential to identify 
performance, given the richness of the data held. Finally, an introduction to Patient 
Reported Outcome Measures (PROMS) is undertaken and how their use has 
entered clinical practice. Their potential uses as a performance tool are also 
considered. This chapter concludes with consideration of what method, measure, or 
combination of measures may be most suitable for the identification of the highest 
performing units from the measures already available. 
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3.2 Clinical registries 
Dr Ernest Amory Codman MD, 1869-1940, is regarded as the modern father of 
healthcare quality assessment in the United States. He was the Chief of Surgical 
Services who, whilst at Massachusetts General Hospital (MGH) in the early part of 
the 1900’s, was obsessed with the concept of the “End Result”.  Codman believed 
that by following up all patients who were operated upon a year later he would 
ultimately be better informed as to their outcome. This unpopular concept (at the 
time) led to his resignation in 1911 and to open his own hospital- “The End Result 
Hospital”. The final straw was when Codman displayed a picture of an ostrich 
laying golden eggs with its head in the sand at a standing room only medical 
seminar at MGH. The ostrich was a metaphor for the hospital; the golden eggs 
were the vast wealth accrued by the MGH staff. 
 
Figure 4 Digitization of Codman’s original image- The Golden Goose-Ostrich with its head beneath the 
sand, taken from Internet Archive (https://archive.org) in accordance with Terms of Use, Privacy Policy, 
and Copyright Policy 31 December 2014. 
 
Codman asked the question as to whether the goose-ostrich would still be laying 
golden eggs if patients knew the true outcomes from the hospital. His intention was 
that every patient operated upon should be followed-up. This was for the benefit of 
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patient and surgeon alike. For the surgeon this process offers an opportunity to 
understand the out of hospital functional outcome and how the patient has 
progressed or otherwise as a result of the medical intervention. Furthermore, 
follow-up would allow the surgeon to assess any post-operative complications that 
may have occurred out of hospital that the surgeon may not otherwise be informed 
about. For the patient, Codman-style follow up allows reporting of functional 
outcomes and of any non-expected recovery events. Codman realized the 
importance of both interrogating outcomes but also of learning from them. 
Furthermore, Codman believed that patients’ presenting complaints, procedures 
and outcome should be publicly reported annually. 
There was general and widespread dissatisfaction amongst the medical 
establishment. Surgeons were unhappy with the implied potential criticism. In 
support of his theory, Codman created the first clinical registry. 
In 1920 he attempted to catalogue and track nationally all bone sarcoma patients 
with the intention of improving care. He noted that despite all advances during his 
lifetime, including the discovery of X-radiation (X-rays) and subsequent 
radiographs, amputations were still the favoured cure for most bone tumours. 
Furthermore, anecdotally at least, patients seemed to have differing outcomes after 
these procedures in different centers. By cataloging the variability in outcomes of 
all sarcoma patients he intended to embarrass the establishment into reconsidering 
its record and recall practices. In six years he had only catalogued 17 patients onto 
his registry from an organization of over 7,000 members. The essence of his beliefs 
are reflected well in this quotation- 
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‘‘The common sense notion that every hospital should follow every patient it treats, 
long enough to determine whether or not the treatment has been successful, and 
then to inquire, ‘If not, why not?’ with a view to preventing similar failures in the 
future’ 
Codman c.1910 
 
Codman realized that only by analyzing one’s results would one be able to reflect 
on the appropriateness and success of any intervention. In a primitive form, 
Codman touches upon setting quality standards and self-audit and evidence based 
practice as we know them today. These processes are undoubtedly crucial in the 
process of defining quality. What he did attempt to do was create the first recorded 
surgical registry. 
Presently, with respect to surgical pathologies there are five national cancer-related 
registries and one benign-related registries registered with the Information 
Commission (IC) and the National Clinical Audit Support Programme (NCASP) 
[http://www.ic.nhs.uk/services/national-clinical-audit-support-programme-ncasp]. 
Two other notable registries exist in the form of the Vascular and Cardiac registries 
that are independently resourced. 
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Table 4- Table of National audits and registries of surgical outcome 
Pathology Name 
Bowel Cancer The Bowel Cancer Audit 
Head and Neck Cancer The National Head & Neck Cancer Audit 
Breast Cancer National Mastectomy and Breast 
Reconstruction Audit 
Oesophago-Gastric 
Cancer 
National Oesophago-Gastric Cancer Audit  
Vascular National Vascular Database 
Adult Cardiac Surgery  The Adult Cardiac Surgery Audit 
 
The value of self-reporting or so-called voluntary reporting systems has been 
previously questioned. In one study of a national clinical registry, after 
retrospective validation checks were made, up to 31% of cases were not reported to 
the registry over a 2 year period by one unit. Within these cases, 22% had some 
form of complication or adverse event (Dreisler et al., 2001).  The submitting 
format is arguably the most important factor when considering using registries for 
performance assessment. Without 100% (or mandatory) submission, there is the 
real risk that cases are not recorded or submitted. This not only skews the unit’s 
apparent performance but also that of the entire cohort.  
The benefit of clinical audits is the level of detail that is contained within the 
audits. The audits are designed to record very detailed patient-specific information 
usually including pre and post-operative outcome as well as the pre-operative and 
in some cases intraoperative processes undertaken. Such information is vital for the 
true understanding of the pathologies and how they are treated on a national level. 
However with these benefits comes the limitation that they are labour intensive to 
complete and, on the face of it, do not necessarily confer any direct benefits for the 
individual submitter. 
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Most recently the government in England invited all vascular surgeons to be part of 
a national drive openly to report their outcome data on a basket of high risk 
procedures, including open and endovascular aortic aneurysm repair and carotid 
surgery. There was a 99% response rate and the figures were publically and openly 
reported in July 2013 (http://www.vsqip.org.uk/surgeon-level-public-reporting) in 
the Vascular Services Quality Improvement Programme (VSQIP).  
 
Some such as the National Mastectomy and Breast Reconstruction Audit have 
heavy emphasis on PROMS, as patients undergoing elective breast surgery tend to 
be younger, fitter and mostly undergo planned procedures, making this form of 
assessment more meaningful. Use of PROMS shall be considered and use for 
performance measurement after assessment of the HES dataset will be considered.  
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3.3 Hospital Episodes Statistics (HES) – the modern era 
The HES database is a nationally collated data warehouse containing details of 
admissions of NHS patients in England since 1986. The data are taken from each 
hospital’s Patient Administration System (PAS) for every inpatient and, since 
2003–2004, every outpatient Finished Consultant Episode (FCE). Demographic 
and any procedural/diagnostic information within that admission period is captured 
against a unique patient identifier. The patient identifier allows identification of 
previous or subsequent admissions, or procedural data pertaining to that patient. 
Each record (at the time of writing) also contains up to 20 International 
Classification of Diseases, tenth revision (ICD-10), secondary diagnoses and up to 
24 procedural interventions recorded using the Office of Population Censuses and 
Surveys Classification of Surgical Operations and Procedures 4th Revision  OPCS-
4 codes (Faiz et al., 2008a).  
With regards to in-patient data, most simply HES data is accessible in three 
formats. Firstly it is available nationally aggregated at primary or main procedure 
level annually (HESonline, 2010). This groups procedures such as right-
hemicolectomies and reports the number performed nationally. The second format 
is the reporting of all Finished Consultant Episodes (FCEs) - which is defined as 
the total care a patient receives under a named consultant, per provider. This is 
reported by generic specialty grouping. In this format a group of ICD-10 codes are 
aggregated (e.g code C00-C048 for all neoplasms). Again these reports are 
annually produced. So for example it would be possible to find out how many 
procedures were performed by each Trust. These first two formats are freely 
available on-line (www.hesonline.nhs.uk). In this format researchers are limited to 
looking at trends in national volume of procedures with no further information 
being extractable. The final format available is anonymised patient level patient 
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data reported per FCE per provider. This format allows for more complex analyses 
however separate application and approvals are required to access this data. Such 
application will also report the full patient dataset that includes all diagnostic and 
procedural fields, date of admission and discharge, as well as age at admission. 
Directly reported or derivable from HES, are outcome measures that are useful in 
appraising surgical performance. What follows are details of the outcome measures 
available and critique of them for use as performance indicators that are applicable 
to the appraisal of surgical performance.  
In particular the native HES dataset can be interrogated and analysed to produce 
metrics and information that are of use specifically for the appraisal of surgical 
performance. These metrics can be calculated from the administrative dataset. 
 
3.3.1 HES derivable outcome measure -Length of stay 
This is usually calculated as the complete number of days from admission to 
discharge. Its attractiveness as a measure lies in that it is readily calculated and not 
open to gaming. It is easily derived from administrative datasets and commonly 
quoted as the average LOS. When considering an average length of stay, the mean 
maybe skewed by outliers, thus may misrepresent the population as a whole. 
Furthermore, the mean would likely misrepresent any ‘improvements’ over time 
that may occur in a unit, as historical outliers will still affect more contemporary 
data (Fisher and Altaffer, 1992). The median however, reflecting the central 
tendency of LOS, is not as influenced by outliers.  The median informs us that half 
the population, have a stay in hospital below a certain figure. It however gives us 
little information about the distribution of the rest of the population. To some 
extent this can be inferred from the population range. One statistical approach is to 
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define an acceptable upper limit of LOS. In the methodology the 75
th
 percentile 
population LOS for this limit was chosen. This approach identifies all patients that 
have a LOS above the 75
th
 percentile of the whole population as outliers, and this 
methodology has been described previously (Cohen et al., 2009a). Whilst not a 
perfect approach, this method acknowledges that the population mean is less likely 
to be influenced by outliers than an individual unit mean, and the 75
th
 percentile as 
a cut off reduces the probability of a LOS occurring above this by chance even 
further. 
 
3.3.1.1 Influences on Length of stay 
It must be noted however that LOS measurements may be influenced by non-
clinical factors. Irrespective of the clinical course and subsequent outcome, a 
patient may have their discharge delayed for a variety of reasons. Within hospital 
this may be due to delays in organizing take home medications. Although 
seemingly trivial, a delay of one overnight stay may be proportionately relatively 
significant if the ‘clinical’ stay is under five days. One extra day would represent a 
20% increase in the LOS. Similarly the influence of the day of the week a patient is 
admitted has been shown to have an influence on LOS. In patients whose planned 
discharge falls on a weekend, it has been shown they are more likely to be kept in 
until the following Monday, thus also influencing the LOS (Varnava et al., 2002). 
This may have implications for surgeons who have mid-week or end of week 
operating lists. 
 
Outside hospital factors are also important with the ultimate discharge destination 
having a significant impact upon LOS. It has been shown that patients were 
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significantly more likely to have an increased LOS if they required discharge to 
nursing homes or other institutions (Brasel et al., 2007). These findings are also 
reflected in a National Audit from Scotland published in 2010 which since 2000 
has coded for delayed discharges in their administrative datasets (National 
Statistics Publication, 2010). Furthermore, a recent Cochrane review has concluded 
that the benefits of a structured discharge plan can be reflected in reduced length of 
stay (Shepperd et al., 2010). In colorectal surgery the adoption of enhanced 
recovery programs is likely to have had influence in reducing LOS (King et al., 
2006a). This may be reflected in the coding as operations being performed 
laparoscopically. However, one key concern is that not all operations that are 
commenced in the laparoscopic fashion are completed laparoscopically. It is not 
discernible from administrative datasets which operations are completed in this 
fashion, thus caution is warranted when attempting to afford reductions in LOS due 
solely to laparoscopy, from these datasets. 
 
In the future, novel ways of assessing LOS may be used. These may include 
longitudinal analysis of subsequent admissions and aggregated LOS. Index LOS 
may be too simplistic a measure if patients are subsequently re-admitted for 
prolonged periods. A native index LOS measure would not truly reflect the care 
received. Alternatives may be the calculation of total length of stay if subsequent 
admissions can accurately be assigned to the index procedure (Mamidanna et al., 
2010). This methodology may be a more reflective assessment of LOS if non-
clinical factors can be taken into account as well. 
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3.3.2 HES derivable outcome measure -In-hospital mortality  
Most simply, this is calculated as the number of deaths that occur in-hospital - 
otherwise known as the crude mortality. This can be presented as a rate usually 
expressed as the number of deaths per 1000 hospital discharges. The strength of 
measuring in-hospital mortality as a crude rate is that it is a binomial outcome that 
is well-defined and not subject to variability of interpretation.  Deaths within 
hospital, especially after surgery are affected by ‘non-clinical’ factors to a very 
small degree, as compared with length of stay. Rates are commonly cited in the 
literature and thus should make for easy comparison of units. However the 
problems encountered with reporting of crude rates is that the crude in-hospital 
mortality rate makes no attempt to take into account case-mix (Elsevier, 2010). 
Such case-mix differences may potentially underlie to some degree the reported 
disparity and variation in outcome between units and rates (Rigby et al., 2001, 
Brunelli et al., 2006, Mohil et al., 2008). There is evidence that suggests hospitals 
undertaking major surgical procedures can fall within control limits after case-mix 
adjustment as compared to before adjustment (Ansari et al., 1999). In certain 
populations, however, risk-adjustment has been shown to have little effect (Dimick 
and Birkmeyer, 2008). This said, it would be fair to assume a higher death rate in a 
tertiary center operating on the most complex patients as well as emergencies, as 
compared to a small district unit only undertaking elective ‘routine’ resections. 
 
3.3.2.1 Accounting for case-mix and mortality 
 A development from the crude mortality rate was the concept of standardization 
(Armstrong, 1995) which can either be direct or indirect dependent upon the origin 
of the reference used to weight the strata-specific rates. Standardized mortality 
ratios (SMR) are constructed by taking the observed/expected counts and 
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multiplying by 100. This method can be useful when considering factors such as 
age, sex and race, however, the process becomes difficult when attempting to 
standardize for multiple factors. Its use is only stable when studying a population 
with small numbers of deaths. Critics have questioned the reliability of such a 
measure, citing Standardized Rate Ratios (SRR) which are the ratio of the age-
adjusted mortality rate for a study population to the age-adjusted mortality rate for 
a reference population, as being preferable. This view is not supported when 
applied analytically to a population dataset (Goldman and Brender, 2000). Such 
methods, however, whilst they make some appreciation of case-mix, do not 
account for more complex variation, such as types of operation or presenting stage 
of disease. 
 More complex methods of accounting for case-mix differences have been devised 
using advanced statistical methods. In using logistic regression, taking mortality as 
the dependent, the development of a linear equation for the log of a positive 
outcome is possible. The co-variates influence the odds of the dependent occurring 
and these can be applied to create a predicted probability of the dependent 
occurring in an individual patient which can be aggregated per unit. Such risk 
adjustment has become the method of choice over others for large scale quality 
improvement initiatives (Cohen et al., 2009b). How and which variables to include 
in risk-adjustment models has been the subject of significant debate (Dimick et al., 
2010a). However, what appears to be true is that by including clinical measures, 
such as individual laboratory results, these have been shown to enhance the 
predictive power of the models (Escobar et al., 2008). It is clear however that 
different methodologies of risk assessment can yield both differing (Steinberg et 
al., 2008, Fedeli et al., 2007, Atherly et al., 2004, Shahian et al., 2010) and similar 
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results even when analyzing the same dataset (Aylin et al., 2007a). Thus the 
outcome of risk-adjustment is dependent upon the method and co-variates used.  
 
Finally, when considering case-mix, intention of treatment is commonly 
overlooked (Klugman et al., 2010). This is largely because such data are not 
readily available from administrative datasets. When treatment intention is 
considered in surgical populations, it has been shown that mortality rates are 
almost halved, when palliative and planned end of life procedures are discounted 
from analyses (Gillion, 2005). There has however been criticism of the rise in the 
number of patients being coded with  ‘palliative’ codes (Hawkes, 2010). 
Overzealous inclusion of such codes may influence overall hospital mortality 
statistics and thus ironically call to question the robustness of what ‘adjusted’ 
mortality statistics tell us. 
 
3.3.2.2 When should mortality be measured? 
Although in-hospital mortality is the most commonly cited mortality measure in 
the literature, some have questioned its relevance in certain populations and for 
certain procedures (Jarman et al., 2002, Seagroatt and Goldacre, 1994). Although 
in-hospital mortality may be a more sensitive measure of the clinical course, it may 
not reflect the true outcome of operating on groups such as the elderly. In the 
literature, mortality rates have been quoted at different times post-operatively 
(30days, 90days, 1 year); each is likely to be sensitive to different factors 
(Mamidanna et al., 2012). Mortality after 30 days of an operation, be it in or out of 
hospital gives a fair indication of outcome from any post-operative complications. 
Thirty day mortality is considered by some to be a more accurate measure of 
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hospital performance as it is less dependent on hospital discharge policies 
(Borzecki et al., 2010). Consider a hypothetical scenario of a unit unsafely 
discharging patients very soon after their procedures. Such a unit would have very 
low in-hospital mortality rates; however 30-day mortality would be a more 
reflective indicator of the unit’s true performance if these patients then go on to 
die. Furthermore, in certain conditions and populations, such as cancer resections 
in the elderly, a longer term measure of mortality may be more appropriate. It has 
been shown that in elderly patients undergoing resections for colorectal cancer 
3.7%-12.9% (depending on age band analyzed) of patients are dead after 30-days 
of surgery compared to 14.1%-36.1% at one year (Faiz et al., 2010a). 
In summary, mortality measures are numerous and complex. Choosing the correct 
measure is likely to influence the interpreted outcome from such use. How severity 
and co-morbidities are considered is also a pivotal factor in the meaning of such 
measures. The Department of Health in late 2010 after consultation is introducing a 
universal measure to be used for comparison of all acute NHS Trust hospitals. The 
Summary Hospital-level Mortality Indicator (SHMI) will be reported in context of 
a units workload and is based around existing Hospital Standardised Mortality 
Ratio (Deaprtment of Health, 2010). It remains to be seen whether the technical 
changes made to this measure are more widely accepted. 
It must be noted that non-cause specific in-hospital death is recorded by HES. For 
deaths occurring after discharge, linkage to the Office of National Statistics 
mortality dataset is required. 
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3.3.3 HES derivable outcome measure - Return to theatre rates 
Return to theatre rates have been suggested to be good surrogates for serious 
surgical complications (Ansari and Collopy, 1996, Birkmeyer et al., 2001a, Morris 
et al., 2007a). The crux of defining the relevance of such a measure is whether 
returns to theatre are planned or unplanned. From administrative datasets this is 
usually difficult to discern as coding fields for returns to theatre generally do not 
exist. However, to overcome this challenge, by selectively choosing specific codes 
for certain re-operations (for example post-operative bleeding, post-operative intra-
abdominal abscess) this problem can be mitigated when compared to the dates of 
any subsequent operative procedures within the same admission. Such an approach 
has been used in one English series derived from HES that demonstrated 
significant variation in re-operation rates in colorectal surgery (Burns et al., 
2011b). It has been shown that in patients that require returns to theatre, they not 
only have longer lengths of stay, but also are more likely to be dead at 30 days 
(Morris et al., 2007a). Some have described the factors underlying such a metric, 
specifically that in up to 70% of returned cases surgeon error (Kroon et al., 2007), 
or technical factors are causal (Birkmeyer et al., 2001a) whereas others have cited 
specific patient factors (Ploeg et al., 2008) such as concurrent morbidities. 
It is likely to be true that both patient factors and surgeon factors are responsible 
for a patient requiring an emergent return to theatre. Furthermore an unexpected 
return to theatre is not the same as a planned return to theatre, although not 
discernible from coding. At present, only by record review, can surgeons’ intention 
be considered. In one series it was found that in 50% of cases, surgeons had 
planned to have laparoscopic re-looks on the same admission due to the complexity 
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of the surgery. This, though fully planned, would have been coded as an unplanned 
return to theatre (Birkmeyer et al., 2001a).  
The future of using unplanned returns to theatre as a metric for performance and 
quality control will be in ensuring it is being faithfully derived from whatever 
dataset it is calculated from. Crucially, surgeons’ intention and planning will need 
to be taken into account fully to integrate this metric into acceptable widespread 
use. 
 
3.3.4 Emergency Re-admission within 28 days of discharge rates 
Re-admission to hospital emergently within 28 days of discharge is considered to 
be undesirable for patients and clinicians alike. This metric is derivable from HES 
by using linkage with subsequent admissions. Simplistically this may represent a 
poorly planned initial discharge or a missed complication or evolution thereof. It 
has been estimated that one third occur within one month, and half within 90 days 
(Zook and Moore, 1980, Corrigan and Kazandjian, 1991). Most preventable re-
admissions have been observed to occur within the first 28 days of discharge, 
validating this time period for common use (Sibbritt, 1995). Using re-admissions 
further in time post discharge, may, in fact reflect disease progression and a 
continuum of the original disease, but not necessarily a poor discharge following 
the index admission. It must be noted that not all re-admissions are attributable to 
the ‘index’ admission within 28days (Courtney et al., 2003). For example, a patient 
discharged after an uneventful routine laparoscopic cholecystectomy, who is 
subsequently re-admitted a week later with a fractured neck of femur, would on 
administrative datasets be classed as an emergency re-admission. This is clearly 
correct but potentially misinforming, if used to appraise the quality of the original 
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surgery. Such scenarios are reflective of how datasets should be carefully 
interrogated and understood before deriving assumptions. This being said, the 28 
day re-admission rate is a useful reflection of preventable returns to hospital with 
rates from 12-75% quoted as being preventable in mixed populations of patients 
(Benbassat and Taragin, 2000). Re-admissions to hospital within 28 days of 
discharge are clearly multi-factorial. In a study of 186,000 colorectal patients, 
independent predictors of 28-day readmission included: distal bowel resection, 
benign diagnosis, young age, worse social deprivation and high provider unit 
volume status (Faiz et al., 2010b). This mixed panel of predictors in this population 
demonstrates how the 28 day re-admission rate is complex to understand. It 
appears that whether the admission was related to the index procedure and whether 
it was preventable are key considerations for this marker. It is thus clear to see that 
with further refinement and correct patient level data linkage re-admission data can 
be a strong marker of a unit’s performance. 
 
Table 5- Table summarising the strengths and potential weaknesses of different measures of outcome 
Measure Strengths Weakness 
Length of stay Easily calculated. 
Commonly cited. 
Does not account for any subsequent 
re-admission stay. 
Influenced by external factors (social 
care setup at home, discharge 
destination). 
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3.3.5 Use of HES for surgical performance 
Undoubtedly the information contained within the dataset is of importance in 
appraising surgical performance. Limited advances would be made with the freely 
available information due to the aggregation and the inability to perform 
meaningful risk-adjustment. For these reasons, to pursue use of this dataset, patient 
level information would be required. There have been criticism over the use of the 
dataset for outcome analysis (Williams and Mann, 2002). These largely relate to 
potential inaccuracies of the data due to the fact clinical information is translated 
by non-clinical coders into hospitals PAS systems. Within this translational step, 
errors may be made. Recent attempts to quantify the accuracy of the HES dataset  
have shown coding of primary diagnoses with an accuracy of 96.0% (Burns et al., 
2012). In other words, when analyzing the primary reason the patient is admitted to 
a unit, there is excellent accuracy of HES with retrospective reviews. Furthermore 
HES is being used by clinical registries to cross validate their submissions, 
In-hospital 
mortality 
Easily calculated. 
Commonly cited. 
Less influenced by ‘non-
clinical’ factors. 
Crude values may not reflect case-mix. 
Varied Risk-adjustment methods may 
lead to different interpretations. 
May occur infrequently for certain 
conditions/operations to be 
discriminatory. 
Will miss deaths occurring shortly 
after discharge. 
Re-admission 
rate 
Easily calculated. 
Commonly cited. 
Complex to calculate re-admission 
cause from administrative datasets. 
Preventability difficult to derive. 
Return to 
theatre rate 
Reflects in-hospital care. 
Not affected by non-clinical 
factors. 
Complex to calculate. 
More dependent upon accurate coding. 
May reflect intra-operative processes 
more closely. 
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reflecting the greater accuracy of the dataset (www.ic.nhs.uk/bowel). A recent 
systematic review has identified HES being increasingly used for health-care 
outcome assessment. In 1994, 2 papers were identified by the review as compared 
to 26 in 2010 (Williams and Mann, 2002). 
 
3.4 Patient Reported Outcome Measures (PROMS) 
PROMS were developed by the NHS to assess the effectiveness of care delivered 
from the patient perspective. After piloting, national rollout occurred in 2009 for 
four elective surgical procedures: groin hernia surgery, hip replacement, knee 
replacement and varicose vein surgery. The methodology captures patients’ health 
status before and after the operative interventions (London School of Hygeine and 
Tropical Medicine, 2005). The aim is scientifically to assess the interventional 
impact from the patients’ perspective. The recorded information briefly comprises 
four elements before and after the procedure: 
1. A generic measure of health status, 
2. Condition specific measures that are designed to be sensitive to change in 
health status for that condition, 
3. An assessment of the patients living arrangements to adjust and contextualize 
results, 
4. An assessment of whether the patient feels he or she has any disability and 
whether any assistance was sought to complete the questionnaires. 
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Other PROMS measurements are undertaken as in the case of the National 
Mastectomy and Breast Reconstruction Audit. However, these are independently 
managed by the respective specialist societies. From the most recently available 
finalised national PROMS data (April 2010 to March 2011), pre-operative uptake 
stood at 69.9% with subsequent post-operative uptake at 81.0% (Comission., 
2012). Uptake rates are considered as a percentage of eligible procedures, as 
recorded from the corresponding time periods on HES.  
Participation in PROMS is voluntary for the patient. As a result uptake rates are 
very variable by procedure. The graph below demonstrates pre-operative 
participation rates with monthly linkage to HES by procedure. 
 
 
 
 
 
Figure 5- taken from NHS guidance on the routine collection of Patient Reported Outcome Measures 
(PROMS). For the NHS in England 2009/10 
Figure 6- Graph demonstrating patient participation rates in PROMS taken from 
NHS guidance on the routine collection of Patient Reported Outcome Measures 
(PROMS). For the NHS in England 2009/10 
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It is clear that the more major procedures (joint replacements) have much higher 
consistent uptake rates. This is likely to be multi-factorial but it almost certainly 
reflects the fact that these patients reside in hospital for several days and thus are 
more likely to be captured. Groin and vein surgery are mostly done as day cases 
and thus patients spend less time in the department to be captured and/or have the 
process of completing the PROMs questionnaire explained to them.  
As with clinical audits, without complete capture of all events it would be difficult 
to infer with reasonable rigor national differences. However on an individual unit 
level, for example, trends may appear in patients’ experiences between differing 
surgeons. For these reasons PROMS are a valuable tool but limited in use for 
national benchmarking with participation rates as they are. Furthermore the 
national program only considers elective procedures and has not been validated for 
use in more major surgery such as emergency abdominal surgery. One attempt to 
reconcile the lack of clear reportable measure was a national initiative called the 
Better Metrics Project. 
 
3.5 Others methods of measuring surgical performance 
In England a national ‘Better Metrics Project’ was launched to identify evidence-
based metrics that may be used to measure and benchmark performance across a 
broad array of medical and surgical subspecialties (Care Quality Commission, 
2009a). With regard to surgery, colorectal cancer surgery was chosen and after 
wide professional and expert consultation, three metrics were decided upon to be 
reflective measures of quality. These were: the proportion of patients operated on 
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for rectal cancer with a permanent stoma, the surgeon-specific and institutional 
caseload for colorectal surgery, and participation in a national colorectal cancer 
audit (Care Quality Commission, 2009a).  At the time of writing the project has 
been discontinued with no metric refreshing undertaken since 2009. Possible 
reasons include few to no publications demonstrating the validity of the chosen 
metrics in promoting quality care. 
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THESIS AIMS 
What is currently known on national surgical performance is that many different 
metrics may be used, each with its own strengths but equally all have specific 
characteristics that pertain to different aspects of the care given. There is a need to 
review and appraise these metrics to identify potential metrics that can best reflect 
high performance in surgical practice. Colorectal cancer surgery has been chosen 
for the on-going analyses in this thesis.  
Current national surgical performance measurement predominantly uses clinical 
registries. At the time of writing many were voluntarily subscribed and submitted 
to. The value of clinical registries, especially if they are voluntarily subscribed to, 
may misinform on the actual performance of a unit or even affect national outcome 
statistics. It is necessary to identify whether differences exist between using 
voluntarily and mandatorily submitted data where possible in colorectal cancer 
surgical performance appraisal. The peri-operative period has been identified for 
further analysis. 
Whilst administrative datasets such as HES are mandatory in data collection, their 
current use is limited to the information that is currently reported by them. To 
maximise the utility of such datasets it is necessary to investigate whether 
clinically relevant information can be derived from such datasets. Specifically no 
appraisal of surgical performance would be complete without an assessment of the 
management of complications. It remains to be seen if such an important metric is 
derivable for the first time from nationally collected mandatory collected 
administrative data. 
Whilst hard-outcome data and potentially derivable metrics are important in 
appraising surgical performance, there is an important aspect that cannot be 
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discerned from analysis of such datasets. Organisational and teamwork factors are 
associated with high performance and it would be important to incorporate an 
assessment of these traditionally very difficult to appraise factors in any 
comprehensive overview of performance. 
Finally it would be informative to try and relate the findings of the study of the 
organisational and teamwork factors to the hard outcome measures previously 
identified.  
 
The aims of this Thesis are to: 
1. Identify and review what metrics are important to consider in appraising 
performance in colorectal cancer surgery.  
 
2. Identify whether any outcome differences exist between using current methods 
of performance appraisal (e.g. clinical registries) and mandatory data sources 
(e.g. HES) using comparable end-points and time periods. 
 
3. Acknowledging the limitations of administrative datasets it is necessary to 
appraise whether it is possible to creating meaningful novel metrics, such as 
the outcome from the management of complications, from these datasets. 
 
4. Determine whether it is possible and feasible to appraise the national 
performance of all colorectal cancer units on a number of selected important 
metrics. 
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5. Design and pilot a methodology for capturing organisational and teamwork 
factors associated with high performance from clinical units. 
 
6. Finally, to examine the association between organisational and teamwork 
factors and surgical outcomes from these units. 
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4.0 ESTABLISHING QUALITY IN SURGERY- A 
REVIEW OF THE LITERATURE 
4.1 Chapter overview 
This chapter consists of a review of the literature on what may constitute quality in 
colorectal surgery. The purpose of this review is to offer a contemporary 
perspective and highlight potentially important markers of quality in colorectal 
surgery in current use. An introduction to the review precedes the search strategy 
implemented. Results are offered according to the structure, process, and outcome 
framework. Other measures are also considered, including patient satisfaction 
ratings and functional outcome assessment. 
Structural and process metrics, as well as clinical and patient reported outcome, are 
reported with a view to support quality appraisal in colorectal surgery. A clear 
appreciation of the scope of individual metrics for quality appraisal purposes is 
demonstrated if they are to be used meaningfully for performance benchmarking. 
Further work is debated including the requirement to understand the role of public 
and internal reporting of performance measures in colorectal surgery as drivers of 
quality improvement. 
 
4.2 What do we mean by quality in colorectal surgery? 
Clear definition and measurement of quality within surgery are pre-requisites for 
improving standards. Although it is accepted that service providers should strive to 
improve quality, what exactly does quality mean to colorectal surgeons and their 
patients? Previous attempts have been made to define quality markers in colorectal 
cancer surgery by using qualitative research  methodologies (McGory et al., 2006). 
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It is necessary to explore current definitions and describe the methods available for 
quality measurement in colorectal surgery.  
 
4.3 Aims 
The aim of this chapter is to review the current literature to understand what 
quality in colorectal surgery is. Surgical and patient related outcome are considered 
to give a balanced view. 
 
4.4 Methods 
4.4.1 Search Strategy 
The search terms used included the Medical Subject Heading terms and Boolean 
characters: 'colon' OR 'colorectal', OR 'rectal' OR 'rectum' AND 'Quality 
Indicator$' OR 'Quality Assurance' OR 'Quality of healthcare' OR 'Reference 
Standard$' OR 'Quality' plus a variable floating term. A two person independent 
review was undertaken from resulting citations and their consequent reference lists. 
The search was limited to citations from 2000 to 2010, humans and the English 
language. The most recent search was performed on the 7th February 2010 
Duplicates were removed at all levels. 
 
For colorectal specific indicators the following Medical Search Headings (MeSH) 
and Boolean terms were employed: 
1. ‘colon’ OR ‘colorectal, OR ‘rectal’ OR ‘rectum’ AND 
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2. ‘Quality indicator$’ OR ‘quality of healthcare’ OR ‘quality assurance’ OR 
‘reference standard$’ OR ‘quality’ AND 
3. a floating keyword(s) according to the indicator in question (see table 6 – the 
indicators selected for searching are described according to the structure, process, 
outcome framework). 
Table 6- Table showing use of static and variable floating terms used in search 
 
4.4.2 Eligibility Criteria/ Inclusion Criteria/Floating terms/Study Selection 
Inclusion Criteria 
Meta-analyses, Randomised controlled trials (RCT), controlled clinical trials 
(CCT), cohort and case-control studies as well as review articles were considered. 
Studies were included if they reported on colorectal surgery with respect to 
improving outcome or defining standards of quality care. Studies from 2000-2010 
Static term  Variable ‘floating’ term  Citations 
returned 
Included 
in review 
‘colon’ OR ‘colorectal, 
OR ‘rectal’ OR ‘rectum’ 
 
AND 
 
‘Quality Indicator$’ OR 
‘Quality Assurance’ OR 
‘Quality of healthcare’ 
OR ‘Reference 
Standard$’ OR 
‘Quality’ 
A
N
D
 
Operative caseload 
‘Surgeon’ OR ‘Hospital’ AND ‘Volume’ 
structure 58 16 
Technical factors 
‘TME’ OR ‘total mesenteric excision’ 
OR 
‘APER’ OR ‘abdominoperineal 
resection’ 
process 
236 11 
Pathology measures 
Lymph node$ AND ‘pathology’ 
78 14 
Intraoperative measures 
‘surgical blood loss’ 
outcome 
2 2 
Perioperative  surgical morbidity 
measures 
‘anastomotic leak’ OR ‘anastomotic 
dehiscence’ OR ‘re-operation’ 
330 11 
Perioperative mortality measures 
‘operation’ OR ‘surgery’ AND 
‘mortality’ AND ‘outcome$’ 
‘mortality’ AND ‘outcome$’ 
97 7 
Oncological Outcomes 
‘survival’ AND ‘local recurrence’ OR 
‘loco-regional recurrence’ 
131 8 
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were evaluated for a contemporary perspective in the initial search. Articles in 
press and published online in English were considered. Reference lists from cited 
articles were also examined and cross-referenced articles were included where 
relevant. 
 
Exclusion Criteria 
Studies were excluded if they did not answer the study question being examined in 
the relevant part of the review or if they did not describe or critique standards or 
measures that could be used to define quality, or bench-marking, in colorectal 
surgery. Studies were excluded if they did not pass the quality assessment. 
Correspondences and letters were also excluded. 
 
Floating terms 
The floating terms used in the search were chosen by the senior authors. These 
were chosen to complement the Donabedian search theme and were selected after 
consensus was reached. 
 
Study Selection 
Two reviewers independently performed the searches with concordance of all 
references. Selection occurred with two reviewers independently screening the 
titles and full abstracts for relevance and excluding those that did not meet the 
inclusion criteria. Discordant decisions were arbitrated by a third author. From this, 
full text articles were retrieved both electronically and manually. Studies were 
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included if they fulfilled the inclusion criteria and passed the quality assessment 
and were relevant to the discussion point of the article as agreed by two reviewers. 
 
4.4.3 Information sources 
OVIDSP incorporating the MEDLINE, EMBASE, PsycInfo databases as well as 
the Cochrane database were electronically searched. Government and specialist 
society guidelines (e.g.,ACPGBI, ASCRS), cancer networks (e.g., ASCO, NCCN), 
and organisations that monitor quality of medical and surgical care (e.g., NICE, 
CQC) were considered to identify currently available contemporary clinical 
practice guidelines via printed documents and their websites. 
 
4.4.4 Quality assessment 
Quality assessment of the included studies was carried out using the Newcastle-
Ottawa Scale for the non-randomised studies where appropriate e.g case-control 
studies, cohort studies. At least one ‘star’ per category on the Newcastle-Ottawa 
scale of the assessed nonrandomised studies was achieved per relevant study. 
Further details of the scale and its application can be found at 
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. 
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4.5 Results 
4.5.1 Structural factors of quality in Colorectal Surgery 
4.5.1.1 Operative Caseload 
Of the 16 articles included that related specifically to the volume-outcome 
relationship in colorectal surgery, poor outcome and low surgeon, or low hospital, 
caseload have been demonstrated in at least five of these studies (Bentrem and 
Brennan, 2005, Borowski et al., 2007, Luft et al., 1979, Schrag et al., 2000, Schrag 
et al., 2002). Conversely, reduction in perioperative mortality and increased 
survival have been observed amongst adult patients (Schrag et al., 2000) (Ko et al., 
2002) and elderly (Dimick et al., 2003) patients undergoing colon cancer surgery at 
high volume institutions. Furthermore, longer term studies have shown significant 
survival advantage at 5 years amongst patients undergoing colorectal cancer 
resection in high volume hospitals (Rogers et al., 2006). No such relationship with 
either survival or local recurrence rates (Engel et al., 2005) was however observed 
amongst 884 patients treated for rectal cancer in one study. Significant variability 
between high volume surgeons has also been shown when comparing anastomotic 
leak rates in one series of 556 patients following bowel resections (small and large 
bowel), with a six-fold difference in leak rate between the extremes (Hyman et al., 
2009). The patients in the latter study were however neither randomised nor case-
mix adjusted for.  
 
A positive association between either institution, or surgeon, caseload and 
perioperative mortality or intestinal continuity rates in elective rectal cancer 
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surgery was not identified in one large North American retrospective population-
based cohort study (Schrag et al., 2002). The latter trial did however confirm a 
two-year survival advantage to patients operated upon by high volume surgeons. A 
systematic review by Salz and colleagues investigating the impact of operative 
volume in rectal cancer surgery observed that high volume centres and surgeons 
perform more sphincter-saving procedures and are associated with lower 
postoperative mortality. However, the complication rates, local recurrence rates 
and overall survival did not show benefit in higher volume centres (Salz and 
Sandler, 2008). In a recent meta-analysis of thirty-five studies, postoperative 
morbidity following treatment for colonic cancer was associated with surgeon 
caseload and education. Moreover, reduced postoperative mortality was also 
associated with high hospital, and surgeon, caseload (Iversen et al., 2007). These 
findings are reflected in an English population-based audit where high volume 
surgeons (deemed as those with operative caseloads>18.5 cases per year) and 
colorectal specialists were observed to be more likely to perform sphincter saving 
procedures for rectal cancer (Borowski et al., 2007). Moreover, a prospective 
multi-centre observational study of 1557 patients identified that sphincter 
conservation was more likely to occur in higher volume centres (Ptok et al., 
2007a). Schrag and colleagues also demonstrated hospital and surgeon volumes as 
important predictors of stoma rates in patients undergoing a primary resection for 
colon cancer (Schrag et al., 2003). In another study Harling and co-workers from 
the Danish National Colorectal Group demonstrated, from a national database 
comprising over five-thousand patients, a significantly higher risk of a permanent 
stoma amongst patients undergoing rectal cancer procedures in low volume 
institutions (Harling et al., 2005). They did not however identify any differences in 
anastomotic leak rates, 30-day mortality or 5-year survival rates. Considerable 
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controversy exists regarding the relationship between surgical caseload and 
outcome and its consequent impact on colorectal service provision worldwide. In 
the United Kingdom (UK) it is now recommended that a colorectal surgeon 
perform at least 20 colorectal cancer procedures per year (NICE, 2004).  
 
4.5.2 Process factors of quality in Colorectal Surgery 
4.5.2.1 Technical factors 
Abdomino-perineal excision (APE) is a procedure that may be inherently 
associated with poor oncological outcomes (Marr et al., 2005) in addition to the 
obvious need for a permanent stoma. Process measures like APE rates and the 
quality of surgical excision, as evidenced by the quality of the plane of rectal 
dissection evaluated on histological examination of the mesorectal fascia (Quirke, 
2003), may be used to benchmark aspects of surgical quality in rectal cancer 
treatment.  
Grading of mesorectal quality into three categories according to the completeness 
of excision, can distinguish between the technical proficiency of surgeons.  In an 
analysis of 100 patients undergoing total mesenteric excision (TME) surgery for 
rectal cancer anatomical factors were more likely to predict inadequate mesorectal 
quality than clinical factors (Hyuk Baik et al., 2008). Quality of mesorectal 
excision may potentially be of use as an assessment tool for evaluating technical 
proficiency in rectal cancer surgery. The relationship of this process measure to 
outcome is however as yet uncertain.   
The drive to raise standards has involved efforts to decrease non-restorative 
operations in favour of sphincter-saving procedures. This has been echoed by the 
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‘Better Metrics Project’ in the United Kingdom (Care Quality Commission, 
2009a). The reason for poorer oncological outcomes in the lower rectum may 
relate to the more advanced nature of rectal cancer in this location (greater 
proportion of T4/R1/circumferential resection margin (CRM) positive cancers with 
higher rates of tumour or bowel perforation) (Marr et al., 2005); (Wibe et al., 
2004), and/or, to deficient surgical technique leading to ‘waisting’ of the rectal 
specimen rather than achieving a cylindrical excision (West et al., 2008a). It is 
important to note that there is not universal agreement that APE is necessarily 
independently associated with poorer outcomes (Chuwa and Seow-Choen, 2006).    
Morris and co-workers, using NHS routinely-collected data linked to the cancer 
registry observed wide variation in the use of APE across colorectal service 
providers in England (Morris et al., 2008). The Association of Coloproctology of 
Great Britain and Ireland (ACPGBI) have, however, recommended that the 
proportion of resectable rectal cancers treated by APE should be less than 30% of 
total rectal cancer excisions (Association of Coloproctology of Great Britain and 
Ireland, 2007). 
 
Functional outcome after rectal cancer surgery is a key factor when considering the 
most appropriate procedure for an individual patient. Surgeon-related factors are  
as important in preservation of function as in long-term local oncological control 
(Moriya, 2006). Furthermore evidence exists that the surgical approach (i.e. 
laparoscopic versus open) seems to confer neither benefit, nor disadvantage, 
functionally when performing TME surgery (Morino et al., 2009). Poor functional 
outcome has been shown to be associated with preoperative factors too. In patients 
undergoing low anterior resection and TME, differences in faecal incontinence 
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rates were observed between patients that underwent pre-operative radiotherapy 
and those that did not, when assessed five years’ post treatment (Lange et al., 
2007). Functional outcome following rectal cancer treatment is therefore 
multifactorial relating to patient, surgical and adjuvant treatment factors, and is an 
important marker of operative success and quality. 
 
4.5.2.2 Pathology measures 
The American Society of Clinical Oncology (ASCO) have derived a range of 
surgical quality process metrics that evaluate both the surgical and adjuvant 
management of colorectal cancer (Desch et al., 2008). These metrics include: 
administration of adjuvant treatments for colonic and rectal cancer and lymph node 
yield (excision and examination of > 12 lymph nodes in colon cancer) (Desch et 
al., 2008). The relationship between oncological outcomes, such as survival, and 
lymphadenectomy yield is however complex. In terms of patients being restaged 
due to lymph node yield, it has been shown that, at low lymph node yields, the 
likelihood of detecting a positive lymph node increases up to 5-6 nodes. Above this 
value, it is less likely that >7 lymph nodes will change a patient’s stage (Baxter et 
al., 2010). Average lymph node yields in excess of 12 nodes are more likely 
amongst surgeons with higher caseload and those who are sub-specialised (Dillman 
et al., 2009). Poor 5-year survival rates correlate with both adverse tumour 
characteristics as well as with low lymphadenectomy yields for Stage II and III 
cancers (Morris et al., 2007c, Chang et al., 2007). Conversely, node negativity has 
been associated with significantly improved survival (Wong et al., 2002).  
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In a systematic review of 61,371 patients it was found that a greater number of 
lymph nodes evaluated after surgical resection was positively associated with 
survival in patients with stage II and III colon cancer however the association is not 
clear cut (Chang et al., 2007). It has been demonstrated that specialist pathologists, 
as well as surgeons,  are more likely to achieve adequate lymphadenectomy results 
(Morris et al., 2007c). However in a UK-based single-center audit lymph node 
harvest, following case-mix adjustment, was shown to vary according to the 
reporting pathologist but not the operating surgeon (Evans et al., 2008). 
Interestingly, patients with one or more positive nodes have greater nodal harvests 
than those with negative nodes (Evans et al., 2008, Johnson et al., 2002). In a 
further study the number of identified lymph node metastases increased 
continuously with increased total lymph node recovery in pT3 colon cancer 
(Tornroos et al., 2009). Variation in histo-pathological techniques may however 
substantially alter lymph node yield. Hernanz and colleagues have demonstrated 
that ‘fat clearing’ methods enhanced lymph node yield by an average of 10 nodes 
when examining fifty mesorectal specimens (Hernanz et al., 2009). As a result 
three patients in their study were upstaged. Other studies employing acetone 
preparation have similarly demonstrated efficacy at increasing lymph node yield 
using additional techniques (Vogel et al., 2008). Injection of methylene blue ex- 
vivo into the superior rectal artery of rectal cancer specimens has been shown to 
enhance lymph node detection by approximately 13 nodes in a small case-control 
study (Markl et al., 2007).  
 
In rectal cancer, a prospective randomized multi-centre trial of 1227 patients found 
large variations in lymph node yield between pathologists and laboratories and also 
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post neo-adjuvant radiotherapy as compared with those not undergoing neo-
adjuvant therapy. In the same study patient age over 60 years and low invasion 
depth of the tumour were also associated with a lower yield. Recurrence free 
survival was shorter in patients who were node negative with fewer than seven 
lymph nodes retrieved as compared with node negative patients with more than 
eight nodes examined (Mekenkamp et al., 2009).  
 
Recent validation of the Royal College of Pathologists minimum dataset for 
reporting colorectal specimens, using retrospective patient data from the UK, has 
shown the variables therein to be of prognostic significance and furthermore the 
failure to report on certain factors confers worse outcomes than clinical absence of 
the factors (Maughan et al., 2007).   The collective efforts of the surgeon and the 
pathologist determine lymph node harvest. If this metric is to be used as a 
meaningful marker of quality of colon cancer care efforts to standardise surgery 
and histopathological techniques require consideration. 
 
4.5.3 Outcome Metrics of quality in Colorectal Surgery 
4.5.3.1 Intra-operative measures  
Blood loss 
Blood loss has been cited as a potential quality indicator in cancer surgery and 
although no recent randomised controlled trials have been  published a narrative 
review of blood loss as a quality indicator in oncological surgery concludes the 
possible negative effects of transfusion in terms of immunosuppression, increased 
morbidity and potential long-term adverse effect upon oncologic outcomes. 
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Accurate measurement and reporting make this a potential marker that requires 
further evaluation (Dixon et al., 2009). Specifically, in colorectal surgery the 
receipt of blood transfusion was shown, amongst other factors, to be an 
independent predictor of anastomotic leak in patients undergoing elective anterior 
resection (Yeh et al., 2005). This is likely to be multi-factorial encompassing intra-
operative as well as post-operative factors. 
 
Perioperative surgical morbidity measures 
The short-term problems surrounding anastomotic leaks are well known, but the 
potential long-term consequences are less well understood. Law and colleagues 
demonstrated significantly higher local and systemic recurrence rates as well as 
worse five year survival in a prospectively studied cohort of patients undergoing 
potentially curative resections for colorectal surgery in those patients that suffered 
anastomotic leak (Law et al., 2007). This may justify using leak rates as a quality 
measure in operations for colorectal cancer. In a study of 978 patients independent 
risk factors for anastomotic leakage included the use of irrigation-suction drains, 
blood transfusions, and an anastomotic level of 5 cm or less from the anal verge 
(Yeh et al., 2005). Interestingly, in rectal cancer surgery a review of 35 studies 
demonstrated no association between surgeon caseload and experience with respect 
to anastomotic leak rates (Iversen et al., 2007). A recent meta-analysis of the use of 
defunctioning stomas after low anterior resection has favoured the use of stomas in 
reducing clinical anastomotic leak rates and reoperation rates (Tan et al., 2009). 
The benefit of covering stomas has also been shown in other studies (Eberl et al., 
2008, Den Dulk et al., 2009, Gastinger et al., 2005). In a smaller series employing 
hand-sewn anastomoses (Huh et al., 2007), defunctioning did not confer any 
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advantage. A Cochrane review however has shown insufficient evidence to 
demonstrate benefit of hand-sewn over mechanical anastomosis in terms of 
complication rates (Lustosa et al., 2002).  
 
As illustrated by Kingham and colleagues in their review, the causes of 
anastomotic leak may be multi-factorial and in some instances largely due to 
patient factors rather than technique as is highlighted by the bimodal distribution, 
with a significant proportion occurring whilst these patients are at home (Brisinda 
et al., 2009). Anastomotic leaks are a major cause of unplanned return to the 
operating theatre following colorectal surgery. Other causes in the perioperative 
period may include bleeding, wound dehiscence or stoma related complications. 
‘All-cause’ unplanned return to theatre (i.e. re-interventions) has been cited as a 
potential quality marker in colorectal surgery. Morris and colleagues analysed 
26,638 patients that underwent operations for colorectal cancer and found that 
amongst patients who underwent an unplanned intervention, a complication 
demanding intervention was associated with a significant increase in the likelihood 
of postoperative mortality (relative risk of 2.2). Moreover, the relative risk of 
mortality rose to 7.2 if further complications were encountered (Morris et al., 
2007b). Significantly increased mortality rates have also been shown in other 
surgical specialities amongst patients requiring re-operation (Birkmeyer et al., 
2001b). Merkow and colleagues found significant variability in re-operation rates 
between NSQIP hospitals in patients undergoing colorectal procedures and that 
ASA grade and being male (amongst others) were correlated highly with the 
likelihood of re-intervention (Merkow et al., 2009a). 
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4.5.3.2 Perioperative mortality measures 
Perioperative mortality outcomes in colorectal surgery must reflect, at least in part, 
the performance of the surgeon. Consistently good outcomes are likely to represent 
a combination of strong pre-operative decision-making, appropriate case selection, 
the operative skill of the surgical team, as well as their synergy with intensivists 
and the wider hospital community when required. Postoperative mortality is an 
outcome measure that is easily collected, and can be validated and risk-adjusted 
(Keogh et al., 2004). It should be borne in mind however that postoperative 
mortality measures excludes patients who were declined for surgery. Unadjusted 
30-day in-hospital mortality reported over a ten year period from the Hospital 
Episode Statistics database, a routinely-collected national dataset that encompasses 
the entire NHS in England, suggests that 30-day in-hospital mortality following 
elective colonic and rectal resection for cancer is 3.4% and 3.3% respectively (Faiz 
et al., 2009b). Investigators using a large US administrative database observed that 
between 1996 and 2003 30-day death rates in over 30,000 patients undergoing 
segmental colectomy for cancer were 6.7% at non-National Cancer Institute (NCI) 
designated centers and 3.2% at NCI centers. Mortality after proctectomy was 5.0% 
and 1.9% at these centers respectively (Paulson et al., 2008). In contrast, 30-day 
postoperative mortality following colorectal resection in Denmark was 9.9% as 
recorded by a prospective national audit over an eight month period (Nickelsen et 
al., 2005). Although seemingly high, the inclusion of urgent cases in the Danish 
study renders direct comparison to other countries difficult.  
 
Interestingly, a national prospective audit of clinical registry data in the United 
Kingdom observed an unadjusted mortality risk of 7.5% following colorectal 
resection (Tekkis et al., 2003). Discrepancy between unadjusted HES mortality 
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outcomes and those from the national clinical registry arise mostly due to the 
inclusion of urgent cases on the latter database. Furthermore, HES describes in-
hospital mortality only, whereas the higher rates recorded within the clinical 
registry relate to in and out-of-hospital mortality. Such large differences in the 
measurement of unadjusted mortality rates highlight the difficulties encountered 
with apparently straightforward outcome metrics.  
 
Critics of 30-day mortality highlight that a significant percentage of deaths occur 
after this 30-day window but within 90 days of surgery. In one study of patients 
undergoing colorectal surgery 90-day mortality rates were 4.1% and 28.9% for 
elective and emergency patients versus 1.4% and 15.5% for the same patient cohort 
at 30 days (Visser et al., 2009). A colorectal risk calculator devised using National 
Surgical Quality Improvement Programme (NSQIP) data allows surgeons to offer 
patients a ‘hospital specific’ preoperative mortality risk - which may offer a more 
meaningful insight into personal operative risk (Merkow et al., 2009a).  
 
4.5.3.3 Oncological outcomes of quality in Colorectal surgery 
Local recurrence following rectal cancer surgery is related to tumour factors that 
include: tumour site and its differentiation, the presence of lymph node metastases, 
lymphovascular tumour invasion, extramural vascular invasion, circumferential 
resection margin or serosal involvement (Dresen et al., 2009). Anastomotic leak 
requiring operative intervention has also demonstrated an association with loco-
regional failure (Ptok et al., 2007b). However, what about surgery and oncological 
outcomes – does surgical proficiency matter in this regard?  It been demonstrated 
by some (Garcia-Granero et al., 2009, Maslekar et al., 2007), but not all (Jeyarajah 
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et al., 2007), investigators that in rectal cancer surgery, the quality of mesorectal 
excision is independently associated with oncological outcome metrics such as 
local recurrence. 
 
But to what extent do the surgeon and the oncologist determine local disease 
failure?  The Cooperative Investigators of the Dutch Colorectal Cancer group 
(Kapiteijn et al., 2002) compared outcomes from the Total Mesorectal Excision 
(TME) study that involved rectal surgery carried out by surgeons credentialed in 
TME, with outcomes from an older Cancer Recurrence and Blood Transfusion 
(CRAB) study where conventional surgery was performed without quality control. 
Local Recurrence (LR) rates were 16% in CRAB and 9% in the TME study 
suggesting that TME technique favours local control. The latter study offered a 
homogenous study population as none of the patients underwent radiotherapy and 
all were treated with curative intent. TME surgery appears to confer advantages 
over traditional rectal cancer surgery. Moreover, high quality TME, i.e. perfect 
mesorectal excision as evaluated by pathological examination, has been found by 
some investigators to be associated with improved local disease control (Garcia-
Granero et al., 2009, Maslekar et al., 2007).  
 
The impact of surgical intervention on loco-regional disease control is also 
influenced by the administration of adjuvant as well as surgical treatment. Dutch 
collaborators demonstrated the effect of short course preoperative radiotherapy 
(RT) followed by TME versus surgery alone. They reported LR rates of 2.4% in 
the RT+TME group versus 8.2% in the surgery only group at two years (p<0.001). 
They did not however identify a relationship with survival (Kapiteijn et al., 2001). 
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With regards to LR the magnitude of protection afforded by radiotherapy appears 
substantial. Moreover, significantly improved local disease control was also 
observed by the Dutch investigators when the study cohort was re-evaluated at six 
years (Peeters et al., 2007).  
 
4.6 Discussion 
In this section, the findings from the wider literature of surgical research, across 
various subspecialties are considered. This recognises that other non-colorectal 
specific works may have implications for colorectal surgery. 
 
4.6.1 Structural metrics in general  
Structural factors relate to any characteristics of hospital organizations’ that may 
influence the quality of care delivered. Within healthcare various structural factors 
been shown to influence outcome. Although volume has been mentioned 
previously, specifically with reference to colorectal surgery, its use as a potential 
maker of quality has also been shown across a range of surgical procedures 
(Bentrem and Brennan, 2005, Luft et al., 1979, Birkmeyer et al., 2002, Begg et al., 
1998, Sosa et al., 1998, Hannan et al., 2003, Wu et al., 2004, Katz et al., 2001, 
Killeen et al., 2007). Other  structural factors that have been identified as relevant 
in health care investigations include: the number of doctors at a given institution 
(Jarman et al., 1999), their medical qualifications or degree of sub-specialisation 
(Chowdhury et al., 2007, Prystowsky et al., 2002), the nursing-to-patient ratio 
within institutions (Elixhauser and Halpern, 1999), the presence or absence of 
specialist equipment, the management culture of an institution (Glickman et al., 
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2007) as well as the numbers of surgical beds within a surgical department (Brook 
et al., 1996). Structural factors represent easy quality metrics to assess but if they 
are to be used for these purposes it is essential that they accurately and consistently 
reflect the quality of the service being appraised.  
 
Certainly, the evidence cited within the results section, drawn from the 
investigation of routinely-collected databases, offers support to the existence of a 
volume-outcome effect in colorectal surgery. Caution is perhaps warranted 
regarding the assumed validity of this association, and its consequent implications, 
for three reasons. Firstly, publication bias – resulting from the reluctance of journal 
editors to publish studies with apparent negative findings, may account for the 
paucity of reports of an insignificant relationship within the literature. Secondly, 
the volume-outcome relationship might confound the impact of other factors that 
genuinely influence outcomes. For example, in a ‘free’ referral system, surgeons 
deemed poor amongst their colleagues are unlikely to receive abundant referrals 
and therefore their volumes are likely to be low. Under these circumstances 
increasing surgical workload is unlikely to ameliorate poor performance. Thirdly, 
the volume-outcome relationship offers no insight into individual surgeon’s, or 
institution’s, ability to carry out a given procedure. Interestingly, a recently 
reported study, based on the data from Clinical Outcomes of Surgical Therapy 
(COST) study, demonstrated that ‘credentialing’ (i.e. establishing the proficiency 
of surgeons at a given technique) eradicated the volume-outcome effect in 
laparoscopic colorectal surgery (Larson et al., 2008). Perhaps such demonstration 
of proficiency by surgeons, or centers, represents a relevant, fair and accurate 
means of assuring surgical quality.     
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4.6.2 Process metrics in general  
Process markers directly reflect the interactions that lead to effective care. Ideally, 
compliance with process measures should be reflected in subsequent good clinical 
outcomes. Often process metrics seek to compare current care with treatment 
standards and protocols and thereby highlight areas where quality may be lacking. 
Arriaga and colleagues, in their report from the ‘Better Colectomy Project’ have 
established a clear link between adherence to evidence based practice in colorectal 
surgery and good postoperative outcome (Arriaga et al., 2009). Specifically, they 
observed 40% non-adherence to a basket of thirty-seven evidence-based processes 
agreed by a consensus of expert opinion. In their retrospective review each 
consecutive failure to adhere to important processes increased the risk of 
postoperative complications by 60%.  
 
Surgeons vary in their choice of surgical technique as well as their outcomes 
(McArdle and Hole, 1991). Although uniformity of practice is desirable on a 
societal level, benchmarking surgeons individually, according to their choice/use 
of surgical techniques may be hazardous. In colonic surgery use of the 
laparoscopic approach is not only dictated by surgeon choice but also by access to 
adequate training and facilities for minimal access surgery as well as appropriate 
case-mix. Evidence from a small study (n=72) investigating the place for minimal 
access rectal cancer surgery suggested that more complete macroscopic TME 
specimens were recovered following the laparoscopic approach – probably due to 
improved pelvic views (Gouvas et al., 2009b). However, complex inflammatory 
bowel disease, T4 stage colorectal cancer and re-do surgery represent 
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circumstances where the evidence base for the laparoscopic approach is not clearly 
established at present. A single metric that evaluates laparoscopic usage as a 
quality marker may bias against surgeons who safely undertake significant 
proportions of such cases albeit using conventional surgery.  
 
Some care processes that relate to the perioperative period have been shown to 
influence outcome. Approximately twenty perioperative processes including early 
nutrition (Fearon et al., 2005), epidural analgesia (Gendall et al., 2007) and goal-
directed fluid administration (Noblett et al., 2006) have been incorporated into 
Enhanced Recovery Programmes (ERP’s). A recent consensus document has been 
produced by the Enhanced Recovery After Surgery (ERAS) group which provides 
recommendations for each evidence based item for inclusion in an ERP (Lassen et 
al., 2009). Benefit differences have not been shown between either laparoscopic 
and open procedures within ERPs due to the paucity of high quality trials 
addressing this issue (Vlug et al., 2009). However, ERP’s have demonstrated 
consistent efficacy at accelerating recovery after major elective colorectal surgery 
(King et al., 2006b, Wind et al., 2006). The overall benefits of ERP in colorectal 
surgery has been demonstrated in a meta-analyses by Gouvas and colleagues which 
showed reduction in lengths of stay, reduction in hospital morbidities and 
complication rates in elective patients undergoing colorectal resections (Gouvas et 
al., 2009a). It is uncertain whether this ‘package’ of evidence-based components 
that comprise ERP’s represents the determinant behind improved outcomes, or, 
whether these are achieved through standardization of clinical care. It is known 
that team communication and coordination are qualities that are linked to low-
morbidity hospitals (Young et al., 1998). Perhaps greater emphasis on team-work 
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and clinical care processes underlie, at least in part, the benefits observed with fast-
track surgery. Moreover, the latter underlying factors may only be effective if the 
correct processes are followed and furthermore if these processes are faithfully 
reproduced to a high standard. 
 
4.6.3 Outcome measures in general 
Outcome markers are obvious attractive quality metrics that commonly represent 
objective markers of clinical performance. Patient interpretation of clinical services 
through Patient Reported Outcome Measures (PROM’s), as well as evaluation of 
the patient experience, can also be used to denote service quality and satisfaction.  
 
Perioperative mortality has been used as a performance marker across various 
surgical specialties. Caution regarding its use as an index of quality in colorectal 
surgery is perhaps warranted as it is an outcome not necessarily determined solely 
by quality of surgical care. In fact, Iezzoni (Iezonni, 2003) described determinants 
of outcomes as the sum of patient factors, effectiveness of care as well as random 
variation that occurs between individual patients and providers. Thus over reliance 
upon mortality monitoring, or even outcome measurement in general, for 
benchmarking performance within colorectal surgery may mislead. Despite the 
above cautions mortality following surgery may represent an important marker of a 
hospital’s ability successfully to manage patients who develop postoperative 
complications. In a recent report Ghaferi and co-workers demonstrated from eighty 
five thousand patients undergoing general or vascular surgery in American 
hospitals that patients suffering major postoperative complications were more 
likely to die in hospitals with high overall mortality rates (Ghaferi et al., 2009b). In 
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contrast a patient’s chance of survival following complications was greater when 
managed at low mortality centers. This study suggests that the management of 
complications, rather than the ability to avoid them, is perhaps an emerging, 
important marker of strong clinical care.  
 
Four methodological factors provide potential impediments to the use of clinical 
outcomes as reliable discriminators of surgical performance. These include 
difficulties associated with accurate case-mix adjustment, the integrity of the 
dataset used for performance measurement and the magnitude of absolute numbers 
required for outcomes to identify poor performers in an appropriate time frame. 
Regarding risk adjustment, well-known scoring systems have been applied to 
colorectal surgery. These include systems such as the American Society of 
Anaesthesiologists Classification (ASA) (Davenport et al., 2006), the Association 
of Coloproctology of Great Britain and Ireland Colorectal Cancer Model , the 
NSQIP risk-adjustment method (Khuri et al., 1997, Young et al., 1998), APACHE 
II (Acute Physiology and Chronic Health Evaluation II)(Khwannimit and 
Bhurayanontachai, 2009b) , SAPS II (Simplified Acute Physiology Score-II) 
(Khwannimit and Bhurayanontachai, 2009a) and the Physiological and Operative 
Severity Score for the Enumeration of Mortality and Morbidity (POSSUM) score. 
The latter is a British scoring system that is used widely to predict mortality 
(Copeland et al., 1991) as well as benchmark surgeon performance (Sagar et al., 
1996) in patients undergoing colorectal surgery (Midwinter et al., 1999, Sagar et 
al., 1994, Al-Homoud et al., 2004). Variants of the POSSUM score, such as the 
Portsmouth POSSUM (P-POSSUM) and the Colorectal POSSUM (CR-POSSUM) 
have also been developed. Comparison of the latter POSSUM scoring systems for 
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the purposes of mortality prediction in colorectal surgery has failed to reach 
consensus regarding the superiority of one system over another (Senagore et al., 
2004, Bromage and Cunliffe, 2007, Vather et al., 2006). 
 
When considering statistical power calculations approximately 250 cases are 
required to identify a meaningful difference between a national average 30-day 
mortality rate of 3% and an institution with a mortality rate of 6% - i.e. a doubling 
of mortality risk. Two hundred and fifty cases may represent an appropriate 
caseload for institutional benchmarking as it reflects the cumulative caseload for an 
NHS institution over a 2-3 year period. It might however demand a decade of data 
to identify an outlying individual surgeon. Similar arguments may extend to other 
quality metrics when applied to the individual surgeon, such as local recurrence 
rates or use of restorative and non-restorative procedures for rectal cancer surgery. 
Amalgamation of outcomes into meaningful composite metrics may in the future 
address this problem. 
 
4.6.4 The patient perspective 
Patient experiences may not always directly coincide with performance outcomes 
as evaluated by surgeons. Health Related Quality of Life (HRQoL) questionnaires 
seek to quantify the effect of a disease, and its treatment, on patient wellbeing. 
Generic tools such as the EuroQol 5D (EUROQOL, 2009) and SF-36  (Medical 
Outcomes Trust, 2009) estimate overall quality of life irrespective of underlying 
disease. Specific tools used in colorectal cancer are the European Organisation for 
Research and Treatment of Cancer (EORTC QLQ CR38) (EORTC, 2009) and 
Functional Assessment of Cancer Therapy – Colorectal Scale (FACT-C) 
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questionnaires (Ristvedt and Trinkaus, 2009). Quality of Life (QoL) scores are 
however time-dependent. In a study that examined QoL between two and five 
years following rectal cancer treatment the factors that were associated with lower 
scores on the FACT-C HRQoL instrument included severe faecal incontinence and 
male gender. Being further out from treatment was associated with more 
favourable scores. Interestingly, patients who had a colostomy did not have lower 
FACT-C scores or post-traumatic stress disorder symptoms  (Ristvedt and 
Trinkaus, 2009) whilst having an anxiety trait predicted for poor QoL scores at 2-5 
years following treatment.  
 
 Generic Specific 
Structure Hospital size, volume of 
cases, staffing levels, 
equipment in use, no. 
theatres. 
 
No. of colorectal 
procedures performed by 
surgeon and Trust, No. 
colorectal surgeons, No. 
specialist colorectal nurses. 
Process Operative time. Blood loss in CRC 
procedures, Lymph node 
retrieval. 
Outcome Diagnostic lead time, length 
of stay post op, mortality 
rates, re-intervention rates. 
Case mix adjusted LOS, 
mortality rates, morbidity, 
functional outcome. 
Table 7- Generic and specific markers of performance in surgery and colorectal surgery 
 
Included within a patient’s experience are both evaluations of the treatment 
received as well as appraisal of the service delivered. The latter is often termed 
satisfaction. Recently in England assessment of patient satisfaction has become 
compulsory amongst NHS hospitals. The Care Quality Commission (CQC), an 
independent healthcare regulator, surveys patients each year on their opinions 
regarding the care that they have received (Care Quality Commission, 2009b).  
These surveys cover broad aspects of care such as the admission process, ward stay 
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and attitudes of medical and nursing staff. The relationship between patient 
satisfaction, HRQoL and actual clinical outcomes remains understudied at present. 
 
4.7 SUMMARY 
Considerable effort has gone into defining quality in colorectal surgery yet there is 
still no one metric or marker than can encapsulate this. Perhaps this stands to 
reason; with so many variables the likelihood that one metric serves this purpose is 
too optimistic. Having highlighted the importance of a multitude of different 
metrics and measures it is clear both quantative and qualitative measures are 
important. 
What is apparent from the introduction is that choosing the correct dataset for 
performance benchmarking is vital. In the following study an appraisal of the two 
datasets available is undertaken. The HES administrative dataset will be compared 
with the colorectal specific NBOCAP registry to assess the strength of going 
forwards with either dataset for national perioperative colorectal resectional 
benchmarking. 
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5.0 COMPARISONS OF A VOLUNTARILY 
SUBMITTED CLINICAL REGISTRY WITH 
MANDATORY COLLECTED NATIONAL DATA FOR 
ASSESSING PERI-OPERATIVE MORTALITY IN 
COLORECTAL CANCER RESECTIONS. 
 
5.1 Chapter overview 
In this chapter comparisons are made between the reported outcome from two 
sources to appraise their potential use for national surgical benchmarking in 
colorectal surgery. Firstly the National Bowel Cancer Audit Programme 
(NBOCAP) is considered. This at the time of analysis is a voluntarily submitted 
clinical registry for colorectal cancer. This is compared to the HES data submission 
where submission is compulsory.  To keep the comparison as reliable and free 
from interpretation bias as possible mortality, length of stay and readmission 
within 28 days, between the two data sources, for matched time periods have been 
chosen to compare. The overall aim is to assess which source may be more reliable 
given the differing reporting natures of each. This will then identify a data source 
going forwards for further analysis for the rest of the thesis.  
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5.2 Introduction 
Quality and outcome measurement is becoming increasingly important within the 
National Health Service. Following the introduction of statutory regulation from 
the Department of Health in 1999, continual review of clinical performance, both 
from within one’s own hospital and from outside, has become mandatory (Health, 
1999).  Compulsory self-audit became part of the General Medical Council (GMC) 
revalidation process for doctors from late 2009 (GMC, 2009). Given the 
importance of outcome measurement and the high prevalence of colorectal cancer 
(CRC) in the United Kingdom (UK) ensuring accurate and reliable outcome 
statistics for procedures undertaken is important for continual individual and 
service improvement (UK, 2006). The validity of outcome measurement may, 
however, depend upon the nature of how information is submitted.  Voluntary 
reporting to clinical registries perhaps permits appraisal of only the best 
performing institutions whilst poor performing units that choose not to submit data 
remain undetected. This calls in to question the very nature of whether voluntarily 
reported outcome datasets are appropriate to use for performance measurement. 
 
National patient outcome measures can be derived from datasets such as clinical 
registry data or routinely collected datasets.  In the United Kingdom, the National 
Bowel Cancer Audit Programme (NBOCAP) is the principal clinical registry for 
colorectal cancer outcome. The Hospital Episode Statistics (HES) database 
comprises information relating to all patients admitted to NHS hospitals in England 
(all specialities).  HES data are primarily collected for administrative purposes but 
have also been utilised extensively for clinical and health service research purposes 
and has been described in the introductory chapters in more detail (Dawson, 2005). 
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At the time of this study, NBOCAP represented a self-reporting dataset.  Its data 
are derived from individual units submitting their own annual data. HES data are 
derived directly from Trusts’ administrative data reporting systems (Faiz et al., 
2008b) and it is compulsory to submit records to this dataset. National colorectal 
caseload and postoperative mortality have previously been compared between 
these two respective data sources (Garout et al., 2008). It is not, however, currently 
known whether voluntary data submission is associated with improved, or 
differing, clinical outcomes.  
The aim was specifically to assess whether institutions that voluntarily self-report 
to NBOCAP demonstrate differing peri-operative clinical outcomes, as recorded by 
HES, than non-reporting institutions. This will help ascertain which data source of 
the two nationally available ones to take forward, for further use throughout the 
thesis.  
 
5.3 Methods 
Using the NBOCAP dataset, released in October 2009 (this was the most recently 
published document at the time of the analysis), Trusts was assigned to either  
‘submitting’ or ‘non-submitting’ status depending on whether they had submitted 
data to NBOCAP from 1
st
 August 2007 to 31
st
 July 2008. Trusts that submitted 
<10% of their colorectal cancer resection workload were also termed non-
submitters. Amongst Trusts that submitted <10% of their total colorectal cancer 
resection workload the range of submission was 1.3%-7.1%. Outcome for all 
patients operated on in the two groups using information from the HES database 
were compared. All NHS Trusts in England that performed the selected procedures 
were included. 
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Procedures were chosen that appeared on both datasets and were classified 
according to Office of Population, Census and Surveys codes, version 4 (OPCS-4). 
During the study period, HES records were retrieved for patients with a primary 
diagnosis of colorectal cancer. This included colon, recto-sigmoid and rectal 
cancer. Patients that had undergone the following operations were included: right 
hemicolectomy (OPCS-4 codes, H06-7), transverse colectomy (OPCS-4 code, 
H08), left hemicolectomy (OPCS-4 code, H09), sigmoid colectomy (OPCS-4 code, 
H10),  abdomino-perineal excision of rectum (APER; OPCS-4 code, H33.1) , 
Hartmann’s procedure (OPCS-4 code, H33.5), anterior resection (OPCS-4 codes: 
H33.2-4, H33.6 ) in keeping with the NBOCAP dataset. Site of tumour was re-
coded into three categories- colon, recto-sigmoid or rectal according to the 
NBOCAP registry. 
Patients undergoing excision of benign lesions were excluded as were patients that 
underwent procedures in two Trusts on HES that did not appear in the NBOCAP 
dataset were excluded. Only three consultant episodes were excluded through 
removal of the latter two Trusts. Furthermore, one Trust was excluded that 
appeared in the NBOCAP report, as it is an oncological centre not performing any 
surgery. Laparoscopic and open, elective and emergency operations were included 
in the initial analysis. 
 
5.3.1 HES database 
The HES database is a nationally collated data warehouse containing details of 
admissions of NHS patients in England since 1986. The data are taken from each 
hospital’s Patient Administration System (PAS) for every inpatient and (since 
2003/4) outpatient Finished Consultant Episode (FCE). Demographic and any 
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procedural/diagnostic information within that admission period is captured against 
a unique patient identifier. The patient identifier allows identification of previous 
or subsequent admissions/procedural data pertaining to that patient. Each record 
also contains up to 13 International Classification of Disease 10
th
 revision (ICD-
10) secondary diagnoses and up to 12 [at the time of the analysis] procedural 
interventions recorded using the OPCS-4 codes (Faiz et al., 2008a). Deriving 
clinical outcomes from HES has been previously reported (Faiz et al., 2010c). 
 
5.3.2 Charlson co-morbidity Index 
The Charlson comorbidity scoring system is validated for use to predict patient 
outcomes based on concurrent co-morbidities (Newschaffer et al., 1997). It is a 
commonly used comorbidity index developed for administrative datasets and has 
been previously used in CRC patients (Rieker et al., 2002, Almoudaris and Omar 
Faiz, 2010). Comorbidities conferring worsening outcomes are given greater 
values. The secondary diagnosis fields were used to create the Charlson 
comorbidity index. 
The Carstairs index is a composite deprivation score calculated at the output-area 
level (average population 1500) converted into population-weighted quintiles. The 
score has been shown to be a good reflection of material deprivation factors. The 
index is used by health economists and government agencies for this purpose 
(Dolan et al., 1995, Morgan and Baker, 2006).  This was included for assessment 
as a social deprivation co-variate in to the model. 
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5.3.3 Emergency Status 
Admission status on the HES database is recorded as ‘elective’ or ‘non-elective’. 
All non-elective admissions were considered as emergencies.   
 
5.3.4 Outcomes 
30-day in-hospital mortality, length of stay (the mean natural logarithm with back-
exponentiation) and 28-day readmission rates were primary end points from the 
HES database. 30-day in-hospital mortality is defined as death from all causes 
occurring in hospital within 30 days of admission.   
 
5.3.5 Statistical Analysis 
Mortality, length of stay and readmission within 28 days were analysed using HES 
data and compare to outcomes between submitting and non-submitting units using 
the NBOCAP dataset. Chi-square testing was used to assess categorical variables 
including age that had been re-coded into age bands. Owing to its non-normal 
distribution, length of stay was analysed by log-normal transformation and 
independent t-testing with back exponentiation.  Multiple logistic regression 
analysis of 30-day mortality was performed. Covariates with significance p≤0.1 on 
univariate analyses were included in multifactorial regression analyses. 
Statistical Package for Social Sciences, version 17 for Windows was used for the 
statistical analysis (SPSS, Chicago, IL, USA).  
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5.4 Results 
Between 1
st
 August 2007 and 31
st
 July 2008, 17,722 patients were identified from 
HES as having been diagnosed with colorectal cancer and who underwent a major 
resection for colorectal cancer.  Over the same time period NBOCAP reported 
14,780 cases (83.4%). The same 152 Trusts in England were compared between 
the two databases. There were 20 Trusts in the non-submitter group (15 Trusts that 
submitted no data and a further 5 Trusts that submitted less than 10% of their total 
caseload). 3 missing emergency/elective admission status records were found in 
the submitter arm and were thus excluded from further analysis. 
Submitters and non-submitters were statistically similar in terms of age and gender 
and type of procedure performed (Table 8). 
 Table 8-Table of demographics of submitter versus non-submitter groups 
 Submitter (%) 
n=15815 
Non-Submitter (%) 
n=1907 
p-value 
Sex 
Male 
Female 
 
8829 (55.8) 
 6986(44.2) 
 
1039 (54.5) 
868 (45.5) 
 
0.265 
Age group   0.717 
20-40 390(2.5) 40 (2.1) 
41-60 4227(26.6) 505(26.5) 
61-80 9925(62.8) 1198(62.8) 
>80 1273(8.0) 164(8.6) 
   
Charlson Index 
0 
1 
2 
3 
4 
5 
6 
 
229 (1.4) 
60 (0.4) 
8984 (56.8) 
2629 (16.6) 
524 (3.3) 
2537 (16.0) 
843 (5.3) 
 
 
40 (2.1) 
14 (0.7) 
 1074 (56.3) 
289 (15.2) 
48 (2.5) 
332 (17.4) 
110 (5.8) 
 
 
 
 
0.013 
    
Carstairs    
Less deprived-1 3196(20.2) 377(19.8)  
2 3695(23.4) 481(25.2)  
3 3534(22.3) 497(26.1) <0.001 
4 2950(18.7) 328(17.2)  
Most deprived-5 2423(15.3) 224(11.7)  
Unclassified 17(0.1) 0(0.0)  
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 Co-morbidity scoring differed statistically between submitters and non-submitters 
(p=0.013). Fewer patients with comorbid disease were present in the submitting 
group. Submitters performed relatively more operations utilising the laparoscopic 
approach than non-submitters 18% (2847/15815) vs. 15% (287/1907) (p=0.001) 
(Table 9). Submitting Trusts performed fewer operations as emergencies (i.e. non-
electives) than non-submitting Trusts: 17.5% (2761/15815) vs. 19.3% (369/1907) 
(p=0.041) Table 9. 
Table 9- Table of type of resection and mode of admission by submitter status 
Table 9 Submitter (%) Non-Submitter (%) p-value 
Diagnosis 
Colon  
Rectosigmoid  
Rectum 
 
10213 (64.6) 
1322 (8.4) 
4280 (27.1) 
 
1237 (64.9) 
156 (8.2)  
514 (27.0) 
 
 
0.954 
   
Laparoscopy  
Yes 
No 
 
 
2847 (18.0) 
12968 (82.0) 
 
287 (15.0) 
1620 (85.0) 
 
0.001 
Admission type 
Elective 
Emergency 
 
13051 (82.5) 
2761 (17.5) 
 
 
1538 (80.7) 
369 (19.3) 
 
 
0.041 
 
 
A statistically significant increased risk of in-hospital death within 30 days of 
admission was observed in the non-submitting institution group [5.2% (100/1907) 
vs. 4.0% (628/15815), p=0.005]. Following case-mix adjustment for age, gender, 
comorbidity, social deprivation, use of laparoscopic technique, emergency/elective 
admission status and bowel location of tumour, submission of data to NBOCAP 
was associated with an independent reduction in 30-day mortality risk (OR=0.76, 
CI=0.61 0.96, p=0.021) (Table 10). A greater mean length of stay, following 
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natural logarithmic transformation and back-exponentiation, in the non-submitter 
group was also observed (Table 11). 
Table 10- Univariate and multivariate analysis of variables influencing 30 day mortality 
  
Univarate analysis Multiple regression analysis 
OR 
95% CI 
p OR 
95% CI 
p   Lower Upper Lower Upper 
Submitter vs non-submitter 0.77 0.61 0.96 0.022 0.76 0.61 0.96 0.021 
 
Elective vs Emergency 4.26 3.57 5.07 <0.001 4.04 3.43 4.77 <0.001 
         
Age 1.08 1.07 1.09 <0.001 1.08 1.07 1.09 <0.001 
 
Laparoscopy vs open 0.59 0.44 0.78 <0.001 0.58 0.43 0.77 <0.001 
 
Carstairs    <0.001    <0.001 
Less deprived-1  1.00    1.00    
2 0.96 0.74 1.25 0.777 0.96 0.74 1.25 0.782 
3 1.18 0.92 1.51 0.200 1.18 0.92 1.52 0.196 
4 1.39 1.08 1.79 0.011 1.39 1.08 1.79 0.010 
Most deprived-5 1.56 1.20 2.02 0.001 1.56 1.20 2.02 0.001 
         
Gender female vs male 0.82 0.70 0.96 0.014 0.81 0.69 0.95 0.010 
 
         
Charlson Score    <0.001    <0.001 
1  1.00    1.00    
2 2.93 1.45 5.92 0.003 2.94 1.45 5.93 0.003 
3 1.14 0.70 1.84 0.609 1.14 0.70 1.84 0.607 
4 2.16 1.32 3.55 0.002 2.15 1.31 3.54 0.002 
5 3.29 1.89 5.73 <0.001 3.27 1.88 5.69 <0.001 
6 1.99 1.21 3.28 0.007 1.97 1.20 3.24 0.008 
7 3.52 2.10 5.89 <0.001 3.48 2.08 5.83 <0.001 
 
Diagnosis         
Colon  1.00   0.131     
Rectosigmoid  0.97 0.71 1.33 0.855     
Rectal 1.24 0.99 1.53 0.051     
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Table 11- Study endpoints combined for patients undergoing elective and emergency surgery in 
submitting and non-submitting Trusts 
Study End points Submitter (n=15815)(%) Non-Submitter (n=1907)(%) p-value 
30-day mortality 
 
628 (4.0) 100 (5.2) 0.005 
Length of stay 
 
Mean 
 +/- SD 
 
 
 
 
10.9 
 +/-2.0 (8.9,12.9) 
 
 
 
11.5  
+/-1.9 (9.6,13.4) 
 
 
0.013 
Readmission 
No 
Yes 
 
14023 (88.7) 
1792 (11.3) 
 
 1703(89.3) 
 204 (10.7) 
 
0.408 
 
5.5 Conclusion 
A minor but significant difference in mortality rates between reporting and non-
reporting Trusts to a clinical registry have been demonstrated.  The clinical 
significance of the difference observed in real terms appears small however it may 
belie wider implications. If the findings potentially reflect genuine outcome 
differences that arise between Trusts that do and do not voluntarily submit data to 
clinical registries, then mandating reporting to such registries may be a future 
consideration if they are to be used nationally to benchmark performance and 
quality amongst surgical providers. However at the time of this analysis, it appears 
that the HES database is more reliable in reporting of important outcome measures 
in colorectal cancer surgery during the peri-operative period. For this reason and 
given the fact that this thesis is concerned with peri-operative outcome it has been 
decided to progress using HES as the primary data source. 
However, the limitation of HES that makes the use of clinical registries attractive, 
with respect to peri-operative outcome, is the recording of complications and 
patients subsequent outcome. At the time of writing HES had not been used to 
report on complications in colorectal cancer surgery. If some inference of 
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complications and their management could be made, this would greatly support the 
future use of HES for national quality performance appraisal. 
  
120 
 
6.0 FAILURE TO RESCUE-SURGICAL (FTR-S): A 
NOVEL MARKER OF SURGICAL COMPLICATION 
MANAGEMENT IN COLORECTAL CANCER 
PATIENTS DERIVED FROM HOSPITAL EPISODES 
STATISTICS (HES) 
 
6.1 Chapter overview 
If the HES database is to be used going forwards, as identified from the quality 
metrics and the systematic review, as well as the wider literature, complication 
management is a vital determinant of patients’ subsequent outcome. This is 
especially true in the peri-operative period. What the HES database lacks in its 
native form is any reflection of such complications. In this chapter attempt is made 
to derive a novel metric from the HES database and see if it can be used to report 
on aspects of surgical complication management that would strengthen the use of 
HES for national benchmarking and the identification of high performing units. 
 
6.2 Introduction 
 The management and prevention of complications has been the focus of increasing 
research interest in contemporary surgical literature (Berenguer et al., 2010). This 
is especially true in patients undergoing major colorectal surgery, where the 
presence of serious postoperative morbidity significantly increases the likelihood 
of death (Longo et al., 2000). Similar findings have been observed in other 
specialities also (Lebeau et al., 1990). Silber and colleagues termed the phrase 
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‘Failure to Rescue’ (FTR) describing patients who died after an acquired 
complication in hospital (Silber et al., 1992).  The metric they described represents 
the proportion of deaths that occur in those patients who experience complications. 
In a study investigating patients undergoing cardiac surgery they ranked hospitals 
according to their case-relevant mortality. They observed significant differences in 
FTR rates, between the best and worst ranked units despite equivalent complication 
rates (Silber et al., 1995). This suggests that the institutional management of 
complications is an important factor determining whether patients survive 
following the occurrence of morbidity. As such, FTR potentially represents a 
useful metric of complication management. 
The Agency for Healthcare Research and Quality (AHRQ) is the health services 
research arm of the United States Department of Health and Human Services 
(HHS) (Services, 2010). It produces freely available indicators of hospital quality, 
termed ‘Patient Safety Indicators’ (PSIs) that make use of inpatient hospital 
administrative data. Currently, one such indicator is termed ‘Death among surgical 
in-patients with serious treatable complications’(AHRQ, 2010) and is synonymous 
with FTR. The AHRQ defines this as the number of deaths in patients suffering 
one or more complications, from a select group of medical or surgical 
complications, per 1000 discharges. Furthermore, potentially avoidable 
complications represent a significant economic burden also. Medicare and 
Medicaid, two US governmental programmes that provide medical and health 
services to non-privately insured US citizens, have introduced measures 
withholding remuneration for certain perceived avoidable complications (Services, 
2008).  
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While FTR is undoubtedly an important concept, current analyses using 
administrative datasets may not effectively distinguish between pre-existing 
conditions (Talsma et al., 2010). Conditions Present On Admission (POA) have 
been shown to impact upon FTR rates when recalculated using refined algorithms 
(Moriarty et al., 2010) or upon case record review (Horwitz et al., 2007, Moriarty 
et al., 2010, Talsma et al., 2010). This questions the fitness for purpose of FTR in 
such a form.  Under these circumstances prior studies that have included total 
morbidity, i.e. complications of all severity, yield complication rates of up to 
36.4% (Ghaferi et al., 2009b). As a result, it may not be immediately apparent to 
what degree complications occurring in surgical patients are attributable to the 
surgical processes/decision making and what degree they are attributable to 
conditions present on admission that manifest after surgical interventions. 
Refinement of the FTR paradigm in the surgical context should consider the fact 
that patients experiencing some of the worst preventable complications are those 
that necessitate a return to theatre in the postoperative period. Evidence also 
suggests that patients that are re-operated are more likely to die (Ricciardi et al., 
2012).  It is suggested that this group of patients with the most serious surgical 
complications i.e. requiring a reoperation represent a well-defined group that could 
be a useful target for quality improvement.  The term ‘Failure To Rescue -
Surgical (FTR-S) is introduced as- the proportion of patients with surgical 
complications that die during their index admission following an unplanned re-
operation. 
The aim is to firstly see if such a metric can be derived from the HES. If possible 
to derive, the applicability of using FTR-S rates, as a reflection of complication 
management will be explored. If derivable from routinely-collected data, this may 
123 
 
represent a potential novel marker of surgical quality assessment. Secondly, the 
aim is to assess if any variability in FTR-S rates exists amongst units in England, in 
patients who have undergone a primary resection for colorectal cancer. This may 
help to validate this novel metrics for use.  
 
6.3 Methods 
6.3.1 Patient identification 
The methods follow those described in Chapter 5. For this analysis, patients were 
grouped into four age cohorts: 17-54, 55-69 and 70-79 and>79 years for purposes 
of the analysis.   
 
6.3.2 Risk adjustment models 
Similarly, the models were created in-line with the methodology described in 
Chapter 5. In this analysis, the Charlson score was considered in three categories 0, 
1-4 and ≥5. 
 
6.3.3 Re-operation 
A patient was classed as undergoing a re-operation if, on their index admission 
they were returned to theatre for a procedure as shown in Table 12. Elaine Burns is 
acknowledged for coding the initial re-operation dataset. From this, discrete re-
operative procedures were chosen. The choice of procedures aimed to reflect those 
that were most likely to represent unplanned returns to theatre, due to surgical 
complications. Time to re-operation was calculated as the number of days from the 
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index operation to re-operation. Returns to theatre up until midnight on the same 
day as the index resection are not discernible from the HES database for any 
procedure except for re-opening of abdomen- which is considered in the washout 
of abdomen category. Returns to theatre for examination under anaesthetic alone 
were excluded as these procedures were rarely solely coded for as the only reason 
for a return to theatre. More often they were coded alongside an additional reason 
for return to theatre; therefore, these patients were considered under the more 
‘major’ codes. 
 
  
Lowest Mortality 
Quintile 
Highest Mortality 
Quintile p- value 
No. of 
reoperations 
(n=1144) 
Deaths 
(n=127) 
No. of 
reoperations 
(n=1386) 
Deaths 
(n=233) Reoperations Deaths 
Primary reason for 
reoperation 
Washout of abdomen 177 (15.5) 22 (17.3) 221 (15.9) 45 (19.3) 0.681 0.281 
Small bowel resection 75 (6.6) 14 (11.0) 80 (5.8) 19 (8.2) 0.413 0.351 
Further colorectal 
resection 
192 (16.8) 26 (20.5) 238 (17.2) 67 (28.8) 0.933 0.073 
Drainage of intra-
abdominal abscess 
45 (3.9) 5 (3.9) 54 (3.9) 5 (2.1) 0.873 0.247 
Division of adhesions 86 (7.5) 7 (5.5) 78 (5.6) 14 (6.0) 0.037 0.881 
Stoma formation / 
operation on stoma 
351 (30.7) 55 (43.3) 430 (31.0) 105 (45.1) 0.681 0.690 
Wound complications 218 (19.1) 18 (14.2) 285 (20.6) 20 (8.6) 0.380 0.094 
 
6.3.4 Organizational structural information 
Information on hospital structural variables were derived from the Department of 
Health Hospital Activity Statistics website (Department of Health, 2010). Yearly 
data were collated and averaged over the study period for each Trust. 
Consideration has been made for the merging of units by aggregating the average 
values of merged units over time. To account for differences in unit size, structural 
factors were calculated per bed number and subsequently compared. For ease of 
Table 12-Types of reoperation and association with high and low mortality quintiles 
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description, average Intensive Care Unit (ICU) and High Dependency Unit (HDU) 
bed numbers and the number of theatres per in-patient bed were each multiplied by 
a factor of 100. Inclusion of structural data is intended to be reflective of the wider 
hospital within which the colorectal units function. 
 
6.3.5 Statistical analysis 
Statistical analyses were carried out using SPSS Version 18.0 (Statistical Package 
for Social Sciences, SPSS, Chicago, Illinois, USA).  Categorical variables were 
investigated using the Chi-squared test. The Mann–Whitney U test was used for 
non-parametric tests of structural data. Logistic regression analysis was used to 
investigate predictors of postoperative re-operation and for risk adjustment.  
Factors with a significance level of ≤ 0.1 on univariate analysis were included in 
the following step of the regression analyses.  For tests of significance, p values of 
<0.05 were considered significant.  
The methodology of ranking and comparing units was based on a previously 
published study (Ghaferi et al., 2009a). The overall risk-adjusted mortality was 
calculated for each unit. The risk-adjustment model included the type of resection, 
patient age, use of laparoscopy, gender, admission status (elective or non-elective), 
Charlsons comorbidity score and Carstairs index as co-variates. Logistic regression 
was used to predict the probability of death for each patient; these were summed 
for patients at each unit to estimate expected mortality rates. Next, the ratio of 
observed to expected mortality was multiplied by the overall mortality rate for each 
operation type to obtain the risk-adjusted mortality rate for each unit. Units were 
then stratified into quintiles (n=30 units per quintile) according to their risk-
adjusted overall mortality rates. 
126 
 
Units in the lowest mortality quintile are abbreviated to LMQ and those in the 
highest mortality quintile are abbreviated to HMQ.  LMQ and HMQ units were 
compared based on overall risk-adjusted mortality rate. Intermediate quintiles were 
also analyzed and to demonstrate any stepwise same direction effect in outcome- 
otherwise known as a montopic effect. 
 
6.3.6 Funnel plot 
Funnel plots were constructed using the tools available at 
http://www.erpho.org.uk/topics/tools/funnel.aspx. Funnel plots are validated 
methods of graphically representing performance data (Mayer et al., 2009a). The 
control limits use a normal approximation to the Poisson distribution.  
 
6.4 Results  
6.4.1 Demographic clinical characteristics 
144,542 patients underwent primary colorectal resections for colorectal cancer 
between the study dates in 150 English NHS units. 110,587 (76.5%) patients 
underwent elective procedures with the remaining 33,955 (23.5%) undergoing non-
elective procedures. There were 80,400 (55.6%) men and 64,142 (44.4%) women 
in the study. The number and type of resections for the whole cohort is described in 
Table 13.  
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6.4.2 Demographics according to quintile 
There were 25,082 (17.35%) patients in 30 units within the LMQ compared with 
27,630 (19.12%) patients in 30 units within the HMQ. Table 13 offers a description 
of characteristics for patients operated on between the extreme quintiles. Overall 
older patients were operated on in the LMQ units (p<0.001). More men were 
operated on in HMQ units (55.6% vs. 54.7%, p=0.026). There were more socially 
deprived patients in the LMQ units compared with more co-morbid patients in the 
HMQ units (p<0.0005). There were no differences in open / laparoscopic approach 
between the quintiles (p=0.927), but more rectal and subtotal/total procedures 
(p<0.008) were performed in the HMQ units (Table 13). 
  
 Lowest mortality 
quintile 
n=25,082 (%) 
Highest mortality 
quintile 
n=27,630 (%) 
p-value 
Age bands 
17-54 
55-69 
70-79 
>79 
 
2310 (9.2) 
8246 (32.9) 
8863 (35.3) 
5663 (22.6) 
 
2630 (9.5) 
9405 (34.1) 
9845 (35.6) 
5750 (20.8) 
 
<0.001 
 
Sex 
Male 
Female 
 
 
 
13,709 (54.7) 
11,373 (45.3) 
 
 
15,369 (55.6) 
12,261 (44.4) 
 
 
0.026 
Admission method 
Elective 
Emergency 
 
19,393 (77.3) 
5689 (22.7) 
 
21,177 (76.6) 
6453 (23.4) 
 
0.067 
 
Charlson  
0 
1-4 
>5 
 
 
13,536 (54.0) 
2105 (8.4) 
9441 (37.6) 
 
 
16,686 (60.4) 
2379 (8.6) 
8565 (31.0) 
 
<0.001 
 
Carstairs 
Less deprived 1 
2 
3 
4 
5 
Unclassified 
 
 
5558 (22.2) 
6699 (26.7) 
5737 (22.9) 
4340 (17.3) 
2704 (10.8) 
44 (0.2) 
 
 
5103 (18.5) 
6100 (22.1) 
6064 (21.9) 
5468 (19.8) 
4890 (17.7) 
5 (0.0) 
 
<0.001 
Table 13 Demographics between the different quintile groups 
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Colectomy / resection type 
Left sided * 
Right sided 
Subtotal / total 
Rectal 
 
 
5790 (23.1) 
8978 (35.8) 
1007 (4.0) 
9307 (37.1) 
 
 
6297 (22.8) 
9588 (34.7) 
1192 (4.3) 
10,553 (38.2) 
 
 
0.008 
 
Surgical approach 
Open 
Laparoscopic 
 
 
23,580 (94.0) 
1502 (6.0) 
 
 
25,970 (94.0) 
1660 (6.0) 
 
 
0.927 
*included Hartmann’s resection 
6.4.3 Organisational structural factors 
No significant differences were demonstrated between the quintiles in terms of the 
average number of in-patient beds (p=0.196), use of radiological imaging 
(Computerised Tomography [p=0.174], non-gynaecological ultrasound [p=0.515] 
or fluoroscopy [p=0.069]), the number of available theatres [p=0.233] or Intensive 
Care Unit beds [p=0.425]). A difference was however observed in the number of 
High Dependency Unit (HDU) beds available between the LMQ and HMQ units 
favouring more beds in the lower mortality quintile units (p=0.011) Table 14. 
Structural factor compared Lowest mortality 
quintile  
(median) 
Highest mortality 
quintile 
(median) 
p value 
Size-    
Average no. beds per unit 683.82 791.00 0.196 
    
Imaging-    
CT scanning 17.33 14.66 0.174 
Ultrasound scanning (non 
gynaecological) 27.54 28.90 
 
0.515 
Fluoroscopy 9.82 7.40 0.069 
    
Level I+II beds-    
ITU beds 1.32 1.05 0.425 
HDU beds 1.04 0.78 0.011* 
    
Theatres- 2.30 2.20 0.233 
    
 
Table 14- Median values of the number of scans performed per patient-bed per year, number beds per 
inpatient beds multiplied by a factor of 100 and number of operating theatres per inpatient bed 
multiplied by a factor of 100, Mann-Whitney U test 
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6.4.4 Overall Mortality by quintile 
A significant difference was observed between unadjusted mortality rates at the 
LMQ units (4.1% [1016/ 25,082]) and in the HMQ units (7.6% [2106/27,630], 
p<0.001). When this is adjusted for the previously described co-variates the overall 
risk-adjusted mortality for the best and worst quintile units was 5.42% and 9.31% 
respectively (p=0.029). 
 
6.4.5 Re-operation rates 
 
Quintile Mortality rate 
(adjusted) % 
Re-operation Rate 
(adjusted) % 
FTR-S rate (%) 
1st (lowest mortality) 4.1 (5.4) 4.6 (4.8) 11.1 
2nd 5.3 (5.2) 4.7 (4.7) 13.0 
3rd 6.2 (5.5) 6.0 (5.0) 14.4 
4th 7.2 (6.7) 5.1 (4.8) 15.4 
5th 7.6 (9.3) 5.0 (4.8) 16.8 
 
When including all quintiles the overall re-operation rate was 4.8%. 
(6911/144,542).  When units were stratified into quintiles for overall risk-adjusted 
mortality, re-operation rates were similar at the LMQ and HMQ units respectively 
[4.6% (1144/25,082) and 5.0% (1386/27,630), p=0.125]. When the re-operation 
rates were risk adjusted, the re-operation rates were comparable at 4.8% and 4.8% 
respectively (p=0.211) see Table 15. 
 
 
 
Table 15- Mortality, reoperation and FTR-S rates per quintile with figures in parenthesis 
representing adjusted values 
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6.4.6 Time to re-operation 
Figure 7 shows the distribution of days from index procedure to re-operation 
between quintiles. This demonstrates that patients were returned to theatre at 
equivalent times after their index procedure between LMQ and HMQ units (6.5 
days vs. 7.0 days, p=0.858) and peaked in a bimodal distribution for both types of 
units at 24-48hours and then at 7-9 days. 
 
 
 
 
 
 
 
 
6.4.7 Reasons for return to the operating room 
In patients that required a re-operation, besides division of adhesions where there 
was a small statistical difference in frequency between the quintiles, there was no 
statistically significant difference in the reasons for return to theatre between the 
two quintiles for any other cause of returns to theatre see Table 12.  
 
Figure 7- A paired bar chart demonstrating time to re-operation for high and low mortality 
quintile groups 
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6.4.8 Failure to Rescue rate after serious surgical complications (FTR-S) 
Despite differences in overall risk-adjusted mortality, little significant differences 
have been demonstrated in the patient demographics, availability of structural 
factors, re-operation rate, types and lead time to re-operation between the extreme 
quintiles.  However, when patients underwent a re-operation, 11.1% (127/1144) 
died in LMQ units versus 16.8% (233/1386) of patients in HMQ units based on 
risk-adjusted mortality (p=0.002). Overall patients requiring a re-operation in the 
HMQ units were 1.7 times more likely to die than had they undergone a re-
operation in a LMQ unit. 
 
6.4.9 Re-operation type before death 
In those patients that were not rescued after a re-operation (i.e. FTR-S), Table 12 
shows which re-operations were undertaken before death, by quintile. Relatively, 
operations for wound complications were more likely to be performed before death 
in LMQ units when compared with HMQ units (14.08% vs. 8.58%, p=0.094) as 
were drainage of intra-abdominal abscesses (4.23% vs. 2.15%, p=0.247); however 
there were no statistically significant differences observed in re-operation types 
undertaken before death between the quintiles.  
 
6.4.10 FTR-S and Volume 
Figure 8 is a funnel plot showing the FTR-S as observed over expected (O/E)  
FTR-S following re-operations for both quintiles. This demonstrates the O/E 
mortality of FTR-S is not clearly related to overall re-operation volume. FTR-S at 
14 units lay above the 2SD control limit signifying greater than merely random 
variation in this outcome measure.  
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Figure 8- Funnel plot demonstrating the Observed over expected number of deaths following 
reoperations by unit volume with those units above one being in the high mortality quintile 
 
7.0 Notable limitations 
Whilst operative re-interventions are important the importance of non-operative 
interventions such as the use of image guided drains in the management of serious 
surgical complications is acknowledged. On analyzing the dataset, such 
interventions were poorly coded. As a result they were excluded from the analysis 
to minimize the influence of reporting bias in the final results. 
 
6.5 Conclusion 
A new surgically relevant marker termed FTR-S has been defined. This marker has 
been derived from routinely collected HES data. The results demonstrate that high 
mortality hospitals (despite equivalent reasons and frequency) of returns to theatre 
have worse outcome from complication management. It has also been shown to 
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discriminate between high and low mortality units giving it construct validity. This 
study demonstrates the ability to identify serious surgical complications and 
importantly also appraise their outcome. This is likely to be a very important 
metric for identifying high performing units from HES.  
Due to the limitations of the data from HES a notable exception to this study is the 
influence of re-interventions that were non-operative- specifically the use of 
image-guided drains. These are important and should be considered in any 
evaluation of a unit’s complication management. As previously stated, at present 
coding in colorectal surgery is not robust enough to include these in a formal 
analysis. Given the importance of such interventions when considering outcome 
after complications it will be attempted to assess whether it is possible to discern 
their use in allied specialities (e.g. upper gastro-intestinal cancer surgery) where 
they occur relatively more commonly, as a proof of concept. 
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7.0 INFLUENCE OF OPERATIVE AND NON-
OPERATIVE RE-INTERVENTIONS IN OESOPHAGO-
GASTRIC CANCER RESECTIONS IN ENGLAND 
FOLLOWING SURGICAL COMPLICATIONS 
 
7.1 Chapter overview 
It remains to be seen whether non-operative re-interventions e.g. image guided 
drains can be derived from HES. Any complete consideration of complication 
management in major surgery must be able to appraise this type of intervention. 
Due to data limitations in colorectal surgery an attempt has been made in this 
chapter to use oesophago-gastric cancer surgery where non-operative re-
interventions occur more frequently and are more robustly coded for. 
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7.2 Introduction 
There were 462,000 new cases of oesophageal cancer (UK, 2011a) and 988,000 
gastric cancer diagnosed annually worldwide (UK, 2011b). Surgery is the mainstay 
for cure. Oesophageal and gastric cancer resections are, however, associated with 
significant postoperative mortality with notable variability between centres. The 
volume-outcome relationship has been demonstrated in upper gastro-intestinal 
cancer surgery (Skipworth et al., 2010, Pal et al., 2008, Markar et al., 2011, 
Anderson et al., 2011), which has led the drive to centralization of services in 
England.  
Another major determinant of outcome is the quality of postoperative complication 
management. The relationship between a hospital’s ranking for complication rate 
and rank for mortality is not a linear one. It has been shown that hospitals that rank 
worst for mortality are not necessarily those that rank worst for the number of 
complications accrued, suggesting that complication rate is not the only 
determinant of outcome following postoperative complications (Silber et al., 1995). 
In colorectal surgery it has been shown that despite similar surgical complication 
rates, variability in outcome following the management of these complications 
occurs between high and low mortality hospitals- this is termed failure to rescue-
surgical (FTR-S) (Almoudaris et al., 2011b). This metric is thought to represent a 
marker of how well post-operative surgical complications are managed. It may 
explain to a degree why such mortality differences and variability occur between 
colorectal cancer surgery units. In oesophago-gastric cancer surgery, such a 
relationship between re-interventions and postoperative outcomes has not been 
examined.  
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The hypothesis is that units with lower overall postoperative mortality re-intervene 
more often and are subsequently more successful than units with high mortality. 
This study aims to observe for differences in patient survival following re-
operations for complications that may occur, between high and low mortality 
hospitals undertaking oesophago-gastric cancer resections in England. A further 
aim of the study is to assess the usage and subsequent outcome of non-operative 
interventions such as endoscopic and interventional radiological therapies. 
 
7.3 Patients and Methods 
7.3.1 Study Design 
This study was a retrospective national cohort study of all patients diagnosed with 
a gastric or oesophageal cancer that underwent an elective primary major surgical 
resection between April 2000 and March 2010 inclusive in England. Data were 
obtained from the Hospital Episodes Statistics (HES) database as described in 
previous chapters.  
 
7.3.2 Patient selection 
All patients that underwent a primary resection for oesophageal or gastric cancer 
were included in the analysis. International Classification of Disease version 10 
(ICD-10) codes were used to identify these patients. OPCS-4 procedure codes used 
to identify oesophagectomy and gastrectomy were G01, G02, G03, G27 and G28. 
Ravi Mamidanna is acknowledged for undertaking the initial coding for procedural 
identification.  
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7.3.3 High and low Mortality group selection 
Units were stratified according to overall risk-adjusted mortality (see risk-
adjustment section below). A cut-off of 5% was chosen as an arbitrary threshold 
for combined mortality of a unit’s oesophageal and gastric 30-day mortality rate. 
This figure was chosen as high volume centers worldwide reportedly reproduce 
such rates for patients undergoing elective resections for cancer (Allum et al., 
2002, Siewert et al., 1998, Al-Sarira et al., 2007, Sano et al., 2004). Units with an 
adjusted mortality of 5% and lower were termed low mortality units (LMU) and 
those units with a higher adjusted mortality (>5%) were termed high mortality 
units (HMU).  
 
7.3.4 Complications / Re-operations 
Serious surgical complications that necessitated re-operations on the index 
admission were termed re-operations. Thus re-operations in this context can be 
thought of as a surrogate for serious surgical complications.  
Patients that emergently underwent one or more of a panel of operative procedures 
subsequent to the index procedure during the primary admission were deemed to 
have undergone a re-operation. The re-operative procedures were selected as those 
that most likely reflect serious surgical complications rather than planned “re-
looks”. The re-operations broadly fall under three categories - thoracotomy, 
laparotomy and laparoscopy. Examples of indications for re-operation include 
bleeding, organ space infections and bowel obstruction. Common procedures 
included under the heading ‘laparotomy’ were drainage of abscess/collection, 
bowel resection +/- stoma formation and washout of abdominal cavity.  
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7.3.5 Non-operative re- interventions (radiological / endoscopic) 
Patients that did not undergo a re-operation that underwent a radiologically guided 
percutaneous drainage procedure or an upper gastrointestinal endoscopic procedure 
post-operatively were identified and termed a non-operative re-interventions. 
Procedures before midnight on the day of the index operation were excluded as 
these may have been planned procedures that were undertaken as a part of the 
primary resection. Reasons for undertaking these re-interventions are not 
discernible from the database. However radiological guided drains and endoscopies 
performed after the day of surgery are likely to reflect a surgeon’s desire/threshold 
to investigate any deviations from a ‘normal’ recovery.   
 
7.3.6 Outcome measures 
The outcome measures were- 
1. Mortality following re-operations (a surrogate for surgical complications)- and, 
2.  Mortality following non-operative re-intervention (endoscopic and 
radiological), 
 
7.3.7 Outcome measures and the modified Clavien-Dindo surgical 
complication classification 
The validated modified Clavien-Dindo classification of surgical complications str-
atifies surgical complications according to seven grades, I to V, with two sub 
grades for grades III and IV ( IIIa, IIIb and IVa, IVb) (Dindo et al., 2004).  For this 
study grade IIIa and IIIb complications were of specific interest. The primary 
outcome measure were Failure to Rescue after non-operative re-intervention and 
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would represent outcome following Clavien-Dindo grade IIIa complications and 
FTR-S would represent outcome following Clavien-Dindo grade IIIb 
complications. Of note the original failure to rescue definition would have 
considered deaths following Clavien-Dindo grades I-IVb complications together 
see Table 16.  
 
Table 16- Modified Clavien-Dindo grading system of surgical complications and how they relate to the 
study outcome measures. 
Clavien-
Dindo 
Grade 
Definition Study outcome measures 
I Any deviation from the normal postoperative course 
without the need for pharmacological treatment or 
surgical, endoscopic and radiological interventions. 
 
II Requiring pharmacological treatment with drugs other 
than such allowed for grade I complications. 
Blood transfusions and total parenteral nutrition are 
also included. 
IIIa Surgical, endoscopic or radiological intervention not 
under general anaesthetic 
Failure to Rescue following 
non-operative 
intervention 
IIIb intervention under general anaesthetic Failure to Rescue- Surgical 
(FTR-S) 
IVa Single organ dysfunction (including dialysis)  
IVb Multi organ dysfunction 
V Death of a patient 
 
 
7.3.8 Statistical Analysis 
Risk adjustment 
Risk adjustment was carried out by creating a multiple regression model to predict 
the likelihood of binary outcomes  with covariates gender, patient age (considered 
in bands <60, 60-70, 71-80, >80 years), Carstairs Index (Taylor et al., 2003), 
Charlson comorbidity score (grouped as those with scores of <2 and those with 
scores of >=2 where latter group indicates more co-morbid patients) and the type 
of procedures performed (oesophagectomy or gastrectomies). Factors with a 
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significance level of ≤0·1 on bivariate analysis were included in the multiple 
regression analyses. Unit-level adjusted death rates were obtained for each hospital 
by dividing the hospital’s observed deaths by its model-predicted deaths and 
multiplying by the national crude death rate. Statistical analyses were carried out 
with SPSS version 18·0 (SPSS, Chicago, Illinois, USA). All p-values stated refer 
to two-sided values. 
 
7.4 Results 
7.4.1 Whole cohort patient demographics  
A total of 25,626 patients were electively admitted to 141 National Health Service 
(NHS) units in England over the 10 year period and included in the study. The 
demographics of the patients are shown in Table 17 as are the odds ratios of 30-day 
mortality as independently predicted by the considered covariates. Patients aged 
>80 years, more socially deprived patients (higher Carstairs index) and patients 
with more comorbidities (Charlson score >2) were more likely to die in hospital 
within 30 days (respective Odds ratios - 5·00, 1·36, 1·84, p<0·05 for all- see Table 
17Table 17.  
Table 17- Final multiple regression model of independent predictors and the relative odds risk of death 
in hospital at 30 days for the whole study cohort 
Covariate Number of 
patients 
n=25,626 
(%) 
Odd ratio of 30-day 
mortality 
(95% C.I) 
Significance 
(p-value) 
Resection Type 
Oesophageal  
Gastric  
 
 14955 (58·4) 
 10671 (41·6) 
 
1·00 
0·78 (0·70, 0·88) 
<0·001 
    
Age 
<60  
60-70 
71-80 
>80 
 
6450 (25·2) 
9402 (36·7) 
8165 (31·9) 
1609 (6·3) 
 
1.00 
1.75 (1·45, 2·10) 
3.28 (2·74, 3·93) 
5.00 (3·96, 6·33) 
<0·001 
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Gender 
Male  
Female 
 
18350 (71·6) 
7276 (28·4) 
 
1·00 
0·90 (0·79, 1·02) 
0·097 
    
Carstairs Index (1=less 
deprived) 
1 
2 
3 
4 
5 
6 
 
 
4487 (17·5) 
5610 (21·9) 
5633 (22·0) 
5157 (20·1) 
4644 (18·1) 
95 (0·4) 
 
 
1.00 
1.02 (0·84, 1·23) 
1.03 (0·86, 1·25) 
1.23 (1·02, 1·48) 
1.36 (1·13, 1·65) 
0.86 (0·31, 2·39)  
 
0·002 
Charlson Score (≤2=less 
comorbid) 
≤2 
>2 
 
 
15141 (59·1) 
10485 (40·9) 
 
 
1·00 
1·84 (1·65, 2·06) 
 
<0·001 
 
7.4.2 Mortality rates 
There were 1348 deaths in the whole cohort giving an overall crude death rate of 
5·3% for oesophageal and gastric resections combined. The crude death rates for 
patients undergoing oesophagectomy were 5·1% (758/14955) and 5·5% 
(590/10671) for those undergoing gastrectomies respectively. 
 
7.4.3 By mortality group (LMU versus HMU) 
When the units are stratified using a risk adjusted mortality threshold of 5%, 65 
units with 11,803 (46·1%) patients appear in the LMU group (≤5% adjusted 
mortality) with 13,823 (53·9%) patients in the HMU group (>5% adjusted 
mortality).  
 
7.4.4 Patient demographics  
There were no statistical differences between the two groups in terms of the type of 
resection undertaken (oesophageal or gastric, p=0·198), patients’ presenting age 
(p=0·765) or patients’ gender (p=0·341). There were relatively more socially 
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deprived patients (indicated by a higher Carstairs index) in the HMU than the 
LMU (p<0·001). There were also more co-morbid (indicated by higher Charlson 
score) in the LMU (p<0·001). More patients underwent minimally invasive 
approach (MIA) procedures in the LMU (985 versus 792, p<0·001) see Table 18. 
 
 
Table 18- Demographics between the mortality groups 
 LMU n=11803 HMU n=13823 p value 
Resection Type 
Oesophageal 
Gastric 
 
6922 (27·0) 
4881 (19·0) 
 
8033 (31·3) 
5790 (22·6) 
 
0·198 
    
Age 
<60 
60-70 
71-80 
>80 
 
2999 (11·7) 
4306 (16·8) 
3769 (14·7) 
729 (2·8) 
 
3451 (13·5) 
5096 (19·9) 
4396 (17·2) 
880 (3·4) 
 
 
0·765 
    
Gender 
Male 
Female 
 
8467 (71·7) 
3336 (28·3) 
 
9883 (71·5) 
3940 (28·5) 
 
0·341 
    
Carstairs Index 
(1=less deprived) 
1 
2 
3 
4 
5 (most deprived) 
6 (unknown) 
 
 
2039 (8·0) 
2510 (9·8) 
2567 (10·0) 
2357 (9·2) 
2237 (8·7) 
93 (0·4) 
 
 
2448 (9.6) 
3100 (12·1) 
3066 (12·0) 
2800 (10·9) 
2407 (9·4) 
2 (0·0) 
 
 
 
 
<0·001* 
Charlson Score 
(≤2=less comorbid) 
≤2 
>2 
 
 
6673 (56·5) 
5130 (43·5) 
 
 
8468 (61·3) 
5355 (38·7) 
 
 
 
<0·001* 
Use of MIA 
 
985 (8·3) 792 (5·7) <0·001* 
Teaching hospital 
status 
10/65 (15.4) 14/76 (18.4) 0.402 
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7.4.5 Re-intervention and mortality rates 
LMU and HMU had equivalent re-operation rates for surgical complications 
(thoracotomy and laparotomy combined) rates (5·4% versus 4·9%, p=0.105). LMU 
and HMU had significantly different non-operative re-intervention rates with the 
LMU performing more non-operative re-interventions (6·7% versus 4·7%, 
p<0·001).  
Patients were significantly more likely to die after re-operations in HMU units than 
in LMU units - what is termed failure to rescue-surgical: FTR-S (24·1% versus 
15·3%, p<0·001). Patients are more likely to die after a non-operative re-
intervention in the HMU (12·5% versus 7·0% p<0·001). 
 
7.4.6 Limitations 
The study is based upon an administrative data source. Any coding errors may 
potentially influence the results. Systemic under-reporting of re-interventions by 
disparate organisations within the same mortality grouping over the study periods 
could in theory lead to reporting bias. This is however unlikely. More general 
coding error could influence the results. However, this is unlikely given the proven 
accuracy of this dataset in recording diagnostic fields (Campbell et al., 2001, Burns 
et al., 2011c). Unfortunately, HES does not capture cancer stage (though the 
Charlson index includes metastases which was included in the adjustment model) 
and this may well have an influence on perioperative outcome, as will case-mix not 
fully adjusted for using the available data. However, it is unlikely that patients with 
stage IV disease would be undergoing major surgery, unlike in colorectal cancer 
144 
 
where some patients with obstructing colon cancer are stented as a bridge to 
elective (albeit expedited) surgery.  
The strengths of the study are that it is not subject to reporting bias. HES has been 
shown to record more deaths when compared with a voluntarily recorded clinical 
registry over similar time periods (Almoudaris et al., 2011a). Given the sample size 
and number of years considered, this study truly reflects the national outcome from 
oesophago-gastric cancer surgery. 
 
7.5 Conclusion 
It has been shown, using English national administrative data when units 
undertaking oesophageal and gastric cancer resections are grouped according to 
adjusted mortality, index admission re-operation rates for complications are 
equivalent between low and high mortality units. Low mortality units are, however, 
more likely non-operatively to intervene and are more likely to rescue patients 
from subsequent death after both re-operative and non-reoperative re-interventions. 
What this study reiterates is that variability in outcome following management of 
serious complications does also occur in patients undergoing upper gastrointestinal 
resection. This is in keeping with the current literature in other specialties (Ghaferi 
et al., 2009a). Our study also demonstrates that Failure to Rescue-Surgical rates 
differ by mortality grouping as in lower gastrointestinal surgery (Almoudaris et al., 
2011b).  
There is variability in outcome following serious surgical complications requiring 
re-operations between units undertaking oesophago-gastric cancer surgery in 
England. Units with lower overall mortality re-intervene more often and are 
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subsequently more successful. Future work should focus on why such variability 
occurs and identify methods for mitigating this variability. This study has shown 
that non-operative re-interventions are feasible to derive from the HES dataset. 
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8.0 BENCHMARKING COLORECTAL CANCER 
RESECTIONAL UNITS IN ENGLAND ON A PANEL OF 
METRICS USING HOSPITAL EPISODES STATISTICS 
 
8.1 Chapter Overview 
In this chapter an attempt is made to appraise the performance of all units in 
England undertaking colorectal cancer resections. This will be performed using a 
panel of metrics. These metrics will include those directly calculated from HES 
(e.g LOS, readmission within 28 days) as well as those sourced using external 
references (e.g death within 30 days- via linkage with ONS) as well as those that 
have been derived during the course of this thesis (e.g. FTR-S).  
 
8.2 Introduction 
In the United Kingdom comprehensive and mandatory healthcare data collection is 
performed routinely (The Information Centre (England), 2011, National Services 
Scotland, 2011, Department of Health Social Services and Public Safety (Northern 
Ireland), 2011). Measures of surgical quality are readily available from such 
administrative data sources. The utility of these measures depends upon their use to 
define quality and influence decision-making at a clinical, managerial or policy 
level. Several metrics relevant to colorectal surgery are derivable from routinely 
held data. These could potentially be used to benchmark performance in colorectal 
surgery. If this process were reliable it could inform broadly on surgeon-specific 
and institutional colorectal surgical performance. Moreover, if reliance upon 
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existing National Health Service (NHS) data sources (that lie within the public 
domain) were maintained for these purposes, transparent reporting of outcome to 
the public would follow. For such a system to be fair and robust two conditions are 
pre-requisites. Firstly, the accuracy of data used for benchmarking must be 
consistent at an institutional and surgeon level. In addition, an understanding of 
how individual metrics inter-relate to reflect high and poor surgical performance is 
needed. High achievement across all measured domains almost certainly reflects a 
proactive and competent provider. Secondly, can one however meaningfully 
comment upon provider performance from measurement of one domain alone? If 
so, what limits are meaningful? Alternatively, do these metrics reflect unique 
aspects of performance and demand individual appraisal (and remedial 
intervention)? 
Validated metrics may be used to benchmark performance between surgical 
providers and to underpin quality improvement initiatives.   Surgical measures that 
are easily obtained from routinely collected data include: 30-day mortality (Dimick 
et al., 2010b), in-patient length of stay (McPherson, 1984), and re-admission rates 
(Chambers and Clarke, 1990).  Additional markers of performance that are of 
relevance to colorectal surgery can also be derived from such data sources 
including short-term re-intervention (Merkow et al., 2009b) and Abdomino-
Perineal Excision (APE) rate (Morris et al., 2008). Other metrics, such as lymph 
node yield, R0 resection rate and quality of mesorectal excision, may be obtained 
from clinical registries (Association of Coloproctology of Great Britain and 
Ireland, 2011). The latter may also be used to evaluate service quality between 
providers (Jeyarajah et al., 2007). The aforementioned measures potentially form 
the basis for future quality improvement programmes (Lindenauer et al., 2007).  
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A publication by Morris and colleagues used administrative data linked to cancer 
registry information to report on the variation that currently exists in 30-day 
mortality rates between English NHS institutions undertaking colorectal surgery 
(Morris et al., 2011). Performance concerns, with regards to short-term survival 
outcome, may be justifiable in a limited number of outlying institutions. 
Clarification that poor peri-operative mortality rates denote poor global standards 
of colorectal surgical practice (e.g. associated high re-intervention rates, poor 
oncological outcomes etc.) clearly justifies public reporting of single performance 
measures.  As such, it is necessary to elucidate what it means to be an institutional 
outlier for 30-day mortality?. Lastly, an understanding of the limitations of specific 
outcome measures is becoming increasingly significant to individual surgical 
practitioners in the United Kingdom due to the implementation of compulsory 
revalidation of doctors (General Medical Council, 2011). Furthermore, as 
previously mentioned, there has been a drive publicly to report surgeons’ outcome 
data from nationally collected data. At present the Association of Coloproctology 
of Great Britain and Ireland (ASGBI) is openly reporting unit and individual 
surgeons’ outcome data following colorectal cancer resections. The outcome 
measure appraised is 90 day mortality following resection for 2012-13 
(http://www.acpgbi.org.uk/surgeon-outcomes/search) from data submitted by 
individual surgeons via their hospitals’ own registration to a national clinical audit 
program (https://clinicalaudit.hscic.gov.uk/nboca). 
 
The primary aim of this study was to explore from an English national 
administrative database the relationships between commonly collected and 
derivable metrics. A secondary aim is to identify whether units can be appraised on 
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a panel of metrics that may be more informative than just the reporting of one. 
Specifically, national data was used to correlate institutional 30-day mortality rate 
with other outcome metrics. In addition, the performance of statistical ‘outliers’ for 
30-day mortality across other quality domains at an institutional level was 
analysed.     
 
8.3 Methods  
Hospital Episodes Statistics (HES) database and patient selection 
The HES database is an administrative dataset to which all National Health Service 
(NHS) hospitals compulsorily submit patient level information and has been 
described previously. 
All patients that underwent a primary major colorectal procedure with a diagnosis 
of colorectal cancer between April 2000 and March 2008 in English NHS Trusts 
were included. Patients were identified using diagnostic and procedural codes from 
the relevant International Classification of Disease 10
th
 revision (ICD-10) and 
Office for Population Census and Surveys Classification of Surgical Operations 
and Procedures 4th Revision (OPCS-4) codes on the HES database. A detailed 
methodology of this process has been described previously (Faiz et al., 2010c). The 
following resections were analysed - right and extended right hemicolectomies, 
transverse colectomy, left hemicolectomy, sigmoid colectomy, Hartmann’s 
procedure, subtotal colectomy, panproctocolectomy, total colectomy, anterior 
resection (AR) and abdominoperineal resection (APER). The corresponding 
OPCS-4 procedural codes are described previously. 
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The Charlson co-morbidity scoring system was developed for administrative 
datasets (Charlson et al., 1987). Co-morbidities that are associated with worse 
outcomes are given greater scores. Secondary diagnosis fields on HES were used 
to create the Charlson co-morbidity index. Charlson score was re-classified into 
three categories 0, 1-4 and ≥5. The Carstairs index (Morgan and Baker, 2006) is a 
composite socio-economic deprivation score calculated at the output-area level  
and converted into population-weighted quintiles (Morgan and Baker, 2006). 
 
8.3.1 Outcome metrics 
i) Length of stay, re-admission within 28 days and mortality within 30 days 
Institutional lengths of admission stay for the above procedures (taken as a basket) 
were described as mean values following logarithmic conversion as the 
percentages of patients that had lengths of stay greater than the population 75
th
 
centile. 28-day re-admission and 30-day mortality rates were expressed as 
proportions (in percentages) of the total caseload. 
ii) Reoperation rates 
Reoperation rates are computed from HES data employing a methodology that has 
been described previously. Reoperation describes any patient returned to theatre 
after their index procedure for a select group of interventions within 28-days. The 
codes for reoperations include those denoting: washout of abdomen, small bowel 
resection, further colorectal resection, drainage of intra-abdominal abscess, 
division of adhesions, stoma formation or operation on a stoma and wound 
complications requiring return to theatre. Reoperation rates are calculated as a 
proportion of the total volume of index procedures undertaken. 
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iii) Abdomino-Perineal Excision (APE) rate 
Where the primary diagnosis was rectal cancer, the APE rate was calculated as the 
number of non-emergency APE resections performed over the total volume of 
other procedures performed for excision of a rectal cancer. Other procedures 
included Anterior Resections, Hartmann’s resections, excision of rectum 
unspecified/other, panproctocolectomy, total colectomy, sigmoid colectomy and 
excision of left hemicolon. These were converted into a percentage. OPCS-4 and 
ICD-10 codes used are previously described. 
iv) Failure to Rescue – Surgical (FTR-S) rate 
FTR-S rate is defined as the proportion of patients that die on their index admission 
after being returned to theatre (for the procedures listed above). The methodology 
used to calculate FTR-S has been described in Chapter 6 (Almoudaris, 2011).  
 
8.3.2 Statistics and funnel plots 
Outcome rates were calculated per institution for correlation and comparison 
purposes. Correlation between linearly distributed outcome variables was 
investigated using Pearson’s statistic. Length of stay required logarithmic 
transformation before application of linear statistical methods.  
Adjustment was carried out using multiple regression analyses. Models 
incorporated covariates including patient gender, age, Charlson co-morbidity score, 
Carstairs deprivation index, type of resection and method of admission - 
elective/emergency. These were aggregated on a per institution level for each 
metric considered and used to create case-mix adjusted funnel plots for each 
dependent variable. Funnel plots (Spiegelhalter, 2005) were created using the tools 
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available at http://www.erpho.org.uk/topics/tools/funnel.aspx. The control limits 
displayed are the exact Poisson control limits. 
 
8.4 Results 
 
8.4.1 Patient Population 
144,542 patients were analysed that had undergone a primary major colorectal 
cancer resection between April 2000 and March 2008 in 149 NHS units. Patient 
demographics are described in Table 19.   
Table 19- Demographics of the patients included in the study 
 Primary major 
 colorectal resections 
2000-2008 
n=144,542 (%) 
Age bands 
17-54 
55-69 
70-79 
>79 
 
13,705  (9.5) 
48,600  (33.6) 
51,598 (35.7) 
30,639  (21.2)  
 
Sex 
Male 
Female 
 
Year of Procedure 
 
 
80,400  (55.6) 
64,142  (44.4) 
2000 
2001 
2002 
2003 
2004 
2005 
2006 
2007/8 
 
Admission method 
Elective 
Emergency 
18004 (12.46) 
17290 (11.95) 
17692 (12.24) 
17488 (12.10) 
17751 (12.28) 
18837 (13.03) 
18511 (12.81) 
18969 (13.13) 
 
 
111,037  (76.8) 
33,505  (23.2) 
 
Charlson  
0-1 
2-4 
>5 
 
 
82,675 (57.2) 
12,598 (8.7) 
49,269 (34.1) 
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Carstairs 
1 (least deprived) 
2 
3 
4 
5 (most deprived) 
Unclassified 
 
28,141  (19.5) 
33,338  (23.1) 
31,917  (22.1) 
28,135  (19.5) 
22,911  (15.8) 
100  (0.1) 
 
Colectomy / resection type 
Left sided * 
Right sided 
Subtotal / total 
Rectal 
 
 
33,354 (23.1) 
50,804 (35.1) 
6,174  (4.3) 
54,210  (37.5) 
 
Method 
Laparoscopic 
Open 
 
 
6,380  (4.4) 
138,162  (95.6) 
 
 
A funnel plot describing risk adjusted in-hospital 30-day mortality rate for all 149 
NHS institutions was charted (Figure 9). The funnel plot depicts the adjusted upper 
and lower 2
nd
 and 3
rd
 standard deviation (SD) control limits for varying caseload. 
Units were described as outliers if they lay above or below the respective 3SD 
control (99.8%) limits. Units were described as lying within acceptable limits if 
they lay below the upper 2SD control (95.0%) limit.  
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Figure 9- Funnel plot demonstrating the risk adjusted 30 day mortality of all units undertaking 
colorectal cancer resections in England 
 
The funnel plot highlighted five institutions whose mortality rates lay on, or above, 
the upper 3rd SD control limit (i.e. have significantly higher than expected 
mortality rates at the 99.8% confidence level). These institutions were termed High 
Mortality Outlier (HMO) units. Fifteen units were identified below or on the lower 
3
rd
 SD control limit (i.e. significantly lower mortality than expected at the 99.8% 
confidence interval). These were described as Low Mortality Outlier (LMO) units  
(Figure 9). 
8.4.2 HMO units 
All five HMO units lay within acceptable limits for re-admissions and APE rates 
(Figure 10 and Figure 11) when identified on case-mix adjusted funnel plots. All 
but one unit (institution D) lay between the control limits for length of stay (Figure 
12).  
155 
 
 
Figure 10- Funnel plot of unit’s re-admission rates within 28 days 
 
 
Figure 11- Funnel plot of adjusted APE resection rates 
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Figure 12- Funnel plot of percentage of patients with lengths of stay greater than the 75th percentile 
 
When the HMO units A-E were charted on a case-mix adjusted funnel plot for 
reoperation rates, unit D lay within acceptable limits whereas unit C lay below the 
lower 3
rd
 SD control limit (i.e. lower than expected reoperation rates). In contrast, 
units A, B and E all demonstrated higher than expected reoperation rates- Figure 
13. 
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Figure 13- Funnel plot of units adjusted re-operation rates 
 
A funnel plot describing case-mix adjusted institutional FTR-S rates demonstrated 
that units A, D and E lay within the acceptable limits (Figure 14). Unit C 
demonstrated a significantly lower FTR-S rate than expected. In contrast unit B lay 
above the upper 2nd SD control limit indicating that a greater number of patients at 
the institution failed to be rescued. 
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Figure 14- Funnel plot of adjusted Failure to Rescue- Surgical rates 
 
 
Table 20 summarises the performance of the HMO units and how they performed 
on the other considered metrics in a simple matrix.  
Table 20- Summary table of how the High mortality outlier units performed on other measures 
High Mortality 
Outlier Unit 
Reoperation FTR-S Re-admission 
rates 
Length of stay APER rate 
A HE - - - - 
B HO HE - - - 
C LO LO - - - 
D - - - HE - 
E HO - - - - 
HO=High Outlier (lying above upper 3rd s.d control limit),  
LO=  Low Outlier (lying below  lower 3rd s.d control limit),  
HE=Higher than expected (lying above upper 2nd s.d. control limit),   
LE=Lower than expected (lying below lower 2nd s.d control limit), 
‘-‘ indicates performance within the expected range. 
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8.4.3 LMO units 
13/15 LMO units performed within acceptable limits with several performing 
better than expected when charted on case-mix adjusted funnel plots for re-
admission rate, length of stay and FTR-S (Figure 10, Figure 12, Figure 14) . When 
reoperation rate was charted one LMO unit was observed to perform less well than 
expected lying above the 2
nd
 s.d. control limit. The remaining 14 units performed 
as well as, or better than, expected (Figure 13). One LMO unit lay above the upper 
3
rd
 SD control limit for APER rates (Figure 11). 
 
8.4.4 Institutional outcome metric correlation  
Correlations between institutional 30-day postoperative mortality rate and other 
outcome measures are described in Table 21.  At institutional level, when 30 day 
mortality is correlated against FTR-S rates a significant correlation is observed 
(R=0.445, p=<0.001). When institutional 30-day postoperative mortality rate is 
correlated against reoperation rate, a weak statistical correlation is observed 
(R=0.191, p=0.020). Mortality did not correlate statistically with: 28 day re-
admission rates (R=0.143, p=0.082), APER  (R=0.119, p=0.147) or length of stay 
(R=0.148, p=0.072). 
Table 21- Table demonstrating individual Pearson’s correlation statistics and significance values per 
metric against 30d mortality (adjusted) 
 Return to 
theatre rate 
FTR-S rate    28d 
readmission 
Length 
of stay 
APER 
rate 
30-day Mortality 
R 0.191 0.445 0.143 0.148 0.119 
p-value 0.020 <0.001 0.082 0.072 0.147 
Significant correlation at p<0.05 have been highlighted in bold 
R= Pearsons correlation R value, sig.=two tailed significance value. 
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8.5 Conclusion 
The current study suggests that high institutional postoperative mortality rate 
following colorectal surgery does not necessarily predict how such units perform 
on other measures of service quality. Benchmarking institutional colorectal 
surgical performance is complex and not generalisable from a single measure of 
outcome, but rather demands global service appraisal across a range of outcome 
measures including those that are novel and derivable from HES. 
However whilst appraisal using the currently available data has been shown to be 
feasible, Lilford’s intervening variables of more subtle markers of institutional 
performance are recalled. Such analysis has not taken such factors into account. 
What follows is an attempt to construct a novel methodology and to pilot it, in an 
attempt to discern whether a truly global perspective of a surgical unit’s 
performance is possible. 
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9.0 DEVELOPING A TOOL TO INVESTIGATE 
DRIVERS OF INSTITUTIONAL QUALITY IN 
COLORECTAL SURGERY 
 
9.1 Chapter Overview 
This study attempts to ascertain whether it’s possible to identify factors that are not 
discernible from appraisal of databases for the assessment of high performance in 
surgery using a novel methodology.  This study has been termed the High 
Performance (HiPer) methodology study. In essence this chapter attempts to 
identify “what lies behind the numbers”. Can a tool/methodology be devised that 
appraises aspects of care such as team-work and institutional culture, which can 
then be related to hard-outcome data? 
 
9.2 Introduction 
High performing organisations exert an understandable fascination for everyone 
concerned with the safety and quality of healthcare and the often inconsistent and 
unreliable nature of much of the care actually delivered.  In healthcare the original 
studies by the Berkeley group of nuclear power, naval aviation and air traffic 
control have been very influential and inspired much commentary and 
interpretation (La Porte, 1996). These High Reliability Organisations (HROs) are 
those which, in the face of considerable hazards and operational complexity, 
manage to achieve high levels of both safety and performance (Hofmann et al., 
1995).  HROs are frequently referenced as models to which healthcare should 
aspire, particularly because their environment and challenges seem to have much in 
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common with the dynamic and uncertain healthcare environment (La Porte, 1996, 
Roberts et al., 2005). 
 
Studies of high reliability organisations, whether in healthcare or other industries, 
have tended to be largely descriptive in nature and present a number of difficulties 
for those wanting guidance on the best route to high performance (Vincent et al., 
2010). The original studies and later interpretations drew attention to a very wide 
range of characteristics said to be important to reliable performance and the range 
of alleged high reliability concepts is now enormous. More recent studies of high 
performing systems have greatly clarified the key elements underlying high 
performance and introduced some welcome conceptual clarity (Baker, 2008).  
Even so, the field has remained resolutely descriptive with few attempts to measure 
high reliability characteristics or relate them to substantive clinical outcomes. The 
challenge now is to take this rather diffuse set of ideas, refine them, and test them 
in a healthcare context. This requires finding a robust and efficient method of 
assessing relevant clinical and organizational characteristics.  
Both researchers and regulators have struggled to find an effective way of 
assessing a hospital or unit's clinical and organisational processes. Self-assessment, 
as used by many regulatory agencies, while useful in that context, is obviously 
subject to numerous potential biases. Survey data suffer from low response rates 
and are unlikely to enable us to discern the nuances of patient care. Site visits, 
while attractive in the depth of understanding that might be gained, are expensive, 
difficult to arrange and potentially disruptive influences in already stretched 
organisations (Vincent, 2013).  However studies in the commercial sector suggest 
that structured telephone interviewing can provide a reliable means of assessing 
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organisational characteristics. This method of assessing organisational performance 
has been found to be remarkably effective, with high reliability obtained between 
interviewers, robust scoring and validity demonstrated by the association of 
findings with objective data (Bloom and Van Reenen, 2007). This management 
measure has been found to correlate with general financial and operational 
outcomes in both healthcare and industry.  
 
The aim is to describe the development of the High Performance (HiPer) 
methodology, a structured method of assessing clinical and organizational 
characteristics of clinical systems producing quantitative data which subsequently, 
may, be linked to clinical outcomes.  
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9.3 Methods 
9.3.1 The evolution of the HiPer Methodology 
The methodology was a planned stepwise progression. There were 4 main steps to 
the creation of the methodology.  
 
9.3.2 Step 1 -Systematic review 
A comprehensive review entitled "Establishing Quality in Colorectal Surgery" was 
initially undertaken (Almoudaris et al., 2011c). The purpose was to identify salient 
structural, process and outcome factors that pertain to high performance and 
quality in colorectal surgery from contemporary literature. The review was used as 
the basis of identifying important factors and themes that needed to be considered 
in appraising and understanding how high performance and clinical quality are 
achieved in a real-world setting.  
 
9.3.3 Step 2- Expert consensus 
The purpose of this stage was to develop consensus as to which themes, from those 
identified in the systematic review, should be used to populate the final tool. The 
specific brief the experts were given was "What aspects of the surgical care 
pathway do you think should be further investigated in a study of high performing 
colorectal surgical units?". The 5 experts were offered all of the themes from the 
review and were allowed to suggest others. The experts were also encouraged to 
explain why they thought selection of the specific facet of care was important. This 
subsequently aided and guided development of the individual questions. Experts 
were independently practicing colorectal clinicians of Consultant grade. Each had 
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published over 50 peer reviewed articles. The experts were chosen from around the 
Western world and reflected the continents of the final participating units. The 
process was undertaken via email with all responses sent to back to me. I co-
ordinated the process and collated the final responses. 
 
9.3.4 Step 3- Development of semi-structured interview protocol 
Once a list of 9 themes had been reached with consensus agreement the 
development of the semi-structured interview began. These were preceded by one 
very broad, open ended theme/question to give a total of 10 questions. Questions 
were estimated each to take 4 minutes to discuss. This resulted in a standard 
interview length of 40 minutes. For each of the identified themes from the expert 
consensus exercise, a question was derived with multiple stems. The questions 
were open ended and purposefully non-specific at times to encourage participants 
to discuss factors that they felt were important rather than be guided by the 
question. Alongside the interview protocol a marking schedule was also developed. 
For each of the 9 marked questions, a 7 point Likert scale was created. For each 
point an indicative response to attain that mark was given. The intention was that a 
score of 1 would represent detrimental care and a score of 7 would represent 
exceptional care. The questionnaires would be delivered by trained interviewers. 
 
9.3.5 Step 4- Interviewer training 
A bank of interviewers was selected and trained in interview techniques. The 
interviewees were also given the brief of the project. All were senior colorectal 
surgical trainees undertaking higher research degrees. Interviewers were given the 
interview schedule and the mark scheme one month before their first scheduled 
166 
 
interview to assimilate. The interviewers were each assigned units and arranged the 
telephone interviews via email. The interviewers would score the response in real-
time for each question. The interviewers were also encouraged to make free text 
notes as well.  
 
 
9.3.6 Choice of participating units and subjects  
9.3.6.1 Participating units- the Global Comparators Project  
Collaboration with the Global Comparators initiative run by Dr Foster Intelligence 
(http://globalcomparators.com/) for piloting this methodology was chosen. Dr 
Foster Intelligence has brought leading global academic hospitals together which 
have individually submitted patient level data. The aim of the project was to share 
best practice, collective learning to improve cost-effectiveness, efficiency and 
ultimately patient outcome. The group consists of large academic teaching 
hospitals from mainland Europe, England and the United States. At the time of the 
study there were over 30 leading academic hospitals involved (more have joined 
since). On joining the project each hospital submits its patient level outcome data 
on a range of pathologies including colorectal surgery to Dr Foster Intelligence. 
Units’ data are then compared by pathology and risk-adjusted. The overview of the 
process and exact methodology has been published by the Global Comparators 
group (Bottle et al., 2013). 
All participating units undertook the necessary ethical and board clearances 
including Institutional Review Board (IRB) for the participating units in the United 
States.  
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Specifically, the main reason for choosing the Global Comparators for the source 
of data comparisons rather than continuing to use HES data for institutions in 
England alone pertains to data governance issues of using HES data. The data 
governance that bound access to HES data meant that it was not possible to 
identify units specifically by name. The inclusion of English units in HiPer was 
made possible as the unit’s individually and independently submitted data outside 
the HES submission pathway and directly to Dr Foster Intelligence hence allowing 
for their inclusion. Without using this collaboration it would not have been 
possible to compare any results from the HiPer study with subsequent outcome - 
one of the final aims of the thesis. All participating units in the Global 
Comparators group were invited to take part in piloting of the HiPer tool. The final 
units that completed the necessary ethics clearance and replied to the request to 
participate in the pilot study are given in Table 22. 
Unit Name Continent 
AMC Amsterdam 
Europe 
Chelsea and Westminster Hospital 
Royal United Hospital Bath NHS Trust 
University Hospitals of Leicester NHS Trust 
University Hospital of South Manchester 
Uzleuven Belgium 
  
Hospital of the University of Pennsylvania 
USA UC San Diego Medical Center  
UT Southwestern Medical Center 
Table 22 Table of the final units included in the HiPer study 
 
9.3.6.2 Selection of interviewees within each participating unit 
It was decided to interview one colorectal surgeon, a ward nurse that cares for 
colorectal patients, an anaesthetist/intensivist and a manager with direct 
responsibility for colorectal surgical patients/department. The aim was to give a 
balanced view of the day to day workings of the department. By gaining an insight 
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from different respondents it allowed for triangulation of responses where relevant. 
The term manager in this context related to any person with responsibilities for 
managing the day to day operation of the unit as well as financial and staffing 
responsibilities. The managers could be clinical or non-clinical. Interviewees were 
selected using a judgement sampling methodology (Perla and Provost, 2012).  
 
9.3.7 Reliability testing 
The interviewers each underwent a mock interview with me to ensure consistency 
and clarity of the interview schedule. All interviews were recorded to allow for 
reliability testing subsequently. A sample of 10 interviews were listened to again 
and the questions were re-scored for inter-rate reliability. I was blinded to the 
original scores during this process. The pooled Kappa value for the sample 
analysed was 0.83 with a p<0.001. 
 
 
9.3.8 Co-ordination of the process 
To ensure the process was delivered on schedule and that all participating units 
were interviewed in a timely fashion I co-ordinated the process. Contact was made 
with one representative member of the Global Comparators group either in person 
or via email that had expressed an interest in participating using a bespoke 
standardised correspondence (Appendix 2). I undertook training and received a 
National Institute of Health Human Subjects Protection training certificate before 
commencement of the study. A database of participants was created at each 
institution with their institutional contact details that was encrypted. Once all 
interviewers were trained and tested, the process went live. Initial contact details 
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for a single institution were given to one interviewer at a time. The interviewers 
then made initial contact via e-mail and sent the four participants introductory 
emails and the overall goals of the project. I was carbon copied into all email 
correspondences. The interviewers were then free to arrange mutually agreeable 
times with the participants to undertake the recorded interviews. Track of all 
interviews performed and progress was noted centrally. An overview of the whole 
process is given in Figure 15 . 
 
  
Figure 15- Scheme of how HiPer was planned and undertaken 
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9.4 Results 
What are reported here are the final results from the interview planning phase and 
the development of the questionnaire. The included themes are given in Table 23. 
Furthermore, preliminary findings are also given to demonstrate the practical 
feasibility of undertaking such a study. 
 
9.4.1 The included themes for the interview protocol 
An outline of the final themes selected for inclusion into the interview schedule 
with example questions and reasoning are given in the table below- 
Table 23- Table of the final themes selected by the expert consensus for inclusion into the questionnaire 
with example questions 
Facet of care 
analysed 
Example question Reason 
Opening 
question 
“Can you talk me through the process a 
patient with colorectal cancer that needs 
an operation at your unit undergoes?”  
Gives the participant the 
opportunity to describe what they 
think is important in the pathway 
at their unit 
Structural 
facilities 
available 
 
(2 questions) 
"Tell me about provision of CT scanners, 
interventional radiology and access to 
the operating room in your unit" 
 
“What about out of hours?” 
To discern whether there were any 
wide variations in the availability 
of structural factors 
Decision to 
operate 
"Who decides when to operate?, is there 
a multi-disciplinary meeting / tumour 
board meeting?" 
This question aims to understand 
the inputs and multidisciplinary 
nature of decision making. 
Pre-operative 
care 
"How are patients pre-assessed and risk 
stratified for surgery?"…."Who does 
this?" 
To identify what routine processes 
patients undergo to be optimized 
for surgery.  
Post-operative 
care 
"Who reviews patients after their 
operation"…"How many years post-
graduation are they?" 
Quantifying how often and how 
senior a review is undertaken in 
the post-operative period   
Identification 
of 
complications 
"What methods does your unit employ to 
detect complications in the peri-operative 
period?"  
To discern whether any early 
warning scoring systems are used 
or other ward based interventions 
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Teamworking "How are patients handed over / handed 
back between nursing staff and doctors 
and clinical teams?" 
To understand the process patient 
information is shared in the 
hospital 
Informatics "Are any outcome measures discussed by 
the team" "If so tell me more" 
Aims to identify whether any 
goals or standards are worked 
towards. Also attempts to identify 
what and who drives this. 
Quality 
improvement 
“What drives quality improvement in 
your unit?” “What role do managers 
have in the unit” 
The role of people with 
managerial responsibilities is 
probed.  
 
9.4.2 Illustrative findings of feasibility 
In all 9, units participated in the initial feasibility study. Included is an excerpt 
from one question to illustrate the methodology in practice. Described are the 
findings from the question entitled “Post-operative care”. This question attempts to 
identify certain key aspects of post-operative care- 
 How often and by whom are patients seen post-operatively (surgical and 
anaesthetic)? 
 What seniority are these people performing the reviews in post graduate 
years? 
 
In these examples a Consultant represents the most senior clinician which 
translates as an attending in the United States. For brevity just the term Consultant 
will be used. 
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Table 24 is an excerpt from the scoring schedule for this question. The score with 
the typical indicative response is given. A higher score denotes higher quality of 
care.  
 
Table 24- A table demonstrating the indicative scores and responses as per the marking schedule 
Score 1 3 5 7 
Indicative 
response 
consultants do 
not review 
patients before 
discharge 
 
juniors only 
review patients 
if ‘required’ 
consultants review 
patients only if 
required  
 
only most junior 
member of team 
reviews patients 
daily* 
consultants review 
patients daily 
 
on weekends 
patients reviewed 
by an on-call team 
(not necessarily 
own team) 
Operating 
consultant 
reviews own 
patients daily 
including 
weekends and 
national 
holidays 
 
*seniority of clinician was standardised by determining how many years post full 
qualification if there were any doubts due to regional variation. 
The table below gives illustrative results as recorded by the interviewers real-time 
for surgeons and nurses for the question in relation to post-operative care in one 
institution. 
 
Table 25- A table demonstrating the scores as recorded by the interviewers between two respondents for 
one question in the same institution 
Unit Respondent Score 
 Surgeon Nurse 
A 5 5 
B 7 6 
C 4 4 
D 4 4 
E 7 6 
F 6 6 
G 6 6 
H 5 4 
I 7 6 
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9.4.3 Free text and on re-analysis of audio-recordings 
Below are excerpts from the audio recordings that illustrate the findings as 
tabulated above. All recordings were re-listened to. The purpose of doing so was to 
extract more in-depth findings. The findings of the free text analysis is illustrated 
using the table below- 
 
 
Table 26- Indicative quotations from free-text analysis for two separate units on the same question 
Unit Indicative quotations 
 Surgeon Nurse 
F “They get seen every day by me, 
well definitely during the 
week…mine might not get to 
see me on a Sunday but a 
registrar will see them, but we 
(the consultants) generally come 
in on weekends even if we are 
not on-call” 
 
“Patients are seen daily by the 
surgical consultant and again by 
the juniors daily” 
 
 
“On weekends Consultants do 
see them but it won’t necessarily 
be their own consultant” 
   
C “Well day to day management is 
done by the registrar… and 
most consultants do a round 
twice a week, but we 
(consultants) do see them on 
day one post-op always” 
 
“On weekends they are seen by 
the on-call team” 
“Well they (the patients) would 
be seen twice a day by a 
registrar…and the consultants 
seeing them, well not every 
day…well, probably, I would 
say, not every day, but again 
depends on the consultant” 
 
“Usually a consultant does a 
ward round on the weekend, if 
it’s not a colorectal consultant 
on-call then they (colorectal 
consultants) sometimes come in 
on the weekends 
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9.5 Conclusion 
Feasibility has been demonstrated in this pilot study. It has been shown that a 
telephone based interview study using the described methodology for attempting to 
discern more subtle factors of surgical performance is feasible and on initial 
analysis that the methodology described, appears to reveal interesting and valuable 
data. It remains to be seen whether this method will translate to clinical outcome, 
however the depth of the information may be valuable to feedback to the 
participating units alone. In the next and final chapter the HiPer study will be 
continued and results of the full study will be reported as well as an attempt to 
correlate the study findings with site specific outcome data. 
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10.0 THE COLORECTAL HIPER PILOT PROGRAMME- 
ALL UNIT RESULTS 
10.1 Chapter overview 
In the previous chapter the development and piloting of the HiPer study protocol in 
colorectal cancer units was described. In this final empirical chapter the findings of 
the full study are correlated the study findings with outcome data from each unit. 
This is a two part chapter. In the first part, the full findings of the HiPer study are 
illustrated with the results of the telephone questionnaire study. In the second part 
of the chapter, these findings are then correlated to outcome data from each 
individual participating unit. A final appraisal of the process is then given. 
 
10.2 Introduction 
Having developed and piloted the HiPer telephone questionnaire, interview process 
and assessment of feasibility, this final study will bring together the completed 
findings of the study. This study attempts to bridge the gap between hard outcome 
data, such as those reported in routinely collected data using a variety of methods 
as described in earlier chapters (e.g outcome data from databases), with the 
questionnaire data from the HiPer study. The aim is to elucidate if any concordance 
can be demonstrated between the hard outcome data collected, and the novel 
methodology or whether HiPer may offer another facet to understanding what lies 
beneath routinely collected data. 
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10.3 Methods 
Whilst a detailed methodology of the HiPer feasibility study and process is given 
in chapter 9, the focus of this methodology will describe how the findings of the 
HiPer study were correlated with the outcome data held for each unit.  
For analysis of the questionnaire data, this was undertaken at multiple levels. 
Firstly the overall scores between interviewees at each institution will be compared 
against one another as well as against those of other units. A more detailed analysis 
on a per unit basis with more in-depth analysis will also be performed. The audio 
recordings have been re-analysed individually and in full length to create a one 
page pro-forma, per unit, that summarises the findings. Specific mention is made 
where scores have been less than (<4 ex 7) or greater than (>5 ex 7). Furthermore 
any aspect of unique care is highlighted. This section will be listed under ‘Results-
Questionnaire Study’. 
For linkage to the outcome data, a different methodology will be employed. For 
each participating unit, outcome data is held on a secure database by Dr Foster 
Intelligence. These data were specifically uploaded to the Dr Foster Intelligence 
server using a standard data submission form by individual units. These data then 
underwent a standardised ‘cleaning’ procedure by Dr. Foster Intelligence and risk-
adjustment (Bottle et al., 2013). The final available outcomes included - length of 
stay, risk-adjusted mortality and re-admission rates for all colorectal cancer 
operations from 2010-2012 (inclusive). This section will be listed under ‘Results-
HiPer linkage to outcome data’. 
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10.4 Results 
10.4.1 Demographics of participating units 
Initially, 18 units were invited to participate in the HiPer study. 9 units completed 
the full study, ethical and research board clearance. Data collection concluded in 
November 2012. These were geographically disparate units with 4 from England, 3 
from the United States of America and 2 from mainland Europe.  
 
10.4.2 Demographics of participating interviewees 
In all 29 interviews were undertaken. It was planned to contact 4 people from each 
unit giving a total of 36 interviews potentially possible. One unit had a clinician 
manager (who answered for both surgeon and manager) hence reducing the total 
number to 35. This gave an interviewee response rate of 83% (29/35) for the whole 
study. 
There were 9 surgeons interviewed (n=100%), 8 nurses (n=89%), 5 separate 
managers plus one clinician manager (n=67%) and 6 intensivists (n=67%) in total 
were interviewed. Parenthesis represents the response percentage from those 
available. 
 
10.4.3 Length of interviews 
In total, 966 minutes or just over 16 hours of interviews were conducted. On 
average, surgeons interviews lasted 40 minutes (range=19-52), nurses lasted 33 
minutes (range=20-46), intensivists lasted 41 minutes (range=28-51) and managers 
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lasted 17 minutes (range=13-21). Note - managers were only required to answer 
the final two questions, hence the shorter interview times. 
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Table 27- Table of all of the individual scores per unit 
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Results- Questionnaire Study 
Interviewee scores within units 
When the overall scores are compared, there is good correlation of average scores 
for the whole interview between the interviewees. This is demonstrated by a 
median score for surgeons of 4.81 (ex 7) and a median score for nurses of 4.44. 
The median scores for the intensivists was 4.81 and for the managers 5.58. The 
scores between the surgeons and nurses (in an individual unit) were statistically 
significant with a p-value of 0.023 - in other words, nurse and surgeons scores 
differed statistically. There were however no other statistically significant scores 
(i.e demonstrating significant differences between the scores) between the other 
interviewees (Table 28). 
Table 28- Table demonstrating the statistical significance of scores between the different interviewee 
types for the whole study 
Interviewee  Surgeon Nurse Intensivist Manager 
Surgeon  - p=0.023* p=0.528 p=0.101 
Nurse  p=0.023* - p=0.550 p=0.750 
Intensivist  p=0.528 p=0.550 - p=0.343 
Manager  p=0.101 p=0.750 p=0.343 - 
     
p-values between the interviewee groups, *denotes statistical significance 
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The clustered bar chart (Figure 16) below demonstrates the score for each question 
on the y-axis. The blue lines represent the surgeons’ scores and the green bars 
represent the corresponding nursing scores adjacent to the surgeons scores (Figure 
16). The numbers on the x-axis represent the unit number. Unit 5 only shows blue 
bars as this unit did not have a nurse respondent. This chart demonstrates how 
closely the nurse’s responses were to the surgeons for each question. In general the 
chart demonstrates how closely the nurses and surgeons scored on each individual 
question with very few scoring +/- 2 away from the other respondent for any 
individual question. Another way to demonstrate this is by formally assessing the 
correlation using a scatter plot. 
 
 
 
 
 
 
 
 
 
Figure 16- Clustered bar chart of the individual scores per question for all units (blue represents the 
surgeon’s scores and green represents the corresponding nurse’s score for the same question). 
Unit 1 Unit 2 Unit 3 Unit 4 Unit 5 Unit 6 Unit 7 Unit 8 Unit 9 
In
te
rv
ie
w
ee
 s
co
re
 
182 
 
When the correlation of 
the scores for each 
question is plotted on a 
scatter plot there is a good 
correlation between 
scores between the 
interviewees. In this case 
between the surgeons and 
the nurses. The scatterplot 
below shows all the 
scores of all the units for 
both surgeons and nurses. Initially there appears to be little correlation however 
when one unit is exaggerated by black diamond’s six major markings are seen. As 
there were 10 questions it would be expected to see 20 diamonds however due to 
the close correlation of the scores many of the scores overlap. Furthermore when a 
line of best fit is plotted, it is seen that there is a linear correlation. The strength of 
this correlation is good as demonstrated by an R
2
 value of 0.530 (Figure 17). 
 
Figure 17- Scatterplot of surgeons (s) scores versus 
nurses (n) scores for all questions 
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A similar finding is seen when the correlation is performed with surgeons and 
intensivists 
questionnaire data. A 
stronger correlation is 
seen with an R
2
 value 
of 0.608. To reiterate, 
what is displayed here 
are the individual 
scores for surgeons 
plotted against the 
scores of the 
intensivists. Again in 
the scatter plot below 
one unit (unit 9) has been selected and emphasised using black triangles. Here again the 
close correlation is seen for this individual unit on the back-drop of all the units. In 
other words this scatter plot shows that the best fit line demonstrates less variability 
than the previous plot. Hence loosely it can be said that surgeons and intensivists 
results are more closely predictable to one another than surgeons and nursing scores. 
Only 6 units are displayed as these where the ones were there were both respondents 
from surgeons and intensivists (Figure 18). 
 
The table below outlines and summarises the individual R
2
 values between the 
groups. The table shows that there is at least a moderate correlation between the 
respondents (Table 29Table 29). 
Figure 18- Scatterplot of surgeons (s) scores versus intensivists (i) 
scores for all HiPer questions highlighting unit 9 
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Table 29- Table of the correlation statistics between the interviewees 
Interviewee  Surgeon Nurse Intensivist Manager 
Surgeon  - R
2
=0.530 R
2
=0.608 R
2
=0.566 
Nurse  R
2
=0.530 - R
2
=0.395 R
2
=0.397 
Intensivist  R
2
=0.608 R
2
=0.395 - R
2
=0.588 
Manager  R
2
=0.566 R
2
=0.397 R
2
=0.588 - 
     
 
 
Per unit assessment 
To investigate any relationships further, assessment of the scores on a per unit level 
will be undertaken. Despite good correlation of scores between nurses and 
surgeons responses the scores were statistically significantly different, indicating a 
difference in the scores to the responses between the nurses and the surgeons. To 
explore this further the table below describes in which units the responses were 
divergent (Table 30). 
Table 30- Table demonstrating whether there were statistical differences between the surgeon and 
nursing scores on a per unit level 
Unit Surgeon-Nurse (p-
value) 
1 0.072 
2 0.390 
3 0.387 
4 0.029* 
5 - 
6 0.950 
7 0.592 
8 0.283 
9 0.453 
 
From the above table statistical differing responses are seen in unit 4, with the 
strongest statistical significance in unit 6. All the other groups showed no statistical 
differences in the responses. 
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Analysis of the results 
Formal thematic analysis is not appropriate as the interview was designed on the 
basis of several themes as identified from the systematic review. Thus the analysis 
of the responses will be performed using a novel approach. The questionnaire was 
designed with the standard of expected care would score 4.  Given the median 
scores were within this region for further analysis where care was rated to be 
specifically good i.e scores of >5 will be investigated further. Furthermore, for 
quality improvement and for less well performing units to identify areas of 
weakness analysis will also be performed where a response scored <4. This will be 
performed on a per unit basis. This has been undertaken by re-analysing all audio 
recordings and identifying the salient points that led to the scores being given. 
Notes in italics represent corroboratory views from other interviewees. 
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Unit 1 
 
Strengths- heavy research base has been demonstrably used to improve patient care 
Improvements- interim step-down unit from ITU 
 
  
UNIT 1 High score (6 or 7) Low score (1-3) 
  
Surgeon  Electronic patient records available from 
clinicians homes include MDT data 
 
Nuclear medicine and radiotherapists attend 
MDT  
 
All patients seen by cardiologist if >45yrs 
old. 
 
Pre-op. assessment week of surgery 
 
>70% laparoscopic rates all enrolled ERAS 
 
Surgery usually <2/52 from MDT date 
Managers viewed as money makers and 
savers 
 
Infrequent meetings with managers and 
clinicians 
Nurse   Little known about managerial input 
into day-day workings 
 
Managers helpful if goal doesn’t cost 
money 
Intensivist  Full time senior intensivist cover 
Dedicated radiology sessions for ITU 
Strong focus on patient centered outcome 
measures 
Key indicators (LOS/readmissions) audited 
monthly 
Very academic unit focusing on integrating 
research with clinical practice 
 
(Managers determine the resources 
available otherwise don’t really impact 
on day-day care) 
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Unit 2 
 
UNIT 2 High score (6 or 7) Low score (1-3) 
  
Surgeon  Patients can be pre-operatively assessed on 
day decision made/discussed to operate with 
patient 
 
Patient can usually be seen by adjuvant 
therapists on same visit 
 
Stoma counseling (as well as 
marking/teaching) is mandatory for all 
patient undergoing ostomies.  
 
Electronic patient records accessible from 
anywhere in world via VPN. 
 
Patients seen once daily by consultant-level 
and twice daily by rest of team including 
weekends. 
 
Dedicated discharge team review every 
patient 
 
Established dedicated provision for 
unplanned returns to theatre with agreed 
timescales 
 
Nurse  Rapid response team for ward patients 
 
Full electronic patient records 
 
 
Operating rooms not ideally placed 
from wards need to go through ‘a few 
buildings’ 
 
Can take over ten minutes to get ward 
patients to imaging 
Intensivist  Return to theatre protocol highlighted again 
 
No barriers to return to theatre/out of hours 
imaging 
 
Manager (Viewed roles as facilitating the service and 
physicians rather than goals based) 
 
(Gave example that by prospectively 
auditing results of patients that were 
developing pressure ulcers new specialist 
beds purchased have improved results) 
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Strengths- Intermediate care facility able to take patients medically fit for 
discharge but requiring recuperation. Nurses very familiar with ‘monthly 
dashboards’ with indicators- PE/DVT/patient satisfaction. Weekly ‘quality’ 
meeting with clinicians and managers. 
Improvements- no formal enhanced recovery pathway. Weekend theatre staffing 
of ‘other surgical teams’ may affect general surgery ‘emergency lists’. Intensivists 
not aware of ERP. Early warning scores on wards may be of benefit- not currently 
used. 
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Unit 3 
 
Strengths- Cohesive and regular meetings between clinical staff and managers 
with direct ability to enact change. Safety net of two separate non-clinical staff 
ensuring cancer patients receive treatment and do not ‘slip through nets’. Strong 
sense of team-work from booking clerks to clinicians and managers. 
Improvements- Look into collecting data on post-operative patient 
care/experience.  
  
UNIT 3 High score (6 or 7) Low score (1-3) 
  
Surgeon  Weekly meetings with managers and 
clinicians and nurses and surgeons to 
prioritise patients and theatre utilization to 
ensure optimal care and resource usage 
 
Nurse  (specialist cancer nurses always contactable 
by patients) 
 
Manager Role viewed as facilitating clinicians to 
manage their individual workload 
 
Heavy emphasis on adhering to national 
treatment targets and making sure operations 
(theatre lists/clinics/capacity) allows for 
these to be met 
 
 
Intensivist Dedicated care pathway adhered to for each 
patient incorporating ERP 
 
All major surgery and intensive care and 
wards within one block as well as radiology 
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Unit 4 
 
Strengths- Pre-operative assessments are undertaken by anaesthetic doctors, 
surgical doctors and a nurse. All structural factors well linked and within 
proximity. 
Improvements- Colorectal unit specific induction may standardise care at 
personnel change-over. Dedicated enhanced recovery nurse may benefit. “A bit 
more support from management would help”. 
  
UNIT 4 High score (6 or 7) Low score (1-3) 
  
Surgeon  All colorectal cancer seen by colorectal 
cancer nurse specialist 
 
Well established ERP program that is 
adhered to as standard 
 
Audio visual diary day-day shown to 
patients that explains all expected 
interventions e.g drains and what to expect 
day-day 
 
Prospective database held of all colorectal 
cancer patients holding >10years of patients 
Feel unable to engage trust to get 
individual surgeons outcome data 
 
“There are no specific drivers for 
quality from higher up” 
 
There is a feeling finances are main 
driver rather than quality of care 
 
 
Nurse    
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Unit 5 
 
Strengths- Lead clinician takes responsibility for ensuring all pre-operative 
investigations and co-ordinates the process from decision to discharge. Close 
follow-up of patients in first two years post-operatively (3 monthly in first year). 
Improvements- more formalised structure/process of discussing patients at 
MDT/tumour board meetings. Current presentation of patients to MDT meetings is 
ad hoc on physician desire to discuss. Consider introducing enhanced recovery 
program. Discharge planning could begin pre-operatively. More formalised 
induction for trainees and consideration of introduction of early warning scores on 
the wards. No discernible audits for quality measurement. The unit may benefit 
from surgeons being aided to understand their clinical outcome to guide patient 
care decisions in the future.  
  
UNIT 5 High score (6 or 7) Low score (1-3) 
  
Surgeon  All resources including outpatients, wards 
and theatres are in same area of hospital 
 
Ease of undertaking CT scanning on same 
day if required e.g. from outpatients to 
decide whether to admit or not 
 
Seen by Consultant level once to twice per 
day and usually by the head of service once 
per day 
 
No reduction in care from senior surgical 
clinicians out of hours 
 
(Feeling anaesthetic work-up could be 
better as are not routinely seen pre-
operatively) 
 
(No real meetings with managers 
regularly focusing on quality and 
outcome) 
Manager   
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Unit 6 
 
Strengths- There was a genuine sense that a cohesive team effort is likely to 
improve care. There is a current flux with respect to post-operative analgesia and 
UNIT 6 High score (6 or 7) Low score (1-3) 
  
Surgeon  
Main surgical wards adjacent to theatres, 
HDU/ITU and above emergency department 
 
2 dedicated colorectal nurse specialists for 
cancer, dedicated- stoma nurse, enhanced 
recovery and IBD nurses. 
 
Anaesthetists informally routinely review 
patients post-operatively on day 1. 
 
Monthly feedback of mortality data-
prospective 
 
Outsourcing of data to external company 
that gives individualized clinician reports. 
 
 
Nurse  
Patients seen daily at least once per day by 
consultant 
 
There are protocols in place for whom to 
escalate care to in case of EWS triggers 
 
Electronic patient board with real-time 
information on how the discharge planning 
process is progressing-e.g. flags if patients 
waiting to see OT/PT etc. 
 
Managers do visit wards regularly and 
attempt to familiarize how improvement 
initiatives can be adopted/rolled out 
 
Manager 
Close relationship with clinical staff and 
walk rounds to see ‘front line’ 
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attempts to improve the service within the anaesthetics department. There was a 
good use of early warning scores on the wards and amongst clinical teams. MDTs 
occur on Fridays thus all patients are verbally discussed for weekend handovers. 
Very strong focus on ensuring data collection is good and that clinical audits are 
acted upon where necessary. 
 
Improvements- More assistance with discharge planning pre-operatively (even if 
concerns highlighted before admission) patient discharges are frequently delayed. 
More input from radiologist at MDT meetings was needed. Interventional 
radiology service was deemed as being of limited availability out of hours.  
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Unit 7 
 
Strengths- Strong evidence basis for practice incorporating laparoscopy and 
enhanced recovery since 2005. Nurses engage with doctors as well to improve care 
e.g. removing patients’ catheters at certain times to regulate when patients should 
be reviewed for signs of retention as a result of nursing evidence. Many protocols 
standardise the post-operative care process. 
Improvements- operating surgeons do not necessarily review patients within 48 
hours due to commitments and workload. There is a departmental requirement that 
data is fed back to clinicians on their own outcome. 
UNIT 7 High score (6 or 7) Low score (1-3) 
  
Surgeon  
Patients discussed in the MDT are seen on 
the same day as the meeting. 
 
Medical oncologists, radiotherapists, 
specialist nurses as well present at MDTs 
 
Large focus on good data for national audit 
 
Dedicated colorectal team and surgeons 
(not standard of care in this country) 
 
 
Nurse  
Well-structured introduction of the EWS 
on the wards with agreed protocols of 
whom to call 
Very keen on accreditation with Joint 
Commission to verify quality of care 
provided 
 
Intensivists 
There is daily interaction with 
management level colleagues with more 
formalized meetings every two weeks 
 
Surgeons closely review patients when on 
the intensive care unit. 
Unsure of MDT meetings and make-up 
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Unit 8 
 
Strengths- Close collaboration with medical and anaesthetic teams in pre-
operative optimisation. Emergency surgery commitments do not impact on routine 
elective lists due to dedicated resident emergency surgeon. Strong emphasis on 
phoning patients post-operatively. Collation of PROMS and national databases to 
review delivery of care all kept prospectively.  
UNIT 8 High score (6 or 7) Low score (1-3) 
  
Surgeon  Electronic records of MDT outcome stored 
locally (not accessible remotely). 
 
Dedicated geriatrician assigned to colorectal 
service to pre-optimize patients including 
anaesthetic work-up 
 
Nurse led follow-up clinics and community 
stoma nurses review patients at home if 
necessary. 
 
 
 
Nurse  2 dedicated stenting lists in the week for 
colonic stents  
 
Close adherence to network guidelines and 
meeting cancer waiting time goals. 
 
GP informed of MDT decision within 24 
hours of any decisions being made 
 
Medical liaison pre-optimisation re-iterated 
with CPEX testing if needed 
 
Daily phone calls post discharge for 1 week 
by specialist nurses 
 
Manager Keen to benchmark care delivery with 
comparable units. 
 
Executive drive to improve patient 
experience and costs by reducing LOS and 
unplanned readmission where possible 
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Improvements- Senior opinions for out of hour’s radiology opinions required to 
support surgical clinicians. Organisational efforts required to assist patients 
discharge when medically fit due to social circumstances or for patients that were 
marginally coping at home pre-operatively. Introduction of early warning ward 
based systems. Emergency returns to theatre difficult due to other specialities 
requirements. Consideration of induction program for rotating clinical staff. Access 
to diagnostics (especially endoscopy) highlighted as an issue at present.  
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Unit 9 
 
UNIT 9 High score (6 or 7) Low score (1-3) 
  
Surgeon  
Very close integration facilities and wards 
facilitating patient care 
 
Important recommendations including MDT 
outcome recorded on an electronic patient 
record available to all clinicians 
 
All patients seen by anesthetist pre-
operatively 
 
Use of ileus reduction pharmaceuticals 
reducing length of stay demonstrably 
 
Senior surgeon will review own patients 
over weekend 
 
Weekly mortality and morbidity meetings 
Little informatics feedback to assist 
clinicians audit care delivery 
 
Ad-hoc managerial meetings 
 
Intensivist 
Good location of ITU/theatres and wards for 
patient transfer. 
Same senior clinician on the unit for whole 
week both surgical and intensive care 
Very focused on patient related outcomes 
and auditing results 
Weekly mortality and morbidity meetings 
re-iterated 
 
Nurse  
Cohesive staff and regular assigned team 
members ensures smooth efficiencies during 
patient care 
Surgeons round with ITU for patients on the 
units 
 
Manager 
Rigorous quality process dictated by 
national requirements 
Focus on patient satisfaction as well 
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Strengths- Consistent information from all clinicians due to agreed care pathways 
leads to patients receiving standardised care. There is a strong focus on auditing 
own results. 
Improvements- Consideration of formalised early warning ward based systems. 
More structured familiarisation of rotating clinical staff with care practices and 
escalation policies. Informal identification of complication rates and potential areas 
for clinical improvement- could be formalised with assistance of institution. 
Assisting clinicians to feedback relevant data to them they can use to improve 
service. 
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10.5 Summary of result findings of the HiPer questionnaire study 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 England United States Continental Europe 
H
ig
h
lig
h
ts
 
All cancer patients 
discussed at MDT 
meetings 
Electronic patient 
records facilitate 
decision making 
including remote 
access facilities 
Electronic patient 
records facilitate 
decision making 
including remote access 
facilities 
Specialist nurses dedicated 
to colorectal cancer 
patients 
Daily senior patient 
reviews including 
out of hours 
Strong sense of 
evidence based practice 
and keenness to take up 
novel processes 
Early warning scoring 
systems common place 
Synergistic working 
between clinicians 
and managers to 
facilitate clinicians 
roles 
 
No issues accessing out of hours radiology 
No barriers to returning patients to theatre if required 
 
P
o
ten
tial im
p
ro
v
em
en
t 
More assistance with 
discharging medically fit 
patients 
Formalize criteria 
for presenting 
patients at tumour 
board meetings 
 
No intermediate care 
facilities 
Consideration of 
implementing 
EWS/MEWS ward 
based systems 
 
 Disparate usage of 
Enhanced recovery 
programmes 
 
Consideration of formalized induction program for rotating clinical staff 
Requirement for senior radiology opinions out of hours 
More support required for clinicians to collect and analyse their own 
individual data 
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Specific highlights of the HiPer questionnaire study 
 
 One unit described that all patients undergoing major resections are shown 
a DVD diary of what to expect on a daily basis. This included the meaning 
of drains and expected milestones on a daily basis. 
 
 Other units described the facility to access electronic patient records 
remotely so they can keep track of patients even off site. 
 
 One unit is using alvimopan (Entereg) for post-operative ileus prevention 
and demonstrated a reduction in length of stay of 1 day on average for 
patients given this.  
 
 
 One unit reported contacting patients by telephone regularly after discharge 
for one week. This initiative was perceived to reduce length of stay. 
Patients that are deemed borderline to go home were sent home with the 
safety net of the regular contact.  
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Results-HiPer linkage to outcome data 
In this section of the results the scores from the interview studies will be linked to 
the actual outcome data for the participating units. As described in the methods, 
this is an exploratory study to analyse the data on records from these units 
submitted and analysed by Dr Foster Intelligence. The primary outcome that will 
be looked at is whether on a per unit basis the interview scores correlate with the 
outcome data held. The outcome end points that have been considered are risk-
adjusted mortality, length of stay and re-admission rates. 
 
When surgeon’s scores are correlated with the risk adjusted length of stay (Figure 19) 
an interesting result is demonstrated. There is a weak correlation with an R
2
 value of 
0.140. Furthermore 
this correlation 
follows that the 
higher the doctors 
questionnaire score, 
the lower the length 
of stay. 
 
Figure 19- Scatterplot of doctors scores and length of stay 
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Specifically when the intensivists scores were analysed their scores have a 
moderate correlation with the institutional colorectal cancer length of stay with an 
R
2 
value of 
0.330. 
Furthermore,  
(as in with the 
surgeons scores 
and length of 
stay) the higher 
the scores of the 
intensivists the 
shorter the 
length of stay 
(Figure 20). 
 
Again when the intensivists scores are analysed against the risk-adjusted mortality 
(Figure 21) rates for the individual units a stronger correlation with an R
2
 value of 
0.357 is seen. Again this 
correlation demonstrates 
that those scoring the 
highest scores on the 
questionnaire were in 
units associated with 
shorter mortality rates. 
Figure 20- Scatterplot of Intensivists scores against length of stay 
Figure 21- Scatterplot of intensivists scores with unit 
mortality 
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Nursing and managerial scores did not show any significant correlation with the 
outcome measures. Neither did surgeons or intensivists scores relate to any of the 
other outcome measures. 
 
Specific comparison with the questionnaire study 
Interestingly in the unit that described the use of ileus prevention pharmaceuticals, 
it was also one of the units with the shortest length of stay across the group. 
In the unit that routinely telephoned patients on discharge, it had one of the lowest 
lengths of stay (in comparable units in the same country) with an average 
readmission rate. 
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10.6 CONCLUSION 
This study has demonstrated that valuable information can be ascertained using the 
HiPer methodology. Specifically, correlation is seen between the different 
respondent groups in scores from the questionnaire study. When relating the 
questionnaire scores to the outcome data, surgeons and intensivists scores did 
correlate with some outcome measures. Whilst the numbers of data points are 
small the study has shown proof of concept and at some level correlation with 
some clinical outcome measures.  
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11.0 THESIS CONCLUSION 
11.1 Overview of findings from thesis chapters 
The primary aim of this thesis was to improve the understanding of what quality 
and high performance is in a surgical context and how it may be measured. This 
has increasing importance and relevance with the advent of open reporting of 
surgeon’s data together with a growing national interest. Colorectal cancer surgery 
and the peri-operative period were chosen to contextualise this assessment for 
clarity and definition. 
 
The introductory chapters reviewed the evolution of surgical quality appraisal 
originating from Codman to the contemporary open reporting of surgeons’ results. 
In chapter 1 the historic and contemporary appraisal of variability in outcome and 
how and when variability is warranted was summarised. However, when variability 
breaches certain control thresholds or parameters further investigation is required. 
Unlike some industries, standardisation of care is very difficult to undertake in 
healthcare. The example of the Shouldice clinic in Canada is testament to the 
benefit of such a system. However, patient selection limits such care-process 
benefits across a wider healthcare system where all comers need treatment. 
Specifically, national healthcare systems need to provide care for all rather than 
selected patients. Thus absolute standardisation of all care pathways seems an 
unlikely answer to optimising care- although it has its place where feasible. 
Chapter 2 studied paradigms of contemporary methods of performance 
measurement. This chapter appraised the Donabedian structure-process-outcome 
paradigm. Structural variables although easy to assess are the most difficult to 
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influence. Process measures are useful if their utilisation can be directly shown to 
benefit care. Finally, outcome measures were considered. These are, in the most 
part, conceptually the easiest to understand. However, outcome measures can be 
ambiguous in nature. For example, length of stay is an outcome measure may be 
influenced by factors external to the quality of the care given in the hospital (e.g. 
social services provisions and the ability to discharge patients). Lilford’s 
intervening variables introduce another aspect of quality appraisal that is typically 
very challenging to assess. Such intervening variables do however represent 
important factors, such as an institutions culture, cohesiveness and morale. Some 
appraisal of these factors is necessary when attempting to address the drivers of 
high quality care.  
Chapter 3 analysed the contemporary methods of appraising national surgical 
performance. The Hospital Episodes Statistics (HES) database is introduced. This 
dataset may, if correctly analysed, not only provide ‘standard’ outcome measures 
such as length of stay and mortality rates but also generate novel ones. Examples 
of novel measures include return to theatre and re-operation rates. Such additional 
novel measures may well strengthen the use of such routinely collected data. 
Clinical registries are introduced while appreciating that the depth of clinical data 
makes their use for performance appraisal a very rich source of information. 
However, not all surgical registries at the time of writing were compulsory and 
thus omission of even a small percentage of patients may grossly misinform 
population averages. For example, if a unit reported data on 95% of patients 
operated on, this headline figure may be appealing. However, in theory at least, the 
unreported 5% cohort of patients may have all the mortality and morbidity within 
it.  Patient perspective data were introduced by considering Patient reported 
outcome (PROM) data. The use of these has been shown to be more informative 
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than reliable as a robust tool for quality appraisal due to the selective nature of the 
reporting and the subjective nature of the results from analysing PROM data. 
Chapter 4 reviewed the literature to better understand what quality in colorectal 
surgery means. This review highlighted many potential markers of quality in 
colorectal surgery. It was demonstrated that the provision of a high quality 
colorectal surgical service demands consensus amongst many different groups. 
These include clinicians, patients, managers and societal stakeholders. Evidence-
based structural and process metrics, as well as clinical and patient reported 
outcomes, may all be used for quality appraisal. With so many potential usable 
factors to appraise quality in colorectal surgery, some appreciation of what is 
feasible on a national level is required going forwards. The role of public and 
internal reporting of performance in colorectal surgery as drivers of quality 
improvement require further research and take us to the next chapter. 
Chapter 5 assessed and compared a voluntary clinical colorectal registry- The 
National Bowel Cancer Audit Program (NBOCAP) outcomes with those derived 
from HES for the same patient cohorts. NBOCAP at the time was a voluntarily 
collected audit that at the time of analysis aimed to assessing peri-operative 
mortality and volumes following colorectal cancer resections. Surgeons were free 
to submit data to this registry or not. NBOCAP is a national clinical audit of bowel 
cancer run jointly by the Association of Coloproctology of Great Britain and 
Ireland and the National Clinical Audit Support Program (NCASP), part of the 
NHS Information Centre for health and social care. This dataset includes specific 
information on histological findings and pathology reports as well as adjuvant 
therapy administered. Trusts that submit data are able to compare their results with 
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the ‘national’ outcomes (pooled data from submitting Trusts) as correlated by 
NBOCAP annually. 
The aim of the study was to identify whether outcome of Trusts varied in 
submitting hospitals from non-submitting hospitals as compared to nationally held 
data (e.g. from HES) of the same units outcome for the same period. The aim being 
that if no outcome differences existed, clinical registries may be a valid appraisal 
of national outcome and performance and as discussed, may, be a richer source of 
information. The advantage of mining clinical registries lies in the fact that, for 
example, oncological measures represent important outcomes following cancer 
surgery. Specifically, oncological margins, lymph node yield and quality of the 
TME plane are predictors of successful surgical treatment (Stocchi et al., 2001, 
West et al., 2008b). Detailed clinical data and operative treatment intent are not 
available on large data sets such as HES, given its administrative origins. However, 
linkage of HES data with cancer registry data has been suggested as a means of 
overcoming the shortcomings associated with using HES alone (Garout et al., 
2008). The crux of the study was to identify whether voluntary reporting yielded 
the same outcome (namely peri-operative mortality) as nationally held data from 
HES on a per unit basis. 
In the comparison of Trusts that did and did not submit data voluntarily to the 
NBOCAP registry with outcome data from the HES database, postoperative 
mortality was higher in hospitals that did not submit data even after correction for 
case-mix differences. In the 2006–2007 NBOCAP report, only 44.3 per cent (70 of 
158) of relevant Trusts in England submitted data. In the present study, using 
2007–2008 data a significant increase in the number of Trusts submitting data was 
observed. Specifically, in the most recent NBOCAP report only 9.9 per cent of 
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Trusts (15 of 152) failed to submit any data. Despite the improvement, 23 per cent 
of Trusts still failed to submit more than 50 per cent of their colorectal cancer 
workload data. Garout and co-workers compared case volume and mortality for 
colorectal surgery between the NBOCAP and HES data sets and found that, at a 
national level, outcomes were comparable (Garout et al., 2008). However, when 
the data sets were compared at individual Trust level, significant inconsistencies 
were observed with respect to mortality, especially that following 
abdominoperineal excision (Garout et al., 2008). It must be noted that more 
recently submission to this audit has become almost mandatory with greater than 
95% of units submitting data. Furthermore these data have for the first time 
become publicly available on a per-surgeon level for elective bowel cancer 
resections as of 2013 and reporting on 90 day mortality. 
The present study was conceived on the basis that, if outcome differences exist 
between Trusts that report and those that do not, the status of voluntary reporting 
may need further evaluation. Following publication of the study submission has 
become mandatory and surgeons’ data are now individually and openly reported. 
Statistically significant differences between submitting groups were demonstrated 
for admission status and Charlson scores. Submitters operated on fewer 
emergencies and on patients with less co-morbidity. However, more socially 
deprived patients were operated on in submitting units. Although these could 
represent potential confounders to the crude observed differences in mortality rate, 
the adjusted analyses included the above factors as co-variables, and submitter 
status was identified as an independent predictor of increased relative risk of 
mortality amongst non-submitting Trusts. 
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Use of postoperative mortality as an outcome measure is appropriate only if it 
occurs frequently enough to discriminate statistically between high- and low-
performing units (Daley et al., 2001). Arguably, outcomes such as mortality in 
patients undergoing elective surgery for colorectal cancer should be fairly 
homogeneous across Trusts. The present data yielded small, but significant, 
differences in absolute mortality outcome between submitting and non-submitting 
institutions. The clinical significance of such a finding is uncertain. Whether this 
mortality difference belies genuine broader differences in quality of care is 
unknown and cannot be deduced from this study. 
Moreover, the present data relate to acute NHS hospital Trusts in England. Given 
that the average NHS Trust comprises more than two hospitals, Trust-level data 
potentially represent amalgamated outcomes. As such, outcome measurement from 
HES represents an oversimplification where opposing extreme outliers could 
theoretically negate one another within the same Trust. One might, however, 
expect this to occur indiscriminately within both submitting and non-submitting 
Trusts. 
The observed difference in mortality between submitting and non-submitting 
Trusts may reflect either a true difference, whereby data submission is a marker of 
genuine, strong clinical performance, or reporter bias, whereby better units tend to 
self-report because of their better outcomes (Marshall et al., 2003). Another 
observation that may reflect differing quality of surgical care between institutions 
is the use of minimal-access surgery. The reduced number of laparoscopic 
procedures performed in the non-submitting group perhaps suggests a greater 
reluctance to adopt newer technologies. However, this difference was small (18.0 
versus 15.0 per cent for submitters versus non-submitters) and may also be partly 
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explained by case-mix differences such as the relative excess in the non-submitting 
group of patients having emergency surgery, who may be unsuitable for 
laparoscopic interventions. 
In a study similar to the present investigation, Aylin et al. (Aylin et al., 2007b) 
compared outcomes between the HES data set and a voluntary reporting vascular 
clinical registry. In particular, they looked at caseload and outcome following 
vascular index operations including aortic abdominal aneurysm and infra-inguinal 
bypass. A principal study finding was that caseload was underrepresented in the 
vascular clinical registry in comparison with HES. The study has echoed such 
underreporting of cases in voluntary clinical registries. 
Although this was not a longitudinal study, the analysis of 1 years’ worth of data 
was chosen because the number of Trusts that submit data to NBOCAP differs year 
on year. Analysing a previous year’s audit would identify 23 further units that 
would be termed non-submitters. These units, however, in the subsequent year’s 
audit (the latest year available) would be termed submitters, and hence 
amalgamating 2 consecutive years may yield erroneous results. However, of the 15 
Trusts that submitted no data in the 2009 report, 13 would have been termed non-
submitters from the previous year’s report, as well, demonstrating that these units 
were consistent non-submitters. 
There has been much debate surrounding the interpretation of outcomes from 
voluntarily submitted data sets (Thompson et al., 2003). The Leapfrog Group is a 
collaboration of Fortune 500 companies and other large healthcare purchasers in 
the USA that, by publishing outcome data for individual hospitals, hopes to drive 
better outcomes from reporting (Leapfrog Group, 2009). Participation in the 
Leapfrog Group initiative and survey is voluntary. It has been suggested that the 
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driver of submitting data to ‘hospital comparison’ websites favours hospitals that 
are seen to have better outcomes, as they are more likely to attract patients and 
funding (Leonardi et al., 2007). The argument is that, possibly, only the best 
institutions would report their data voluntarily and thus the Leapfrog Group may 
not be discriminating between good and poor units but merely reflecting variability 
within good units. Ghaferi and co-workers (Ghaferi et al., 2009c) have 
demonstrated that high-quality hospitals are not overrepresented and that voluntary 
reporting to the Leapfrog survey does not result in a significant bias in outcomes. 
Evidence exists that reporting of clinical outcomes may lead to outcome 
improvement. In the 1990s, the risk-adjusted mortality rate for cardiac surgery 
decreased by 41 per cent in New York state following public reporting of 
surgeons’ outcomes (Hannan et al., 1994). Critics cite increased referrals of high-
risk patients to out-of-state surgeons following public reporting as one reason 
potentially underlying this outcome improvement, although this assertion has been 
challenged (Omoigui et al., 1996, Chassin et al., 1996). In contrast, there is 
evidence from the American College of Surgeons’ National Surgical Quality 
Improvement Program that has shown reproducible clinical outcome improvement 
through a mechanism of internal reporting of clinical outcomes, where hospital 
performance is compared with national averages from participating units 
(American College Surgeons, 2010). This process has been shown to improve 
clinical outcomes and reduce complication-associated costs (Dimick et al., 2004). 
Hibbard and colleagues demonstrated that open (public) reporting led not only to 
improvements in clinical outcomes, but also to institutions undertaking more 
quality improvement measures, and found that patients remembered the outcomes 
of such reports for up to 2 years after publication. Hospitals that had their results 
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publicly reported demonstrated the greatest benefits when compared with hospitals 
that undertook only private or no reporting of their outcomes (Hibbard et al., 
2005). 
Submitter status alone may not be the only consideration of relevance. Even within 
the submitting group there was a wide range of total caseload submission, with 
units submitting between 10 and 100 per cent of their total caseload. If anything 
but 100 per cent of cases is reported, it is conceivable that reporter bias may be 
introduced. A unit may submit 90 per cent of its data, retaining all the morbidity 
and mortality in the remaining 10 per cent – hence misreporting their true 
outcomes despite appearing to be a submitting unit. This may further strengthen 
the argument for mandatory submission (Almoudaris and Omar Faiz, 2010). This 
concept would not affect the present results as only submitter status was inferred 
from the NBOCAP report. Subsequently, all patients in that Trust were analysed 
from the HES database on a per Trust basis. Further work would entail analysing 
clinical outcomes for Trusts before and after submitter status changes. However, 
this would rely upon submitter status being maintained year on year, which has not 
always been the case. 
A minor but significant difference in mortality rates was observed between 
reporting and non-reporting Trusts to a clinical registry. The clinical significance 
of the difference observed in real terms appears small, but it may belie wider 
implications. If these findings reflect genuine outcome differences that arise 
between Trusts that do and do not voluntarily submit data to clinical registries, 
then, mandatory reporting to such registries may be a future consideration if the 
data are to be used nationally to benchmark performance and quality amongst 
surgical providers. 
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Given the result of the study, the use of clinical registries at present without full 
submission may not yield accurate inference of national performance and thus 
make identifying high performing units difficult. From a national perspective the 
HES dataset is left. Despite the potential shortcomings previously identified and 
reiterated in the subsequent section, it does capture national workload. One major 
limitation however is that to date no appraisal of complications has been possible 
from HES. In the review chapter it was identified that the management of 
complications is vital to establishing performance in colorectal surgery. Some 
appraisal of complication management needed to be considered. The following 
chapter attempted to ascertain whether any inference can be made from HES data 
of surgical complications and their subsequent management. 
 
Chapter 6 presented a study of national outcomes from all English NHS institutions 
undertaking colorectal resections for cancer with the aim of commenting upon 
complications and their management. The aim as previously described was that the 
HES dataset was chosen to appraise units due to the outcome differences observed 
from voluntarily collected outcome data from clinical registries when compared to 
HES. However the main shortcoming of HES data was that no ability to comment 
upon complications and management was to date possible from HES. This study 
attempted to see if complications and subsequent outcome was derivable from 
HES.    
In this chapter it was found that reoperation rates (for serious surgical 
complications) were similar among institutions classified within two groups- the 
high mortality quintile (HMQ) and the low mortality quintile (LMQ) groups- see 
Figure 22- Graph of overall mortality of the low mortality quintile (LMQ) units 
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versus the high mortality quintile (HMQ) units with reoperation and subsequent 
failure to rescue-surgical (FTR-S) rates. 
 .  
Figure 22- Graph of overall mortality of the low mortality quintile (LMQ) units versus the high 
mortality quintile (HMQ) units with reoperation and subsequent failure to rescue-surgical (FTR-S) rates 
 
Moreover the types of complication that resulted in reoperation were similar 
among units in these extreme quintiles, as was the time lag between the index 
operation and re-intervention. However, high- and low-mortality units were 
distinguished by their ability to rescue patients following reoperation, with low-
mortality units demonstrating an enhanced ability to prevent death in this context. 
This was termed Failure-to-rescue-surgical (FTR-S). 
The management of emergency patients who develop complications may involve 
some different care processes (and teams) than those employed for elective 
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patients. Nonetheless elective and emergency admissions were combined in the 
present study as this reflects actual practice. Elective colorectal resections are 
associated with low mortality but higher morbidity rates, whereas emergency 
resections have both high morbidity and mortality rates. Units that are inherently 
poor at managing complications are likely to be poor in dealing with both sets of 
patients, with the converse also being true. By combining these patients (elective 
and emergency) it was anticipated to demonstrate differences in FTR-S to a greater 
extent.  
The results suggest that FTR-S is a more precise marker of surgical complication 
management than the more general FTR measure, which may include previously 
acquired medical complications as per Silber’s initial description (Silber et al., 
1992). Application of FTR to patients experiencing surgical complications that 
necessitate a return to theatre represents a meaningful measure of clinical and 
organizational ability to manage serious complications successfully. Moreover it is 
derivable from currently available data sources.  
Most organizational structural factors did not appear to contribute to the observed 
differences in FTR-S rates between hospitals in the present study, although LMQ 
units had a greater number of HDU beds statistically-Table 31.  
 
 
 
 
217 
 
Table 31- Structural factors associated with low and high mortality quintile units 
Structural factor compared Lowest mortality 
quintile  
(median) 
Highest mortality 
quintile 
(median) 
p value 
Size-    
Average no. beds per unit 683.82 791.00 0.196 
    
Imaging^     
CT scanning 17.33 14.66 0.174 
Ultrasound scanning (non 
gynaecological) 27.54 28.90 
 
0.515 
Fluoroscopy 9.82 7.40 0.069 
    
Level I+II beds+    
ITU beds 1.32 1.05 0.425 
HDU beds 1.04 0.78 0.011* 
    
Theatres^ 2.30 2.20 0.233 
    
*indicates significant at the p<0.05 level 
^average number of scans requested per patient bed per year 
+average number of beds per in-patient bed multiplied by a factor of 100 
^average number of theatres per in-patient bed multiplied by a factorial of 100 
 
The significance of this finding is uncertain as greater resource availability could 
not be linked directly to greater HDU use among patients requiring reoperation. It 
is, however, likely that this compromised patient group would benefit from an 
HDU facility if it were available following re-intervention. Moreover, there is 
published evidence to suggest that managing patients in a surgical HDU leads to 
reduced morbidity, with a trend towards shorter length of hospital stay (Jones et al., 
1999). In addition, low patient to nurse ratios are associated with a decreased risk 
of death within 30 days of admission among surgical patients (Aiken et al., 2002). 
One might expect that hospitals with low-quality perioperative care processes 
might fail to recognize patient deterioration promptly, thereby leading to delayed 
re-intervention. No difference was found, however, in the time to return to theatre 
between the two extreme mortality quintiles in this series. Nor was a relationship 
observed between ability to rescue patients following reoperation and number of 
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reoperations. This suggests that institutional experience does not necessarily 
determine mortality risk in the event of a complication requiring reoperation.  
FTR-S reflects processes of care other than traditional markers of surgical quality. 
For example anastomotic leak rates may reflect a surgeon’s ability to perform a 
defunctioning procedure or anastomosis, case selection and technical factors. Such 
variables may also have an impact on mortality, but if a surgical complication 
arises further explanation is needed. An understanding of how well resourced units 
are, the intensity and seniority of ward care, access to radiology and other such 
factors is required. Mortality is not fully explained by standard metrics. For this 
reason FTR-S may explain why some units are able to prevent the conversion of 
serious morbidity to mortality. The rationale of a metric such as FTR-S is to 
understand why some institutions are better at preventing this conversion.  
Overall, the reoperation rates reported in the study are consistent with 
contemporary literature (Merkow et al., 2009b). Patients who underwent 
reoperation were approximately 1.7 times more likely to die in HMQ than in LMQ 
units. No explanatory differences were found between the timing of re-intervention 
or operative caseload at HMQ and LMQ hospitals. As such, perhaps FTR-S is 
more a reflection of the quality of care after reoperation, than a marker of the 
recognition of complications and timely intervention. 
In the study, the primary reason for return to theatre was generally in keeping with 
those reported in the literature, although direct comparisons are difficult owing to 
the discrepancies in definitions used between different studies. Morris and 
colleagues found that 21.1 per cent of patients who had surgery for colorectal 
cancer required re-intervention for wound complications, compared with 19.1 and 
20.6 per cent for LMQ and HMQ units in the present study. Patients who died in 
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this study were most likely to have required either formation of a stoma, further 
colorectal resections, abdominal washout or a combination of these procedures 
(Table 12). These are likely to represent procedures undertaken in the management 
of an anastomotic leak, although there are no data to support this assertion as there 
are no specific HES codes for anastomotic leak. In contrast, among patients who 
died, only 11.3 and 8.2 per cent (depending on quintile) had small bowel resection 
as a contributory re-operative procedure before death. Similarly, relatively small 
numbers underwent division of adhesions before eventual death.  
These results raise some interesting questions regarding the quality of surgical 
decision-making and postoperative care of surgical patients. Further work is 
necessary better to understand the processes that underlie these findings which are 
not discernible from information recorded in administrative databases. This would 
probably involve more qualitative methods to elucidate salient factors such as 
patterns of on-call cover, availability of and seniority of specialist colorectal 
surgeons, and access to interventional radiology.  
The reoperations selected in this study represent commonly occurring surgical 
morbidity following colorectal resection. This group of procedure codes defines a 
homogeneous group of patients who experience severe surgical complications 
demanding specialist expertise and intervention to enhance their chance of 
survival. A surgical provider’s ability to have an impact on this group is therefore a 
potentially important measure of service quality. FTR-S has four criteria that 
strengthen its use as a quality metric. First, use of a discrete event such as 
reoperation is not open to interpretation – a patient is either returned to the 
operating theatre or is not. Attempted addition of less discrete medical 
complications from administrative data sets, such as wound infection not requiring 
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intervention or chest infection, could perhaps render this metric a less reliable 
measure of quality due to the ambiguity of clinical definitions. Second, FTR-S is 
more likely to be based on discrete surgical complications derived from the index 
operation as opposed to medical conditions possibly present before surgery 
(although it is acknowledged that pre-existing conditions may make certain 
postoperative complications more likely). Third, given that reoperation is relatively 
uncommon, it should be feasible and practical to target these patients by using 
FTR-S primarily in quality improvement programmes. Finally, FTR-S may be 
derived from currently available routinely collected administrative data. 
Whilst the study compared the influence of operative re-intervention, it is known 
the non-operative re-interventions are equally important in complication 
management. However, due to the rarity of non-operative interventions (e.g. 
radiologically guided drains/endoscopy) on the colorectal HES dataset it was not 
possible to appraise this in the study. 
Given the importance of non-interventional procedures in complication 
management a further study was undertaken in upper gastrointestinal surgery to 
ascertain whether it is possible to derive the impact these non-interventional 
measures may have, in a setting where these interventions occur relatively more 
frequently.  
Chapter 7 thus was concerned with appraising the impact that non-interventional 
measures such as endoscopy and interventional radiology have on outcome, and, if 
this was derivable from HES. This study showed that low mortality units rescue 
patients after re-operations more frequently than high mortality units. Through 
analysis of non-operative re-interventions, and subsequent outcome, it has been 
possible to reflect on those aspects of surgical care that are encountered when 
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surgeons are faced with serious surgical complications in high and low mortality 
units. In those circumstances, surgeons have the option of watchful waiting +/- 
medical therapy, non-operative re-intervention (radiological drains / endoscopic 
therapy) or re-operation. What determines the treatment path taken is dependent 
upon many factors including the patient’s co-morbidity and physiological reserve 
and the available resources and experience. Ultimately, surgeons bear the 
responsibility on the final decision taken.  
Timely diagnosis of a major surgical complication and the performance and 
reliability of surgical teams are of vital importance. Supportive care such as 
intensive therapy units, physiotherapy and dietetic input may contribute towards 
the successful rescue of a patient. Similarly, structural factors such as out-of-hours 
radiology services and nurse-patient ratios may vary between LMU and HMU. 
Future studies are needed to examine the relationship between Failure to Rescue 
rates in different surgical units and the aforementioned factors that determine the 
treatment path chosen and the outcomes encountered.   
The modified Calvien-Dindo group III types of complications were chosen for 
several reasons see Table 16. Firstly, certain post-operative complications may be 
present on admission such as pneumonia or deep vein thrombosis that are not 
necessarily discernible from administrative databases and are subsequently 
discovered in the post-operative period. This would influence failure to rescue rates 
and whilst important, if they cannot be adjusted for, this would not faithfully 
reflect the actual care given by a unit. The interventions chosen are not open to 
variability of definition.  Certain post-operative complications such as respiratory 
tract infections and wound infections may be under-reported due to differences 
between unit’s definitions. Our study has clearly defined complications in that 
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patients were either returned to theatre or not, patients either underwent post-
operative endoscopies or drains or they did not. Finally, Clavien-Dindo grade III 
complications are arguably those that most likely represent surgical technical 
quality and anastomotic complications (Lee et al., 2011). In oesophogastic cancer 
surgery these are factors that have important implications peri-operatively for 
survival (Yoo et al., 2011, van der Schaaf et al., 2012). 
Re-operation following oesophago-gastric cancer surgery has been repeatedly 
associated with poor peri-operative outcomes in the literature. Such findings may 
influence contemporary decision making by surgeons faced with the difficulties of 
managing postoperative surgical complications. The implications of our study raise 
the question of whether more aggressive appropriate re-interventions can in fact 
confer better outcomes. Surgeons should interpret these findings within the context 
and limitations of their own units. Improved outcome from oesophago-gastric 
cancer surgery is more complex than just the volume-outcome relationship. 
Complication rates have repeatedly been shown to be equivalent between high and 
low mortality units in different specialities. Complication management is becoming 
more widely recognised as an important discriminator of surgical outcome. 
Surgeons should be supported with all the facilities and expertise necessary to 
ensure all facets of the care they deliver are optimal. Thus any appraisal of 
performance should also consider these elements. Thus this study has shown that 
where feasible, non-operative re-interventions are possible to derive from national 
datasets such as HES and can yield meaningful results. From this, the final data 
chapter attempts to bring together all the previous chapters. The chapter attempts to 
appraise all national colorectal cancer units on a panel of metrics for the first time. 
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Chapter 8 utilised HES in an attempt to appraise colorectal cancer units on a panel 
of metric and to examine the inter-relationship. It has been shown that serious 
surgical complication and re-operation metrics can be discerned from HES, 
however, what the following study highlights is the complexity associated with 
service quality appraisal in colorectal surgery. It questions the reliability of 
reporting individual metrics as universal markers of provider performance. The 
findings have important future implications regarding surgical benchmarking and 
quality improvement.  The study suggests that units are not necessarily substandard 
performers across a range of outcome metrics despite being high mortality outliers 
for postoperative mortality. Although the study findings suggest that high 30-day 
mortality outlier status does not necessarily reflect poor overall institutional 
performance, low 30-day mortality outlier status does seem to convey at least 
‘standard’ overall performance. When LMO units were considered across other 
outcome domains only two units performed worse than expected on two separate 
outcome measures.  
Dangers potentially arise when ‘good’ and ‘poor’ performance labels are assigned 
to units on the basis of outlier status using only single metric evaluation. Certainly, 
factors such as case-mix could underlie outlier status and are potentially not fully 
accounted for on routinely collected datasets. The complexity of performance 
appraisal is appreciated when Figure 13 and Figure 14 (Chapter 8) are considered 
together. From the figures unit C has a significantly lower than expected rate of 
returning patients to theatre despite HMO status. Unit C has a lower than expected 
FTR-S rate also. The latter markers (reoperation and FTR-S rates) potentially 
represent high performance when taken in isolation; however the unit is a known 
HMO. The latter unit’s high mortality rate is therefore not a consequence of 
surgical re-intervention. One explanation for this finding may however be that 
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patients at this institution are perhaps not being returned to theatre when it is 
indicated.  Alternatively, perhaps complex case-mix underlies this finding and 
patients are dying from non-surgically related causes postoperatively. When one 
however considers the outcome of units B and E, it can be observed that they both 
return patients to theatre more often than expected (Figure 13 in Chapter 8). Yet, 
these units are distinguished in Figure 14 where unit D lies within normal control 
limits whereas unit B lies above the upper 2
nd
 control limit for FTR-S. This 
suggests that the latter unit is not salvaging the patients it is returning to theatre. In 
contrast, in unit D the high mortality outlier status appears not to be due to failures 
in rescuing patients following reoperations. 
Finally, it may be argued that 30-day mortality performance measures should be 
applied only to patients undergoing elective surgery. The role of the surgeon’s 
ability, in terms of case selection and technical skills, must be influential in this 
context. In contrast, when both elective and non-elective admissions are considered 
together outcome is dictated also by surgical and intensive care teams’ propensity 
to operate and support such high risk patients. Risk-adjusted models for both 
scenarios i.e. elective only (Figure 23) and elective & non-elective resections 
combined (Figure 9) were also considered.  
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Figure 23- Funnel plot of elective mortality of the cohort with high mortality outliers highlighted for 
emergency-elective cases combined 
 
Units identified as HMO (i.e. > 3
rd
 s.d.) when considering both elective and 
emergency resections were also outliers (at the >2
nd
 s.d threshold) when elective 
resections are considered alone (see Figure 23). This implies that factors such as 
mode of admission, are perhaps not overwhelming determinants of performance 
ranking. Moreover, 30-day mortality at all five institutions exceeded 6% within the 
elective setting despite a national adjusted mean of 3.8%. As such, it appears 
reasonable to consider elective and emergency patients together in this form of 
analysis. Furthermore, this method offers appraisal of how a colorectal cancer 
population is treated by a given institution rather than just how patients that present 
via discrete elective or emergency channels may do. Institutional performance in 
colorectal surgery is to some extent denoted by minimising patient exposure to 
non-elective presentation and consequent intervention. As such, efforts such as 
bowel stenting are practised in many centres to avoid emergency operations. Some 
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clinicians consider this practice a marker of high quality service provision. 
Hospitals that successfully employ such procedures consequently operate on these 
patients electively but on an expedient basis. As such, examination of the elective 
workload in isolation may negatively bias their outcome despite arguably 
providing a better service than those that might just undertake an emergency 
operation. For this additional reason, inclusion of both elective and emergency 
colorectal cancer patient groups into perioperative mortality risk models appears 
warranted. 
The low correlation between outcomes corroborates that defining quality in 
colorectal surgery is complex (Almoudaris et al., 2010). This further calls into 
question how quality in colorectal surgery can be quantified and meaningfully 
benchmarked. The fact that little correlation exists between postoperative mortality 
and other metrics suggests that achieving a definition of quality is potentially 
subjective and dependent upon what aspects of quality are prioritised. This 
perspective depends upon the viewpoints of the stakeholders concerned. Moreover, 
the lack of such correlation demands that overarching decision-makers (surgical 
professional bodies, health policy makers, hospital managers) decide upon the 
importance and relevance that should be placed upon individual performance 
targets. Furthermore, extrapolating high performance from such metrics may be 
complicated by the perceptions of good outcome dependent upon the agenda and 
goals of individual stakeholders (Solomon et al., 2003). For example, mortality and 
the formation of a permanent stoma are likely to be of greater concern to more 
patients than length of stay. By contrast, bed stay and its associated cost is likely to 
have greater implications for managers and service providers. As a result, there is a 
need to rationalise which measures should be targeted for benchmarking and 
quality improvement purposes.  
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In terms of groups of measures, moderate correlation was identified in the current 
study between the mortality related measures (i.e. 30-day mortality, reoperation 
and FTR-S). This indicates that, on some level, these measures reflect similar 
aspects of clinical decision-making and care received. This questions whether it 
would be possible to use a single composite metric to describe multiple mortality-
related outcomes. Importantly, however, the funnel plots demonstrate very 
different performance levels amongst the five high mortality outlier institutions 
when FTR-S rates are considered, thereby suggesting that considerable institutional 
difference in prevention of death after re-operations occurs. 30-day mortality, 
despite risk adjustment, may offer little information regarding which deaths have 
arisen that could have potentially been avoided through re-intervention or better 
quality perioperative care. Appraisal of both metrics using funnel plots depicts 
differing apparent ‘poor performers’. It is therefore a subjective decision to 
determine which measure (or indeed both) should be used to reflect the desired 
goal.   
A clear understanding of the scope of each outcome metric used to reflect 
performance in colorectal surgery is required if these are to be openly reported 
(Thompson et al., 2010). Previous attempts to report variability in practice in 
colorectal surgery have been met with mixed response (Morris et al., 2008). This 
has mainly been due to the limited extrapolation that is possible when measures are 
heavily influenced by clinical factors (Faiz et al., 2009a) that are not represented 
fully in the datasets used for the analysis. It is therefore perhaps important that any 
audience is fully informed as to the complex relationships that surround these 
metrics should they be subject to open reporting. In addition, offering information 
on an institution’s performance across multiple outcome measures might allow 
transparency with regards to overall performance.   
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Thus the difficulties associated with appraising units on single, combined and 
multiple metrics for the identification of high performance are acknowledged. As 
described earlier, some appraisal of other factors, such as those identified by 
Lilford, need to be considered. However, such analysis is not possible from the 
interrogation of databases alone. What was needed was a novel approach to 
assessing how units perform day-day and attempt to correlate these findings with 
the clinical outcomes described above. A more in-depth per unit analysis and novel 
methodology is required to try and uncover what ‘lies beneath the numbers’. 
 
Chapter 9 describes such a novel approach to assessing a complex healthcare 
process. This methodology takes from previous work demonstrating that 
assessment of complex managerial strategies can be performed using similar 
techniques. This is the first attempt at such a study in healthcare, in a specific 
focused clinical setting. Central to the success of this methodology is the fact that 
the units are invited to give information about how and what they are doing. There 
is no mention of linkage to outcome or assessment of performance. The 
understanding is that by collection of such data in this fashion, collectively there 
will be areas of excellence that can be shared within the group. There appears to be 
concordance (at least in the question chosen for this feasibility study) with the 
responses between differing healthcare professionals. This will allow for 
retrospective appraisal of those units that score the highest to be re-assessed for 
how they are achieving their results. As the interviews are recorded the opportunity 
is also given for deeper analysis of responses if particular units are found to be 
units performing well both from the interviewers’ ratings and from potential future 
linkage to outcome. 
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This methodology is attractive for many reasons. Firstly, and perhaps of greatest 
importance, is the stepwise approach can be transposed onto any aspect/clinical 
healthcare setting. For example, using this methodology the same process can be 
undertaken to assess the performance of other healthcare settings, including those 
previously considered difficult to appraise. For example such a methodology 
would be transposable to assessing the performance of an acute medical service. 
Using the step-wise HiPer methodology and engagement with clinical units there is 
confidence that similar programmes could be undertaken. It is plausible that HiPer 
be used in any aspect of healthcare. For example, the interview schedule could 
practically be adapted for use in cardiac surgery or in the identification of high 
performing stroke units. This could be achieved by tailoring the interview schedule 
to the relevant speciality. With simple adaptation the methodology can be 
customised for both the institution and the interviewers as well. Given the relative 
flexibility this can be done with relative ease and minimal capital and personnel 
outlay.  Bespoke interview schedules can be created with clinical input and these 
can then be used to train the bank of interviewers. Once familiar with the schedule, 
the interviews would take place as usual without the need for any alterations or 
changes. 
A strength of the methodology is that at the heart of the process, all responses are 
blinded to the units performance. By de-coupling the HiPer methodology from the 
translation of any future analysis to outcome, the respondents are more likely to 
respond in more accurate/truthful ways. Specifically the interviewers are blinded to 
the unit’s performance on any measure. The units that are being assessed are also 
unaware of how they rate on any future linkage of measures, hence minimising 
reporting and reporter bias.  
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By allocating one rater to a unit this allows continuity of raters to engage with the 
participating units. Interviewers were allowed to disclose to interviewees the other 
member of the same unit being interviewed. This allowed both familiarity with the 
units and for the interviewers to state that they may not be as familiar with one 
aspect of care, as for example another of the future interviewers. This allowed the 
interviewees to respond from their own knowledge rather than guess what may 
happen in another domain. In contrast to selective reporting where the promotion 
of relationships and the creation of bonds between raters and the interviewees is 
thought to create a better environment for rating, this is a very subjective process 
and is not amenable to assessment or any form of reliability testing. However with 
the HiPer methodology, such familiarisation is not required and interviewees are 
considered equally by all raters. 
 
Central allocation of interviewers to units removes any biases that may occur at 
this stage. By instructing the interviewers to arrange mutually agreeable times with 
the interviewers via email this allows a familiarisation and some degree of rapport. 
Feedback from the interviewers demonstrated that even with this informal email 
communication the interviewees were all primed to the process and were very 
willing to participate. 
 
There was a minimal capital outlay cost involved in setting up HiPer. Interviewers 
and the interviewees gave up their time voluntarily. A small capital outlay was 
required to purchase telephone recording equipment which amounted to 
approximately £60 (90 US dollars). Another practical advantage was the flexibility 
of the programme. Once the interviewers were trained units were able to join the 
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programme without additional resources needed. Interviewers were allocated more 
units once subsequent units joined the programme.  
This pilot study has shown that the methodology is feasible to perform in practice. 
It has also shown that at some initial level the responses are rich and appear to 
show some consistency from the one question analysed. What remains to be seen is 
whether this methodology is able to correlate with the outcome measures from 
each unit. 
The final results chapter 10 analyses all the responses from the whole project in the 
participating units. Overall, of the participating units there was a good response 
rate of 83% of the interviewees approached. The high uptake from the surgeons 
(100%) may reflect the fact that the surgeons were the primary investigators in 
each unit. It is therefore understandable that all took part. Secondly the nurses were 
the next highest responders (89%) which again may reflect the close working 
relationships that this group of respondents would have with the surgeons. In terms 
of the intensivists and the managers, the lower response rates may reflect the fact 
that these interviewees are less likely to associate with the study and its aims and 
thus the lower response rates (67% for both) may reflect this. 
When the scores were analysed it was interesting to find that the only significant 
differences statistically were between the surgeons and the nurses (p=0.023). This 
may have more likely been a phenomenon of the small comparative samples sizes 
rather a true effect. On a per unit analysis that in fact there was only one unit (unit 
4) where statistically significant differences were identified from the surgeon-
nurses responses (Table 30) and this has had effect on the overall analysis. 
 
232 
 
Furthermore, this effect may have been due to the selection of the nurses. Whilst it 
was stipulated the nurse responder should be ward based and be involved in the 
day to day care of colorectal patients, one unit had a theatre nurse responder- this 
was unit 4. This may have affected the overall correlations as this nurse’s 
responses were less detailed and resultantly scored lower. With such small sample 
sizes this may underlie why the statistical difference was seen. However, when the 
scores of the surgeons and the nurses were correlated (negating in part any 
individual differences) with one another, a good correlation with an R
2
 value of 
0.530 is seen. This is corroborated by the fact only one unit had significant 
differences statistically (unit 4) between the responses and this was the 
aforementioned unit. A stronger correlation is observed between the intensivists 
score and the surgeons. This is unsurprising as the questionnaire itself is strongly 
weighted to peri-operative management of patients. This may reflect the fact that 
the doctors would perhaps be more aware of the findings and reflect these in their 
answers as opposed to the nursing staff that may be less aware of the nuisances of 
peri-operative care. 
When the audio recordings were re-analysed a wealth of information was 
discerned. Interestingly in the units where managers did not respond to the 
interviewers’ invitations to participate, these were also the units that received the 
lowest scores for the managerial questions from those remaining clinical 
interviewees who did respond. 
Despite the disparate units geographically and managerially there were however 
some generalizable findings, including the lack of senior radiological interpretation 
of out of hours scans, and the impact that social care and discharging patients out 
of hospital when medically fit pose as a common problem. Finally, most units 
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expressed the desire to have greater assistance with recording and understanding 
their own results, mainly from managers that would be useful in identifying areas 
that needed closer inspection for improving the service offered. At present the 
overall feeling was that there were few resources available to surgeons to assist 
them in understanding/collecting their own longitudinal data for quality 
improvement purposes. 
Interestingly, the units in the United States had the shortest length of stays and it is 
in these units that all units reported approximately 20% of their patients used 
‘interim care facilities’. These facilities allow patients who are medically fit for 
discharge to be transferred out to these units, thus reducing the mean length of stay 
for the base operating hospitals. 
In summary, this final study has shown that HiPer and the methodology is feasible 
to undertake. There is good correlation of results between respondents, especially 
the medically trained ones. There is also close correlation between clinician’s 
scores and nursing scores. The study has shown that a wealth of data not 
identifiable from routine analysis of databases is discernible from such an 
approach.  
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11.2 Methodological issues 
There has been much discussion concerning the limitations of using HES data for 
clinical outcome measurement (Dixon et al., 1998). Specifically, the HES database 
relies upon accurate coding. In most Trusts, non-clinical staff interpret the clinical 
case notes and transcribe these into relevant diagnostic and procedure codes 
(Commission, 2009). In the studies where HES has been used, inaccurate HES data 
entry at source could obviously misinform regarding the differences in outcomes 
observed.  
However, in a systematic review by Campbell and colleagues in 2001, median 
accuracy of HES coding varied between 91 and 69.5 per cent for diagnostic and 
operation codes respectively, with the overall conclusion that coding accuracy in 
HES data at the time was good (Campbell et al., 2001). A further limitation of the 
HES data set relates to its design rather than use. Tumour stage and curative intent 
cannot be derived from the data. The latter would have an expected impact on 
survival, but arguably not on 30-day in-hospital mortality and the peri-operative 
outcomes as measured in the studies where it has been used. 
Further limitations with regards to the administrative nature of HES data are 
particularly important with regards to rectal cancer. Specifically, without clinical 
information relating to tumour height, APER rates are difficult to interpret. The 
validity of this metric has been questioned when it is derived from HES data (Faiz 
et al., 2009a). Inclusion in this context is for comparative purposes rather than 
judgement of the appropriateness of the procedure. Similarly with re-operation 
rate, clinical corroboration of re-operative need would facilitate performance 
appraisal. Data reliability is central to performance appraisal and benchmarking. 
High overall accuracy of the HES dataset has been demonstrated in a number of 
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reviews (Burns et al., 2011a) (Campbell et al., 2001). Concerns still exist, however, 
that variation in coding accuracy between institutions renders performance 
benchmarking hazardous. 
Case-mix complexity rather than differences in underlying performance is always a 
potential confounder of any epidemiological study. Although adjustment was made 
for all available parameters, there may still have been differences in the case-mix, 
including stage of presentation. Any differences in case mix that persisted over the 
studies could in part account for the observed differences in outcome between 
units. Although individual surgeon case mix may vary significantly within 
institutions, it is unlikely that the case mix presenting to Trusts varies widely 
across England above and beyond the co-variates considered- apart from specialist 
referral centres. 
Surgeon experience cannot be derived from HES data. In the studies of 
complication management, complication rates were similar in low- and high-
mortality units, suggesting that surgeon seniority is a less important factor. 
Seniority may impact on leak rates, oncological outcome and complications 
attributable to surgical technique. However, it is questionable whether the outcome 
from established complications is influenced by the seniority of the operating 
surgeon. 
Finally, regarding the pilot qualitative telephone based questionnaire study, there 
are limitations to such an approach - where one interviewee in a unit does not 
participate this limits full analysis and comparisons due to the sample sizes 
involved. Although the process is very adaptable it is time consuming and requires 
flexibility by interviewers, especially when contacting non Greenwich Mean Time 
(GMT) based units. 
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11.3 Future Research 
Future work would look to combine the richest sources of information available for 
performance appraisal beyond the peri-operative period. For example, it would be 
potentially possible to combine the appraisal of units using HES data and link this 
to national cancer registry data to provide more longitudinal outcome assessment. 
In other words, introducing other metrics such as disease free survival and cancer 
recurrence rates on a per patient basis would be highly informative.  
Furthermore, creating a richer dataset by incorporating the data richness of clinical 
registries with the more comprehensive datasets such as HES would be potentially 
very useful. For example, if other co-variates such as neo-adjuvant therapy and 
exact cancer stage could be factored into subsequent analyses this would refine the 
outcome and performance results. This would also make inter-unit comparisons 
more meaningful. 
Not only should clinical registries be considered, but also the linkage with primary 
care data, for example using general practitioner data on the use of anti-platelets 
and anti-hypertensive medication, could also give richer future results. This could 
help in some way to address the previously mentioned potential limitations of 
addressing case-mix adequately in such national studies. 
With respect to the pilot study HiPer, future work could look at refining the 
methodology and focussing in more upon surgeon specific and nursing specific 
questions that are more likely to elicit focussed responses. In being limited to data 
governance factors that precluded performing the study in one country, such an 
approach may have given a more homogeneous data and responses. This in turn 
may have reflected in greater concordance with the hard outcome data. 
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11.4 Clinical Implications 
 
The clinical implications of this work have in part already been shown. The Royal 
College of Surgeons Clinical Effectiveness Unit cited the work undertaken on 
comparing units that did and did not submit data to NBOCAP (Almoudaris et al., 
2011a) as a driver for mandating submission at the national ACPGBI conference in 
2012. Specifically, however, many metrics can be used to evaluate surgical 
performance in the peri-operative period. Aside from the ‘standard’ metrics of risk-
adjusted mortality and length of stay that can be informative, more subtle markers 
need to be considered. Specifically when accounting for treatment intention (e.g. 
excluding those patients operated on for palliative purposes) the management of 
complications and the metric FTR-S seems to be an important one. Appraisal of 
how units manage their complications appears to be an important discerner of 
subsequent outcome and thus must be included in any appraisal of surgical 
performance. It has been shown that this metric is derivable from routinely 
collected administrative data. 
In addition, performance measurement is too simplistic when it considers one or 
two metrics alone.  Chapter 8- Benchmarking colorectal cancer resectional units in 
England on a panel of metrics using Hospital Episodes Statistics- demonstrated 
that appraising units using multiple metrics, using funnel plots, it is possible to 
elucidate the reasons behind the performance identified. Thus performance 
measurement should incorporate multiple metrics whilst adjusting for all possible 
co-variates and volume of cases. 
Finally and most subjectively, appraisal of more subtle factors such as a unit’s 
view of their management and how well all those that care for colorectal patients 
understand the roles and processes undertaken in caring for colorectal surgical 
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patients may also be reflected in better performance. However, it is still open to 
debate as to what method is best for achieving this. 
From what has been learnt, a high performing unit would be one with low risk-
adjusted peri-operative mortality, comparable complication rates to national 
averages, and with the ability to rescue patients following complications. The unit 
would display cohesiveness, with all members of the team understanding the goals 
of treatment and standardisation of care where possible. These units should also be 
supported with the necessary high dependency care and nursing staff as well as 
senior-level radiological opinions out of hours. 
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OVERALL CONCLUSION  
This thesis has explored whether high performing surgical units can be identified 
from available data sources. It has been found that the analysis of routinely 
collected and voluntarily submitted data can be enhanced with the mandating of 
submission and derivation of novel important metrics. Furthermore, the appraisal 
of other important factors needs to be complemented with a more qualitative 
approach as suggested by the HiPer pilot methodology. It has also been shown that 
such a methodology can in part relate to clinical outcome. 
In future, no single metric or approach is likely to identify high performing units, 
given the complexity of what defines such units. What is clear, however, is that a 
multi-modal approach as described should be employed in any future work to 
identify high performance in surgery. 
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APPENDIX 1 
 
Procedures                              OPCS-4 codes ICD-10 codes 
right and extended right 
hemicolectomies, 
transverse colectomy,  
 
left hemicolectomy, 
sigmoid colectomy, 
Hartmann’s procedure,  
 
subtotal colectomy, 
panproctocolectomy, 
total colectomy,  
 
anterior resection (AR),  
 
excision of rectum 
unspecified/other 
 
 abdominoperineal 
resection (APER) 
 
Laparoscopic procedures 
H06.1-H07.9 
 
H08.1-H08.9 
 
H09.1-H09.9 
H10.1-H10.9 
H33.5 
 
H29 
H04.1, H04.2, H04.3, H04.8, H04.9, 
H05.1, H05.2, H05.3, H05.8, H05.9 
 
H33.2, H33.3, H33.4, H33.6,  
 
H33.7, H33.8, H33.9,  
 
 
H33.1 
 
 
Y50.8,Y75, Y71.4 
 
 
C18-C21, C26 
 
(malignant colorectal codes) 
 
Appendix 1- OPCS and ICD-10 codes used in the analyses 
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Dear Colleague, 
 
We are contacting you as [name of GC contact] has informed us that you have 
kindly agreed to consider taking part in a telephone interview being undertaken as 
part of a quality improvement process that your hospital has signed up to. The 
overall project is called the High Performance in Surgery project (HiPer).  
The enclosed booklet explains the purpose of the study and what sort of questions 
will be asked. Participation is entirely voluntary and we greatly appreciate your time 
and contributions in advance. 
 
1. About HiPer 
The aim of the programme is to gain a better understanding of what defines a High 
Performing (HiPer) surgical unit, and furthermore how this is achieved. The essence 
is ‘looking behind the numbers’ that are so often used for benchmarking or available 
to the public. The objective is to use colorectal cancer surgery for this work with the 
overall aim of developing a framework for quality improvement that might be 
applied across other specialities. 
 
This specific piece of work has been established under the direction of Professor 
Charles Vincent and Omar Faiz using participant institutions from the Global 
Comparators project of Dr. Foster. This work is in collaboration with and co-funded 
by the National Institute of Health Research (UK). The programme of work was 
launched in October 2009. 
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2. About Your Contribution 
You have been asked to participate as an interviewee because of your role in 
colorectal surgery and that you care for such patients. Furthermore you have been 
specifically chosen as it was felt that you would be the most informative person to 
discuss how colorectal patients are cared for in your unit. 
 
3. What is expected of me? 
We ask for half an hour (30minutes) of your time to speak with one of our trained 
interviewers. The interviewers have a framework of questions they can ask but it is 
not a rigid interview by any means. We want to hear what you think is important 
about how your unit achieves its results. We would like to record the interviews so 
that we can re-visit them at a later time rather than need to contact you again. The 
interviews will take place from November 2011 and run into 2012. 
 
4. Who is involved and who are we interviewing? 
Through collaboration with Dr Foster, 10-12 Academic Health Science equivalent 
colorectal units from across the world have agreed to take part. We aim to 
interview 4 people (a surgeon, nurse, intensivist and surgical manager) from each 
hospital.  
 
5. So what is the MAIN AIM? 
The main aim is to understand from you, how your unit looks after colorectal 
patients undergoing surgical resections. There are no right or wrong answers. We 
simply want to know how things are done in your unit.  
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6. What sort of questions am I likely to be asked? 
The types of questions will vary from general questions like ‘how is the decision 
made that a patient needs an operation?’ to more specific questions like ‘what is 
the process of asking opinions from different teams/specialities both in and out of 
hours? What we really would like to hear is what actually happens in your unit. 
There will be specific questions depending upon whether you are a manager, nurse 
or doctor as well. 
 
7. Is the information confidential 
Everything you say is 100% confidential. No one outside the research team will ever 
have access to transcripts of the recordings or the interviews. Furthermore the 
recordings will be coded so neither your institution nor your name will be relatable 
to the recording. Only the research organiser will have this information stored in an 
encrypted fashion. 
 
8. So what happens next? 
If you agree to take part (and we hope you do) one of our panel of interviewers will 
contact you shortly. Please liaise with them via email to arrange a mutually 
beneficial time for you both to undertake the interview. They will know your name, 
hospital and job role. They will clarify this information with you at the beginning of 
the interview.  
 
 
9. How is the project co-ordinated? 
The project is co-ordinated by Alex Almoudaris (PhD Surgical Research fellow at the 
Centre for Patient Safety and Service quality) at Imperial College to whom all 
queries should be addressed- contact details below. 
We thank you for your commitment and contribution. 
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Further Information 
If you have any questions about the process or need further information on the 
purpose of the research please contact the research team by telephoning or 
emailing: 
Alex Almoudaris, Lead Researcher, 
+447970699242: email alex.almoudaris@imperial.ac.uk 
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